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Support and Training for the Evaluation of Programs (STEPs) at the University of Nebraska at 
Omaha is a leader in conducting evaluations of and needs assessments for social service 
programs and policies. The Nebraska Department of Health and Human Services (DHHS) Drug 
Overdose Prevention (DOP) program contracted with STEPs in the fall of 2019 to complete a 
needs assessment that included an identification and analysis of quality datasets, a survey of 
outpatient treatment providers, and focus groups with treatment providers. 
STEPs wishes to acknowledge the contributions of many organizations and 
professionals in the preparation of this report:
• The DOP staff, especially Davidson Wissing
• The Department of Behavioral Health data team
• The Nebraska Hospital Association




STEPs collaborated with the NE DHHS Drug Overdose Prevention (DOP) program to prepare a 
purpose statement for the overall project, as well as each of its contained sub-projects.
Report Purpose
Survey Report The purposes of the survey of treatment providers are to discover 
current patterns in clients’ drug use behaviors, and the unique needs of 
both substance users and treatment providers in the state of Nebraska.
Dataset Report The purpose of the dataset analysis is to provide data on who is 
receiving treatment, who is referring people to treatment, and people’s 
age at first use. The current report includes analysis of quality datasets 
that can be useful now and in future evaluations. 
Interview Report The purpose of the qualitative component of the Drug Use Behaviors 
project was to provide NE DHHS with rich and in-depth information 
regarding the professional experiences and needs of drug treatment 
providers in Nebraska. Through the perspectives and insights of drug 
treatment providers, NE DHHS can better understand the experiences 
and needs of people with substance use disorders in Nebraska. 
Final Report The purpose of the final report is to integrate the results of evaluation 
activities to provide a comprehensive summary, including 
recommendations for next steps in the study of individuals’ drug use 
behaviors in Nebraska.
The purpose of this needs assessment is to deepen DOP’s understanding of 
individuals’ drug use behaviors in Nebraska through the lens of treatment 
providers.
The results of this study will aid DOP in providing training and other resources to 
treatment centers, focusing prevention efforts, and informing their strategic plan 
and future studies. Ultimately, this study will support DOP’s efforts to reduce 
opioid-involved fatal and non-fatal overdoses in Nebraska.
Orientation to This Report
This Drug Use Behaviors: Final Report provides a comprehensive summary of the results of 
three individual reports: a survey report, dataset report, and interview report; it offers overall 
recommendations. Each of these reports, whether they represent primary or secondary data, 
quantitative or qualitative methods, can inform NE DHHS’ Drug Overdose Prevention (DOP) 
program in a unique way. Brought together, this use of multiple methods lends validity to the 
overall findings and recommendations.1
Primary Data
Primary data is collected directly from study participants by members of the research team to 
address a specific question or hypothesis. Primary data collection is often time consuming and 
expensive,2 especially with the challenge of achieving large and representative samples. 
As shown in the table below, the survey and interview reports represent primary data, as 
STEPs prepared the procedures and questions specifically for this project and collected data 










Survey Report √ (√) √
Dataset Report √ √
Interview Report √ √
Secondary Data
Secondary data is often publicly available and may be collected routinely through large ongoing 
surveillance systems.3 Since secondary data typically has a large sample size, it is likely more 
generalizable to an overall population. However, since secondary data was collected for other 
reasons and under other conditions than the current study, the data collection cannot be 
tailored to the current study. Also, data may be masked to protect confidentiality, which impacts 
usefulness for a rural state like Nebraska. 
Secondary data utilized in the dataset report came from 3,330 inpatient and 7,712 emergency 
department discharges from 2016 to 2019, as collected by the Nebraska Hospital Association; and 
from 53,605 discharges from substance use treatment facilities in Nebraska from 2013 to 2017, as 
collected in the Treatment Episodes Database-Discharge system. STEPs located, cleaned, and 
analyzed the data for the purposes of this project, but did not design the items nor collect the data.
(STEPs also worked with the NE DHHS Division of Behavioral Health Data Team to receive data 
from the Nebraska Risk and Protective Factor Student Survey from 2010 to 2018.)
INTRODUCTION
Important note: Substance use treatment providers include social 
workers, counselors, and case managers who provide therapy, crisis 
counseling, and case management and make referrals to medical providers 
for physical health needs. (Click this text box to navigate to a comparison between 
substance use treatment providers and medical providers.)
Orientation to This Report (cont.)
Qualitative Methods
Another important consideration in reading this report is the differentiation between 
quantitative and qualitative research methods. Qualitative research methods provide insight 
into the perceptions, values, and opinions of a target audience, with data typically collected 
through interviews and focus groups. This kind of open-ended inquiry method is essential for
exploring phenomena that do not fit neatly into predefined categories and offers voice to 
participants. Qualitative data can provide a rich source of insight and is often bulky and time 
consuming to code and analyze.4
The interview report represents qualitative methods like the survey report’s open-ended items. 
For both the survey and interview projects, STEPs worked with NE DHHS to develop open-
ended questions and posed them to treatment providers. In this way, participants could openly 
share their perceptions and experiences in providing substance use treatment. 
Quantitative Research
Quantitative research, in contrast, captures numerical data that can be statistically analyzed. 
Ideally, the sample size is large enough to allow results to be more reliably generalized to an 
overall population. By design, quantitative data is consistent and precise, but it may be fraught 




This final report includes individual reports in entirety, including key findings, methodology, 
results, and recommendations. (Click on the symbol to navigate to that section.)
The results of the survey, dataset, and interview reports are summarized here in response to 
six research questions:
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1. What are the characteristics and needs of individuals receiving substance use 
treatment in Nebraska?
2. What are current trends in substance use in Nebraska?
3. What are current trends and needs in substance abuse treatment in Nebraska?
4. What is needed for prevention of substance use and overdose in Nebraska?
5. What are expressed issues/needs specific to NE DHHS?
6. What are possible next steps for research and evaluation in Nebraska? 
1. What are the characteristics and needs of individuals receiving substance use 
treatment in Nebraska?
Across all report data sources, the majority of individuals
receiving substance use treatment in Nebraska initiate 
substance use at age 18 or younger. In survey results, just 
over half of providers indicated most of their clients first 
misused a substance at age 14 or younger with the 
overwhelming majority of providers indicating first use at the age of 18 years or younger. 
Similarly, in the Treatment Episodes Discharge Dataset (TEDS-D) data, one-third of clients 
reported the first use of their primary substance at age 14 or younger and two-thirds of clients 
reported the first use of their primary substance at age 17 or younger. 
While Nebraska Risk and Protective Factor Student Survey (NRPFSS) data suggests a relatively 
small percentage of youth reporting substance use, the percentage of those who reported using 
a substance in their lifetime increased as the students’ grade level increased. This suggests a 
need for primary prevention efforts targeting youth.
Individuals receiving 
treatment in their 30s and 
40s typically initiated 
substance use before age 18.
COMPREHENSIVE SUMMARY
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1. 2. What are current trends in substance use in Nebraska? 
Use of alcohol, methamphetamines, 
and drug combinations are the 
biggest concerns in Nebraska. 
Opioid misuse is growing.
COMPREHENSIVE SUMMARY
Comprehensive Summary (cont.)
While clients may have first used substances at a young age, the majority of those receiving 
treatment are older. According to Nebraska Hospital Association (NHA) data, the average age of 
inpatient patients with a diagnosis related to a substance was 41 years (median of 39) and the 
average age of emergency department patient with diagnoses related to a substance was 34 
(median of 31). Similarly, TEDS-D data indicates most clients were between the ages of 21 and 
49 years in 2013 to 2017. 
According to NRPFSS and NHA data, males and females tended to use substances at similar 
rates. However, according to the TEDS-D data, most clients receiving treatment identified as 
male. The gender gap between those using and those receiving treatment may be explained in 
part by interview responses indicating women disproportionately experience financial and 
childcare barriers to treatment.
The American Community Survey’s 2018 5-year race estimates for Nebraska found 5% of 
Nebraskans identified as Black or African American. However, according to TEDS-D, 9% of 
those in treatment for substance use identified as Black or African American. Similarly, 1% of 
Nebraskans identified as American Indian or Alaska Native but accounted for 8% of those in 
treatment as per TEDS-D data. These trends, along with NRPFSS findings that suggest a higher 
percentage of Alaska Native and American Indian youth report substance use, indicate a 
disproportionate impact on these communities.
Participants in the treatment provider interviews primarily defined the typical client by shared 
experiences, rather than demographic characteristics. Almost all of the participants explicitly 
identified a trauma history as something that all or most of their clients have in common. Most 
participants identified childhood trauma and several participants specified complex trauma, 
which refers to trauma that is chronic and long-term.
Depressants, including alcohol, are a primary concern 
in Nebraska. Outpatient providers indicated in their 
survey responses that over half of their clients 
presented for treatment related to alcohol, followed by 
marijuana and methamphetamines; TEDS-D data
validates this. Analysis of NHA data showed the most common substances related to emergency 
department and inpatient treatment diagnoses were depressants, stimulants, and narcotics. 
NHA data indicated 4% of inpatient and 11% of emergency department patients with 
substance-related diagnoses were associated with cannabis and cannabis derivatives. (Data on 
alcohol was not requested.) In the interviews, providers confirmed that while a growing 
number of individuals seek treatment for opioids, a much higher number of individuals seek 
treatment for methamphetamines, alcohol, and drug combinations.
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1. 3. What are current trends and needs in substance abuse treatment in Nebraska?
Criminal justice makes a high 




Providers indicated in their survey responses that about 25% of their clients in the past year 
had an opioid use disorder. Similarly, the NHA discharge data showed that 25% of inpatient 
patients and 21% of emergency room patients with substance-related diagnoses had diagnoses 
related to narcotics. In contrast, TEDS-D data from 2013 to 2017, showed that 4-5% of clients 
each year reported opioids as their primary substance. Participants interviewed in 2020 spoke 
of opioid abuse as a growing problem in Nebraska, which may account in part for this 
difference in primary and secondary data sources.
According to the NRPFSS, youth in Nebraska were more likely to report using prescription 
drugs at least once in their lifetime than any other substance; inhalants were the second most 
reported substance used.
Based on NHA and census data, Region 6 had a higher percentage of discharged patients (both 
inpatient and emergency room) with substance use disorders than expected based on 
population. Regions 3 and 4 had higher rates of stimulants related to inpatient treatment 
diagnosis compared to other regions where depressants are more common. Treatment 
providers did not indicate unique trends or needs for particular regions, although prevention 
services and treatment delivery methods need to be adapted to overcome geographic barriers.
Survey respondents indicated many of their clients were 
prompted to receive treatment through court-related 
incidents more than any other catalyst. Similarly, TEDS-D 
2017 data showed that 54% of patients were referred from 
courts, criminal justice entities, and DUI/DWIs. Of criminal justice referrals, the greatest 
percentage (27%) of criminal justice referrals came from law enforcement. 
On average, providers indicated in survey responses that this was the first treatment 
experience for 33% of their clients. 2017 TEDS-D data showed that twice as many clients 
(62%) had no prior treatment episodes, which had increased from 44% in 2013.
Interview participants discussed significant barriers to individuals’ ability to access substance 
abuse treatment, especially higher levels of care such as inpatient and residential treatment. In 
their survey responses, providers identified many systemic barriers to treatment and called for 
policy and funding changes to improve individuals’ ability to access needed treatment. 
Barriers to accessing treatment are not evenly distributed across populations. Clients who are 
already vulnerable or marginalized often experience more barriers and experience them more 
intensely. For example, some participants identified that women need residential treatment 
options that allow them to be with their children. Interviewees identified finances as an
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1. 4. What is needed for prevention of substance use and overdose in Nebraska?
Prevention strategies 
aimed at middle and high 




especially high burden for women seeking treatment. 
They also discussed specific barriers to accessing 
treatment for clients who are undocumented, 
experiencing homelessness, or are currently or were 
previously incarcerated. Barriers for vulnerable or 
marginalized populations are often unique and especially burdensome.
Interview participants explained that clients also need access to housing, healthcare, and 
employment for substance abuse treatment to be effective. They indicated that wraparound 
services would increase both access to and effectiveness of treatment.
While the survey results show that 75% of outpatient providers reported referring for some 
type of medication assisted treatment (MAT) for alcohol or opioid substance use disorder, 
TEDS-D data from 2013 to 2017 in Nebraska show that 2⎼5% of clients received planned MAT 
treatment for opioid substance use disorder. This discrepancy is rectified in part as providers 
shared in interviews a newer trend towards harm reduction and MAT approaches.
In their survey responses, treatment providers indicated their interest in training in these 
areas: co-occurring disorders, trauma-informed care, evidence-based practices, and drug use 
trends. In interviews, treatment providers expressed the need for training related to reducing 
overprescribing for prescribers; promoting safe use, raising awareness, and reducing stigma 
for communities; and naloxone access for treatment providers.
Women and vulnerable populations 
experience significant barriers to 
substance abuse treatment and 
have unique treatment needs.
All data sources for this report indicated primary prevention 
strategies aimed at middle and high school students, rather than 
other populations, are the most needed.
Responses to the survey and interviews clearly showed that 
treatment providers do not understand what NE DHHS is doing to prevent drug overdoses. 
Survey responses also showed that providers view NE DHHS’ public service announcements as 
the least helpful of all prevention tools. Treatment providers also do not view the Prescription 
Drug Monitoring Program (PDMP) to be as helpful as other potential strategies (perhaps, in 
part, because they are not prescribers and do not have reason to access or use PDMP). 
Providers indicated their belief that substance abuse treatment plays a significant role in 
overdose prevention. In interviews, participants discussed getting clients into treatment 
immediately after evaluations as a way of reducing overdoses.
10
1. 5. What were expressed issues/needs specific to NE DHHS?
Providers do not have a clear 
understanding of what NE 
DHHS does and does not do, 
and how DOP is differentiated 
from other DHHS programs.
COMPREHENSIVE SUMMARY
Comprehensive Summary (cont.)
Interview participants spoke of the need for policies to 
increase access to naloxone as crucial for overdose 
prevention; survey responses indicate that treatment 
providers do not uniformly value the use of naloxone as a helpful strategy for preventing fatal 
overdoses.
Many survey respondents were very concerned with stigma related to substance use. They 
viewed this stigma as a barrier to clients’ ability to seek and maintain sobriety. Interviewees 
shared their concern that when political leaders believe addiction is a choice, these leaders are 
less interested in funding and addressing substance abuse issues. They also expressed the need 
to decrease individuals’ fears of criminalization as crucial in preventing overdoses. Work is 
needed to reduce stigma and to humanize interventions for people with substance use 
disorders by providing an accurate understanding of who is at risk and the strengths they 
possess.   
Stigma remains a barrier to 
prevention and intervention. 
Interview participants and some providers’ responses to 
the open-ended survey items indicated they view Child and 
Family Services/Child Protective Services as synonymous 
with NE DHHS. A few providers alluded to clients’ lack of 
trust in DHHS due to the fear of NE DHHS taking away their 
children. 
Treatment providers shared the stigmatizing experiences of their clients from NE DHHS as well 
as from other organizations. 
Interview participants called on DOP to partner with stakeholders in drug overdose prevention. 
In addition, they suggested that DOP engage treatment providers in a way that honors their 
expertise, facilitates ongoing communication, and includes them as partners in this important 
work. 
1. 6. What are possible next steps for research and evaluation in Nebraska? 
Research participants are eager for this final report to be made available to them as evidence 
that their perspectives were represented and for use in advocating for changes in practice and 
policy. They also look forward to continued opportunity to offer their expertise and feedback in 




According to NHA, hospitals are currently not collecting data related to race and ethnicity 
consistently. The collection of this data should be encouraged as it would allow for an 
examination of health disparities and barriers to access to care based on race.
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OVERALL RECOMMENDATIONS
Overall Recommendations for Practice
STEPs offers the following overall recommendations for DOP’s consideration.
1. Provide training to policymakers, treatment providers, other community professionals, and 
the general public as outlined in the table below.
*Substance use treatment providers include social workers, counselors, and case managers 
who provide therapy, crisis counseling, and case management, and make referrals to medical 
providers for physical health needs. (A comparison between substance use treatment 
providers and medical providers can be found in the survey report.)
2. Focus prevention strategies toward middle and high school students.
3. Continue to expand access to naloxone. 
4. Reduce barriers to treatment through: 
a. Reviewing treatment programs’ geographic locations, eligibility criteria, payment options, 
and levels of care, and then addressing gaps.
b. Advocating for funding for treatment.
c. Ensuring availability of residential treatment, especially for women with children. 
5. Communicate the role of DOP as distinct from other NE DHHS programs.
6. Create, maintain, and make available a database of statewide resources to help treatment 
providers make appropriate referrals and connect clients to the needed level of treatment. 
The database should include items like levels of care, pay sources, and eligibility criteria. The 












Drug use trends √ √ √ √
Anti-oppressive and intersectional 
approaches
√ √ √
Treating co-occurring disorders 
(substance misuse and mental health)
√
Medication Assisted Treatment (MAT) √ √ √ √
How to access and use naloxone √ √ √
Reducing overprescribing √ √ 
(prescribers)
Reducing stigma √ √ √
13
OVERALL RECOMMENDATIONS
Overall Recommendations for Practice (cont.)
7. Regularly convene a roundtable with treatment providers (perhaps meeting quarterly) to 
increase collaboration and understanding of trends in substance use and treatment, and to 
inform effective prevention and treatment. 
8. Improve communication and collaboration among NE DHHS divisions and programs to 
maximize efficiency of existing programming and to share research data and results.  
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OVERALL RECOMMENDATIONS
Overall Recommendations for Evaluation and Research
Based on all work completed for the DOP program to date, STEPs offers the following 
evaluation and research recommendations to allow for continued use of evidence in planning 
and decision-making.
1. Create a logic model for the DOP program that shows activities, outcomes, and impacts. This 
logic model can inform DOP’s planning and work, enhance communication with 
stakeholders, and inform ongoing evaluation and research.   
2. Utilize primary, mixed methods research methods to assess the impact of the current 
pandemic on all areas of DOP’s work. 
3. Evaluate DOP’s prevention efforts to allow the use of data to inform prevention and outreach 
and to showcase efforts and outcomes to treatment providers and others. 
4. Conduct an environmental scan to identify and remedy gaps in drug treatment services. This 
scan could lead to an interactive resource assisting in linkages to care. Elements to assess 
and show include geographic locations of services, referral criteria, payment types, levels of 
care, and treatment modalities.
5. Seek the perspectives of prescribers, local health departments, and other community 
professionals, as well as other DHHS programs, on substance use trends, prevention, 
treatment access, and stigma.
6. Discover the effectiveness of mandated treatment compared to voluntary treatment in the 
professional literature and consider applicability to Nebraska. 
7. Continue to consider how to ethically collect data directly from individuals who may be 
using or misusing substances to learn about substance use trends, prevention, treatment 
access, and stigma. 
8. Evaluate the effectiveness of DOP’s consumer awareness campaigns, including the 
effectiveness and acceptability of public service announcements for specific populations.
9. Synthesize findings from STEPs’ 3 years of reporting to identify commonalities and reinforce 
trends and highest priorities in Nebraska.
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Drug Use Behaviors Background
Support and Training for the Evaluation 
of Programs (STEPs) at the University of 
Nebraska at Omaha is a leader in 
conducting evaluations of and needs 
assessments for social service programs 
and policies. The Nebraska Department 
of Health and Human Services (DHHS) 
Drug Overdose Program (DOP) 
contracted with STEPs in the fall of 2019 
to complete a needs assessment that 
included an identification and analysis of 
quality datasets, a survey of Licensed and 
Provisionally Licensed Alcohol and Drug 
Counselors (LADCs and PLADCs), and 
focus groups with treatment providers. 
STEPs developed the survey 
administered to treatment providers 
using valid and reliable measurement 
tools for the 2018-2019 DOP Drug Use 
Behaviors (DUB) report.1-6 STEPs 
administered the same survey, with slight 
changes in language, to Nebraska LADCs 
and PLADCs for the current needs 
assessment. The 2018-2019 DOP DUB 
report and other STEPs reports can be 
found on Digital Commons.
Purpose
The goal of this needs assessment is to deepen DOP’s understanding of individuals’ drug 
use behaviors in Nebraska through the lens of treatment providers.
The results of this study will aid DOP in providing training and other resources to treatment 
centers, focusing prevention efforts, and informing their strategic plan and future studies. 





Medication Assisted Treatment: Most providers indicated referring clients for at least one 
medication used in medication assisted treatment (MAT). Rural providers indicated 
providing referrals for MAT medication less often than urban providers. This may 
be due to a lack of access to MAT providers or a lower percentage of substance use 
disorders requiring MAT. Across regions, providers indicated clients need financial assistance 
to receive MAT more often than any other resource option.
Common Substances Used: Providers indicated alcohol is the most common substance used, 
followed by marijuana and methamphetamines. For polysubstance users, providers 
reported these three drugs are consistently paired with each other. Across multiple 
items, providers reported approximately 25% of their clients have an opioid use 
disorder. 
Adolescence: Most providers indicated adolescence as a key age during which many clients 
initiated substance use. Many providers also identified middle school and high 
school students as a population in need of prevention efforts, and indicated school-
based prevention programs as helpful. 
Systemic Barriers: Providers consistently identified insufficient health care coverage and 
wait times to access services as significant barriers to treatment. Providers shared 
that insufficient health care coverage prevents clients from accessing necessary 
services, especially MAT, detoxification, and chemical dependency evaluations. For 
those clients possessing resources and motivation to access treatment, providers indicated 
treatment wait lists can be a deterrent. These wait lists point to a gap in treatment availability 
and were the second most commonly indicated resource need. In addition, many providers 
reported clients’ access to substance use treatment is limited by the gap in support services, 
such as transportation, childcare, and housing.
Future Training Topics: Many providers indicated interest in receiving training on evidence-
based practices. Evidence-based practice topics specifically mentioned by providers 
included Cognitive Behavioral Therapy, Dialectical Behavior Therapy, standardized 
assessment instruments, and trauma-informed care.
Focused Efforts: While national trends call for efforts targeting women of child-bearing age, 
Native American populations, naloxone distribution, and prescription drug 
monitoring, providers indicated these efforts were among the least needed. It is 
unknown if providers do not find these current efforts helpful, or rather, if the need 
in the community has already been filled by existing programming. Providers indicated access 
to mental health treatment as a helpful prevention effort more often than any other effort. 
Regional Differences: Most providers, regardless of geographic area, indicated similar 
substance use trends and needs among their clients. Additionally, systemic barriers 





The purposes of the quantitative survey of treatment providers are to discover current 
patterns in clients’ drug use behaviors, and the unique needs of both substance users 
and treatment providers in the state of Nebraska.
Sample Description
Substance use treatment providers support individuals’ ability to understand and overcome 
their substance use disorder and maintain recovery.
Providers offer
• Intake, assessment, and treatment planning,
• Counseling for individuals, groups, and significant others,
• Case management and crisis intervention, and
• Referrals to medical providers and other professionals when appropriate.
Providers support
• Individuals with substance use, mental health, or co-occurring disorders, and
• Clients in self-help recovery groups, outpatient treatment, intensive outpatient treatment, 
residential or inpatient treatment, or continuing care.
Common Licenses Held by Providers
• Licensed or Provisionally Licensed Alcohol and Drug Counselor (LADC/PLADC)
• Licensed Mental Health Practitioner (LMHP)
• Licensed Independent Clinical Social Worker (LICSW)
Substance Use 
Treatment Providers Medical Providers
• Prescribe medication; 
provide medical care
• Includes doctors, 
psychiatrists, physicians 
assistants, nurses and nurse 
practitioners
• Refer to substance use 
treatment providers for 
mental and emotional 
health needs
Both
• Provide therapy, crisis 
counseling, and case 
management
• Include social workers, 
counselors, and case 
managers
• Refer to medical 
providers for physical 
health needs





• Collaborate with 
other professionals 







DHHS partnered with STEPs in the fall of 2019 to survey outpatient treatment providers, 
specifically Licensed Alcohol and Drug Counselors (LADCs) and Provisional Licensed Alcohol 
and Drug Counselors (PLADCs) in the state of Nebraska. On February 5, 2020, STEPs emailed a 




Of the 1,131 registered LADCs and PLADCs contacted, 213 
treatment providers responded to the survey for a 19% 
response rate. However, 20 providers answered only the 
demographic questions and identified the medications they refer for, 
but did not answer any additional questions. These 20 individuals 
were included in the analyses for medication referral, but were 
removed from all other analyses. Thus the sample size for the majority 
of this report equates to 193 substance use treatment providers.
Missing Data
Missing data was handled using pairwise deletion in which participant responses were included 
in analysis regardless of whether the participant responded to all 24 items. The number of 
participant responses for each item is shown by the “(n= )” in the item headings.
Comparisons
STEPs analyzed the responses to each survey item by provider region and by the provision of 
outpatient provision. STEPs indicated any notable differences, where applicable, in the analyses. 




The majority of providers (85%) 
indicated providing outpatient 
treatment. Since the survey did 
not specify any treatment types, 
no conclusions can be drawn 
regarding the type of service 
provided (if any) by the 
remaining 15% of respondents.
LADC/PLADC Quantitative Survey
Sample Description
Other Licenses or Certificates (n=193)
Most providers (72%) indicated holding other licenses or certificates in addition to their LADC 
or PLADC. Nearly half of providers (47%) indicated also being a Licensed Independent Mental 
Health Provider (LIMHP) and approximately one in four providers indicated being a Licensed or 
Provisionally Licensed Mental Health Provider (LMHP or PLMHP). Just over one in four (28%) 
providers indicated only holding a LADC or PLADC license. The percentages in the below 
graph do not sum to 100% because providers could indicate holding multiple other licenses or 
certificates. An acronym index can be found in Appendix C. 
Grouping Nebraska Regions
Providers responding to this survey indicated serving 66 of Nebraska’s 93 counties. In order to 
compare trends by similar geographic regions, STEPs grouped Nebraska counties according to 
four regions with similar characteristics, including public health region, size and location of 
cities and towns, relative population, and primary economic forces (i.e. agricultural v. other 
service industries). These four regions also allowed for sample sizes to be more comparable 
between regions for the purpose of statistical analyses. The four regions include:
1. Lancaster County;
2. Omaha Metro, including Douglas County and Sarpy County;
3. Rural East, including all eastern counties, with the exclusion of Lancaster County and Omaha 
Metro areas; and
4. West, including all counties west of Knox County.
A detailed table of all 93 counties according to these four regions is provided in Appendix D.
Location of Services
When asked to identify the county or counties in which they provide substance use 
treatment, 39 providers identified more than one county. In these cases, providers 
were categorized according to the following criteria.
• Providers who listed both rural and urban counties were categorized according to the urban 
county listed (e.g. “Hall County, Lancaster County” = Lancaster).
• If a provider listed both an Omaha Metro county and Lancaster County, they were categorized 
into the Omaha Metro region (e.g. “Douglas County, Lancaster County” = Omaha Metro). 
• Providers listing counties in multiple rural regions were categorized into the region in which 
they indicated serving more counties (e.g. “Scotts Bluff, Banner, Pierce” = West).
46%
27%
15% 9% 4% 3%
LIMHP LMHP or PLMHP LPC or PLPC LICSW LIPC CMSW or PCMSW
Other Licenses or Certificates Held by LADCs and PLADCs
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Providers by Region (n=189)
As indicated in the table below, the majority of providers served counties in the 
Omaha Metro (42%) and Lancaster regions (24%). Only 24 providers (13%) 
reported serving Western Nebraska.
Number of Providers by Region
Region Count Percentage
Omaha Metro 80 42%
Lancaster 45 24%
Rural East 40 21%
West 24 13%
Note: Providers could identify providing 





at least one urban county125
Providers by County (n=189)
The below map of Nebraska is divided into the four geographic regions used for analysis: West, 
Rural East, Omaha Metro, and Lancaster. The number in the middle of each county represents 
the number of providers who indicated serving that county. Those counties with a higher count 
of providers are shaded in a darker blue. Over 80 providers indicated serving Douglas County, 






Most outpatient providers (75%) referred for some type of MAT. 
Over half of providers (60%) indicated they referred for one or 
more medications used in MAT to treat both alcohol and opioid 
SUDs, whether that be naltrexone or a combination of other 
medications. 
Specifically, over half of providers (60%) referred clients for 
naltrexone, a medication indicated for use in both alcohol and 
opioid use disorders. Fewer providers referred for disulfiram 
(22%) or acamprosate (16%), medications used only for treatment 
of alcohol use disorder. Only 17 providers (12%) referred clients 
for methadone, a medication used in treating opioid use disorder.
Referral for Medications
For the remainder of this report, the survey question will be stated in full inside the box, 
followed by the relevant analysis. 
Referral for Medications (n=129)
MAT Referral by Outpatient Providers
In preliminary analyses, STEPs discovered that providers who indicated 
providing outpatient treatment had a higher rate of MAT referral than those who 
did NOT indicate providing outpatient treatment. Because the survey cannot 
assure that providers working in other settings are providing direct care (which would be the 
setting appropriate for medication referral), STEPs excluded non-outpatient providers from all 




Providers refer for MAT
MAT Medications by SUD Treated



















Opioid SUD Alcohol SUD
MAT Referral by Outpatient Providers
25% 
Providers do not refer 





Regional Differences in MAT Referral (n=129)
Slightly more providers from the West region indicated only referring for MAT medications used 
in treating alcohol use disorder (12%). Providers serving the West region were also less likely to 
referred for medications used in MAT for opioid use disorder (6%). However, STEPs noted little 
difference in substance use trends between regions.  
No MAT Medication Referrals by Region (n=115)
A greater percentage of outpatient providers serving Rural East counties indicated 
providing no referrals for MAT medications (42%). Approximately 20% of outpatient 
providers from the Omaha Metro, Lancaster, and West regions indicated providing no 
referrals for MAT medications. 










No MAT Medication Referrals by Region
85% 
Providers refer for psychiatric medication
Outpatient Psychiatric Medication Referral (n=129)
The majority of outpatient providers (85%) 
indicated providing referrals for psychiatric 
medication. However, 15% of outpatient 






























Substances Used by Clients (n=193)
Note: Providers responded to each substance independently. Thus, since many clients present 
with multiple substance use disorders, the cumulative percentage exceeded 100%.
Clients Needing Treatment by Substance 
Providers indicated over half of their clients presented for treatment related to 
alcohol (61%), followed by marijuana (58%), and methamphetamines (54%) in the 
past year. Providers from different regions indicated similar substance use trends.
Thinking about clients presenting for substance use over the past year, approximately what 
percentage of these clients have presented needing treatment for the use of:
Providers’ answers to the 
survey item, “Thinking 
about clients you treated 
for substance use over 
the past year, what have 
been their most common
primary drugs of choice?” 
closely mirrored answers 
to this item.
Clients with Opioid Use Disorder (n=180)
In the past year, what percentage of your clients have had an opioid use disorder (prescription 
pain relievers, fentanyl, heroin)?
On average, providers indicated 25% of their clients in 
the past year had an opioid use disorder. However, 
answers to this item ranged from 0% to 100%. 
Providers indicated little difference between the rates of opioid 
use disorder by region.
25%






Clients Who Are Polysubstance Dependent (n=184)
In the past year, what percentage of your clients were polysubstance dependent?
We would like to know about trends you are seeing in the use of multiple substances. For each 
of the primary substances listed below, please indicate the drug or drugs that you commonly 
see paired with each substance. 
On average, providers indicated 59% of their clients in the past 
year were polysubstance dependent. Providers’ responses to 
this item ranged from 0% to 100%. Providers indicated little 
difference in the rates of polysubstance dependence by region.
Most Common Polysubstance Drug Pairings (n=177)
59%
Clients who were 
polysubstance dependent
Primary Drug Pairings
Providers indicated alcohol, methamphetamines, and marijuana are the primary drugs being 
used, and are often paired with each other, particularly alcohol and marijuana. While providers 
reported a variety of other drugs also being paired with these three main drugs, other pairings 
were reported much less often.
Secondary Drug Pairings
Some providers indicated 
clients pair pain relievers and 
benzodiazepines with
alcohol or marijuana, and slightly 
less often with methamphetamines. 
Other providers indicated the pairing of 
antidepressants with alcohol.
Tertiary Drug Pairings
A few providers indicated those who use 
cocaine/crack and heroin as their primary
drug pair these with alcohol, methamphetamines,
and marijuana. 
Variation in Substance Pairings
For this item, 177 providers indicated a drug pairing for
at least one primary drug, but as few as 21 providers 
indicated a drug pairing for less common substances, such as 
inhalants. For those substances included in this visual, 
responses ranged from 168 providers indicating a drug paired with alcohol to 55 providers 
indicating a drug paired with heroin. Providers from different regions indicated little difference 
in substance use trends.











Just over half of providers indicated most of their 
clients first misused a substance at age 14 or 
younger. 1 in 10 providers from the Rural East 
and Omaha Metro regions indicated their clients 
first misused a substance at age 19 or older, 
compared to few providers from the Lancaster (2%) 
or the West regions (0%). Because opioid use can be 
related to a later age of first misuse, STEPs 
compared rates of opioid use between regions and 
found a slightly higher rate of prescription pain 
relievers being the first misused substance for 
clients in Rural East and Omaha Metro regions. The 
slightly elevated rate of prescription pain relievers 




Most Common Substance First Misused (n=191)
What is your perception of the most common substance that is first misused by your clients? 
What age do most clients you serve indicate as their first misuse?
Across regions, providers indicated alcohol (59%), 
followed by marijuana (33%), to be the most 
common substances first misused. However, 1 in 10 
providers serving the Rural East region 
indicated their clients used methamphetamines 
first, which is substantially more than those in any 
other region.















Age of First Misuse
the later age of first misuse in the Rural East and Omaha Metro region are consistent with 
findings from the 2018-2019 DOP DUB survey of inpatient facility administrators.7
LADC/PLADC Quantitative Survey
Providers indicated the top two most common reasons for their clients’ first 
substance misuse was peer pressure or their desire to “experiment/see what it’s 
like.” The top four answers were consistent with those of inpatient administrators 
from the 2018-2019 DOP DUB survey.7 However, inpatient administrators from the 2018-2019 
survey rated “parents or other family members encouraged them to” as the fifth most common 
reason for clients’ first misuse, compared to LADC and PLADC providers who indicated clients 





Most Common Reason for First Misuse (n=191)
In your opinion, what are the most common reasons for clients’ first substance misuse?
Response Options
• Pain relief
• Relax or relieve tension
• Experiment/see what it’s like
• Feel good/get high
• Help with sleep
• Help be alert or stay awake
• Help study or concentrate
• Help with feelings or emotions
• Help lose weight
• Parents or other family members encouraged them to







Relax or relieve tension
Feel good/get high
Help with feelings or emotions
Experiment/see what it’s like
Peers encouraged them to





Source of First Misuse (n=191)
77%
10% 5%







Source of First Misuse
Treatment Barriers and Facilitators
Reasons to Not Receive Treatment (n=191)
What are the most common reasons people do NOT receive treatment?
The full list of response options are provided in Appendix B.
45% 39%
16%
Intrinsic Reasons Access to
Treatment
Lack of Support
Reasons to Not Receive Treatment For this item, providers could choose 
multiple reasons from the list provided 
as to why clients did not seek treatment. 
Providers gave a collective total of 937 
responses (n=191). Of those 937 
responses, STEPs classified 45% as 
“intrinsic reasons,” 39% were deemed 
“access to treatment” issues, and 16% 
were classified as “lack of support.”
According to the majority of providers, 
clients most commonly obtained their 
first misused substance “from a friend 
or relative for free.” The top three 
answers for providers all related to the 
source being a friend or relative. These 
responses closely mirror those of 
inpatient administrators from the 2018-
2019 DOP DUB report.7 Providers’ 
answers differed little across regions.
Where did clients most commonly get the substance they first misused?
Response Options:
• From a doctor
• Stole from doctor’s office, clinic, 
hospital, or pharmacy 
• From friend or relative for free 
• Bought from friend or relative 
• Took from friend or relative without asking 
• Bought from drug dealer or other stranger 
• Some other way 
This breakdown resembles that of the inpatient administrators from the 2018-2019 DOP DUB 
survey.7 However, in the previous survey, 64% of the responses were categorized as “intrinsic 





Most providers indicated 
clients did not seek 
treatment due to intrinsic 
reasons. One in four responses related 
to clients not wanting treatment or not 
thinking they needed treatment (28%).
Access to Treatment
Nearly 40% of responses 
related to systemic 
barriers to accessing 
treatment. The most common systemic 
barrier related to individuals’ lack of 
health insurance. In contrast, the most 
common barriers reported by inpatient 
administrators from the 2018-2019 
survey7 involved the availability of 
treatment beds.
Lack of Support
Few providers reported a 
lack of support as a 
treatment barrier for people. 
The most common “lack of support” 
barrier indicated by providers related 








Unsure how to access
Do not think treatment
will help
Do not think they need
treatment


















Wait times too long





Providers indicated individuals did not 
seek treatment because they did not 
want treatment
LADC/PLADC Quantitative Survey
No Health Care Coverage
As indicated in the graph to 
the right, most providers 
from the Lancaster, West, and 
Omaha Metro regions indicated lacking 
health care coverage impeded 
individuals from receiving treatment. 
However, fewer providers in the Rural 
East indicated health care as a barrier.
Takes Too Long to Access Treatment 
While wait times were a 
significant factor for clients 
not receiving treatment in all 
areas, more providers in the Rural East 
indicated wait times as a notable 
barrier.
No Transportation/Too Far Away 
Approximately 40% of 
providers in the West, Rural 
East, and Lancaster regions 
indicated transportation as a barrier to 
accessing treatment, in contrast to only 




Treatment Barriers and Facilitators
Reasons for Not Receiving Treatment by Region (n=187)
Providers from the Lancaster region (n=44) most often indicated a lack of health care 
coverage as a treatment barrier (82%), followed by “do not think they need treatment” (70%). 
The majority of providers serving the West region (n=24) also indicated no health care 
coverage as a primary treatment barrier (75%), followed by “takes too long to access 
treatment” (71%). Rural East (n=39) providers most often identified “takes too long to access 
treatment” (82%) and “do not think they need treatment” (77%). Finally, providers from the 
Omaha Metro region (n=80) indicated a lack of health care coverage and the wait time for 
accessing treatment were barriers to treatment at the same rate (71%).
Providers indicated “no health care coverage” and “takes too long to access treatment” as 
treatment barriers more often than any other option. While “no transportation/too far away” 
was not the most common answer for any region, providers’ answers did vary significantly by 
region. The regional breakdown for these three notable barriers is shown in the graphs below. 
42% 41% 41%
24%
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Treatment Barriers and Facilitators
Information for DHHS (n=100)
When given an open-ended opportunity to reflect on the most important issues impacting their 
work, providers passionately described service gaps and access barriers. Four primary themes 
emerged from providers’ responses:
1. Description of clients and reduction in stigma
2. Gaps in services
3. Barriers to service, and
4. Relationships between gaps and barriers.
Many providers viewed this question as an opportunity to “set the record straight” 
regarding the humanity and personhood of their clients. At times, this message 
seemed to be pointedly addressed toward stigma they perceived coming from DHHS. 
Those provider responses categorized into Theme 1 varied little across region.
“They are not just another number or problem on [the DHHS] caseload.”
“[DHHS is] not willing to help clients.”
“[Clients] don’t trust DHHS.”
“Nobody is a monster!”
Providers articulated the many hardships and barriers their clients encounter, especially the 
rigorous and sometimes conflictual requirements required by multiple systems in which 
their clients are involved (i.e. child protective services, courts, public assistance, schools, etc.).
“They have an illness. Not every family looks the same. Do not set a standard for them to live up to 
that is not realistic.”
In light of these difficulties, many providers described practices they have found to be more 
effective than many current practices, which they described as being shame-inducing and 
stigmatizing. Those practices most often identified by providers as beneficial included:
• Partnering and establishing a relationship with the client,
• Reducing or eliminating waiting lists to ensure treatment is accessible when they are ready, 
• Meeting basic needs (i.e. housing, food, childcare) so clients are able to focus on treatment, 
and
• Carefully reconsidering mandated treatment, because it is often NOT helpful.
“There needs to be treatment available when clients are ready, waiting list [sic] are death 
sentences for some and cruel to the rest.”
“Court ordering treatment does not work [sic] The client needs to want this for themselves, or it is 
just a waste of state monies.”
What would you most like DHHS to know about your clients, and your work? 




Treatment Barriers and Facilitators
Information for DHHS (n=100)
Many providers pointed to systemic gaps which often acted as barriers to clients overcoming 
substance use disorders. While a few gaps appeared to be community specific, the most 
prominent gaps described seem to exist across the state, regardless of the provider’s location.
The most common gaps noted across the state included:
• Adequate provider reimbursement from public insurance,
“NE total Care and Wellcare suck in regards to everything this survey is seeking data on. Wellcare
and NTC pretend like they do, but we see their patients every day with nowhere else to go and are 
forced to turn them away. Despite repeatedly expressing concern [NTC and Wellcare] just don't 
care. This is probably how they make a 15% profit on their contracts with the state despite being 
capped at 3% by contract. NTC and Wellcare provide profit for their shareholders and limit patient 
access to care. That has been our only experience and persists to this day.”
“I quit taking Medicaid.”
• Necessary services are often not covered by insurance, most notably chemical dependency 
evaluations and detoxification,
• Services to assist with basic needs (i.e. transportation, childcare, housing),
• Funding for essential services that support substance use treatment (i.e. healthcare, case 
management, community outreach),
“Programs are less helpful when under funded. MAT is dangerous when not appropriately 
monitored.”
• Early prevention services (targeted at younger age groups),
• Training for professionals, especially related to trauma and co-occurring disorders, and
• Wait lists for substance use treatment services.
Additionally, providers articulated the region-specific gaps provided below.
Lancaster County:
• Services for adolescents
• Services for those involved in the criminal justice system
• Services for women and their children
What would you most like DHHS to know about your clients, and your work? 




Treatment Barriers and Facilitators
Information for DHHS (n=100)
Douglas and Sarpy County:
• Recent closure of facilities resulting in significant gaps in community services and certain 
levels of care
“It is important that Nebraska has multiple programs that offer all of the levels of care. There have 
been several good substance abuse programs that closed in the last few years and it has left gaps 
in resources.”
• Services for those involved in the criminal justice system
• Training on MAT
Rural East and West Counties:
• Availability of 12-step groups
• Availability of treatment for co-occurring disorders
• Availability of all levels of care
• Workforce capacity
“Funding is the number one concern, followed by capacity/access to treatment without extensive 
intake paperwork, followed by a provider workforce that understands co-occurring disorders.”
Often as a result of the gaps discussed, providers reported clients encounter significant barriers 
in accessing substance use treatment services, as well as services that support their recovery. 
Providers identified similar barriers across the state, regardless of geographic area. 
The most common barriers noted across the state include:
• Inability to pay/lack of insurance coverage,
“Most of our patients are trying very hard to complete treatment, but have financial issues in 
paying for treatment.”
• Extensive wait lists and lost opportunities for obtaining treatment,
“Long wait lists make it difficult to get people into treatment because substances [sic] users often 
change their mind as to if they want treatment or not.”
What would you most like DHHS to know about your clients, and your work? 
Theme 2: Gaps in services




Treatment Barriers and Facilitators
Information for DHHS (n=100)
• Unmet basic needs, especially housing, transportation, and childcare, and
“Often times the biggest barriers to someone getting the help they need is basic things like 
transportation, gas money, and insurance. We need more in-home providers as well.”
• Fear of losing custody of children.
“Losing their children often times pushes them into deeper substance use because they can't cope 
with the devastating loss of their kids.”
What would you most like DHHS to know about your clients, and your work? 
Theme 3: Barriers to service
“Transportation and childcare are two 
significant barriers when it comes to treatment. 
Many are on probation or involved with DHHS 
and expected to attend meetings, counseling, 
have a job, doing family counseling, UA daily, 
attend parenting class, practice family activities 
within the home and go to probation classes all 
within a 7 day week and there is limited means 
of transportation or they have kids who can not 
attend probation classes or therapy with them. 
Many can't drive or have no car. We often have 
kids waiting in the waiting room which is not 
always ideal and parents get distracted working 
in sessions. There are many single parent 
households so when they have an AA meeting or 
probation class, they rely on friends or family to 
watch the kids because daycares are closed in 
the evenings.”





Treatment Barriers and Facilitators
Information for DHHS (n=100)
While providers discussed both gaps in the community, as well as barriers encountered by 
clients, a clear connection between the two phenomena became apparent. 
What would you most like DHHS to know about your clients, and your work? 
Theme 4: Relationship between gaps and barriers
Gaps in the Community Barriers for Clients
Inadequate reimbursement to 
providers from public insurance 
Lack of quality providers for low-income 
individuals
“Medicaid reimbursement for treatment doesn't sustain programs and isn't financially 
viable if you want to keep qualified clinicians doing the hardest work.”
Lack of funding for services often not 
covered by insurance (i.e. 
detoxification, evaluations)
Since these services are often pre-
requisites for entering treatment, clients 
are not able to access treatment
“Omaha and Nebraska have disgracefully few treatment alternatives for the uninsured 
and almost no realistic detox options.”
Inadequate services to help meet 
basic needs, especially 
transportation, housing, and 
childcare
Inhibits clients’ ability to connect with, or 
fulfill the obligations of treatment
“The more support they are provided with the better the outcomes i.e....transportation 
child care housing energy assistance etc…”
Lack of funding to organizations for 
support services, such as healthcare, 
case management, and outreach
Inhibits clients’ ability to successfully 
complete treatment, transition to self-
sufficiency, or maintain sobriety
“My individuals are at most need for services in the community for when then [sic] 
transition to life.”
Few treatment facility options, with 
long wait lists
Missed opportunities for clients to seek 
treatment within the window of 
opportunity in their lives
“Our waitlist hovers around 2-6 months and often times those on the waitlist can’t wait 





Treatment Barriers and Facilitators
Catalysts for Treatment (n=191)
Which of these statements best describes how your clients were prompted to get treatment?
The full list of response options are provided in Appendix B.
For this item, providers could choose multiple reasons 
from the list provided as to why their clients seek 
treatment. Providers gave a collective 402 responses 
(n=191). Of those 402 responses, 66% were extrinsic 
reasons, categorized as “courts and other legal entities” 
(45%) and “other people” (21%), and 34% were 
categorized as “intrinsic reasons.” Inpatient 
administrators from the 2018-2019 DOP DUB survey7
also identified “courts” as the most common catalyst 
(53%), but identified “other people” as a catalyst for 

















181Ordered to get treatment
CourtsCourts and Other Legal Entities 
Providers indicated their 
clients were prompted to 
receive treatment due to 
court-related incidents more than 
any other catalyst. 
Intrinsic Reasons
Approximately one-third 
of provider responses 
indicated clients sought 
treatment due to intrinsic reasons. 
One-third of all providers indicated 
their clients decided to get treatment 
on their own.
Other People
Nearly half of providers 
indicated their clients 
sought treatment because 












Treatment Barriers and Facilitators
Catalyst for Treatment by Region (n=187)
In each region, providers most often indicated “they were ordered to get treatment” as the 
reason someone sought treatment, followed by “they got treatment because someone else 





















West (n=24) Rural East
(n=39)
Someone Else Thought They Should
Ordered to Get Treatment 
Most providers from all 
regions indicated clients 
sought treatment due to 
having been ordered to get treatment, 
but this was especially pronounced in 
the western half of the state.
Someone Else Thought They Should 
Over twice as many 
Lancaster providers as 
West and Rural East 
providers indicated the influence of 
others was a significant reason their 
clients sought treatment. 
First Treatment Experience (n=187)
On average, providers indicated it was 
the first treatment experience for 33% 
of their clients in the past year.
Providers from the West region 
indicated a slightly higher percentage 
of their clients in the past year had 
never had a previous treatment 
experience (40%).
First treatment experience 
for one in three clients
For what percentage of your clients in the past year was this their first treatment experience 
EVER?














Helpful Prevention Efforts (n=189)
Most Often Indicated Prevention Efforts
Nearly half of providers (44%) indicated prevention programs targeting middle school students 
are helpful primary prevention efforts and just over half indicated addiction screening at 
primary (medical) care facilities is a helpful secondary prevention effort (52%). Nearly 80% of 
providers indicated increased access to mental health treatment is an effective prevention 
effort. Access to mental health treatment was the most often indicated effort in the 
tertiary prevention category and overall. Little difference existed in the answers of providers 
from different regions.
Least Often Indicated Prevention Efforts
Only 18 providers (9%) indicated public service announcements are helpful primary 
prevention efforts. In the secondary and tertiary prevention categories, use of the Prescription 
Drug Monitoring Program and naloxone training and access were the strategies identified least 
often as being helpful.  This is similar to  findings from the previous 2018-2019 DOP-DUB 
report7, in which inpatient administrators indicated MAT treatment and increased access/ 
training on naloxone as helpful the least often.  Few inpatient administrators from the 2018-
2019 report indicated public service announcements as a helpful prevention effort and only 
slightly more indicated use of the Prescription Drug Monitoring Program as a helpful 
prevention effort.
The full chart of prevention efforts ranked from most often indicated to least often indicated is 
provided in Appendix E.
Most Often Indicated Prevention Efforts by Category
Primary Prevention Secondary Prevention Tertiary Prevention
School-based substance use 
prevention programs for 
middle school students
Addiction screening at 
primary care facilities
Increased access to mental 
health treatment
Least Often Indicated Prevention Efforts by Category
Primary Prevention Secondary Prevention Tertiary Prevention
Public service 
announcements and media 
campaigns for general public
Use of Prescription Drug 
Monitoring Program before 
prescribing controlled 
substances
Increased access to and 
training on naloxone
LADC/PLADC Quantitative Survey
In your opinion, what prevention efforts are most helpful?
The full list of response options are provided in Appendix B.
40
SURVEY FINDINGS
In your opinion, what populations are most in need of additional substance use prevention 
efforts? 
The full list of response options are provided in Appendix B.
Prevention Efforts
Populations in Need of Prevention (n=189)
Most Often Indicated Populations 
Providers most often indicated 
middle school students and 
high school students (62%), 
and young adults (61%) as populations 
in need of prevention efforts, closely 
followed by individuals with mental 
illness (58%). These answers are 
consistent with providers’ rating of 
helpful prevention efforts in the previous 
item. Little difference existed in the 
answers of providers from different 
regions.
Least Often Indicated Populations 
Approximately 10% of providers 
indicated American Indians/Alaska 
Natives and women of child-bearing age 
are in need of prevention efforts. Only 
2% of providers indicated 
Latinos/Latinas are a population in need 
of prevention efforts.
The full chart of populations ranked from 
the most often indicated to least often 
indicated is provided in Appendix F.
Populations in Need of Prevention
1. Middle school and high school 
students
2. Young adults (18-25 years)




11. American Indians/Alaska Natives
12. Women of child-bearing age
13. Latinos/Latinas
Note: The darker shade of blue 
indicates more providers identified this 











Training and Resources for Treatment Providers
Future Training (n=188)
Which of the below topics would be useful for future training for yourself or other staff at your 
facility? 
Most Often Indicated Training Topics
Over half of providers 
indicated interest in trainings 
on co-occurring disorders 
(56%) and evidence-based treatments 
(54%). Nearly 40% of providers 
indicated interest in trauma-informed 
care and alternative pain management 
strategies for future training topics. Little 
difference existed in the answers of 
providers from different regions.
Least Often Indicated Training Topics
Providers indicated little interest in 
trainings related to naloxone use, PDMP, 
or treatment for methamphetamine 
addiction.
The full chart of future training topics 
ranked from most often indicated to least 




2. Evidence-based treatments 
3. Alternative pain management 
strategies
4. Trauma informed care
…
…
14. Naloxone use and/or 
administration
15. Prescription Drug Monitoring 
Program
16. Treatment for methamphetamine 
addiction
Note: The darker shade of blue 
indicates providers identified interest 










Training and Resources for Treatment Providers
Additional Resources for Clients (n=178)
What additional resources do your clients need?
Most Often Indicated Resources
Approximately half of 
providers indicated financial 
assistance for MAT and a 
reduction in wait time to access 
treatment, both systematic barriers to 
treatment, are additional resources 
needed by clients. Nearly half of 
providers also indicated community 
outreach as a necessary resource for 
clients. Little difference existed in the 
answers of providers from different 
regions.
Least Often Indicated Resources
Consistent with the rating of prevention 
efforts and future training topics, few 
providers indicated clients need 
additional naloxone kits. Providers who 
indicated “other” specified a range of 
answers including transportation 
assistance, assistance with children while 
in treatment, and aftercare services.
The full chart of additional resource 
options ranked from most often indicated 
to least often indicated is provided in 
Appendix H.
Additional Resources
1. Financial assistance for MAT









Note: The darker shade of blue 
indicates providers identified a need 










Training and Resources for Treatment Providers
Helpful Training Received (n=126)
What training have you received that has been helpful to your work? 
Provider responses to this item generally mirror the same types of training they 
indicated they would find helpful in the future (see previous item). 
1. Evidence-Based Practices (other than trauma)
Providers most often indicated that training on evidence-based practices (EBPs) was 
helpful. This was especially true in the Rural East region, as over half of responses in 
this category were from this region.
EBPs specifically mentioned in this category were those NOT focused on trauma, including 
Cognitive Behavior Therapy, Dialectical Behavior Therapy and training on the following 
standardized assessment instruments:
• Adverse Childhood Experiences Scale 
• Addiction Severity Index 
• Comprehensive Adolescent Severity Index 
• Substance Abuse Subtle Screening inventory
2. Trauma-Informed Care (including EBPs)
Many respondents also expressed that trainings on trauma informed care have been 
helpful. These included both evidence-based models (i.e. Eye Movement 
Desensitization and Reprocessing, Trauma-Focused Cognitive Behavioral Therapy), as 
well as general trauma trainings and treatment strategies. 
3. Substance Use Trends
Many respondents reported training on substance use trends was useful. This was especially 
true for those in the Omaha Metro region, and those in the West region, with approximately 
20% of responses coming from each of those regions.
4. Biological Components of Addiction
Several respondents indicated that trainings related to biological aspects of 
addiction have been most helpful. These include training on MAT, 
psychopharmacology, and neurobiology of addiction.
5. Co-Occurring Disorders
Several respondents indicated trainings related to co-occurring disorders have been helpful. 
However, significantly more providers indicated this type of training would be helpful in 
the future (see previous item), than has already been helpful (current item). This may 




Training and Resources for Treatment Providers
Helpful Training Received (n=126)
6. General Training
Many respondents indicated that, in general, participating in training is helpful. More general 
trainings mentioned by providers included trainings that provide continuing education credit, 
trainings from the American Society of Addiction Medicine, post-secondary training, and clinical 
experience. 
7. Other
Other trainings that providers indicated as helpful included topics such as harm reduction 
strategies, wholistic or alternative treatments, and special populations or issues such as 
domestic violence, sexual addiction, criminal justice, and cultural competency. 





Clarify DHHS’ Role: Some providers’ responses to the open-ended survey items indicated 
they may see Child Protective Services as synonymous with DHHS. A few providers alluded to 
clients’ lack of trust in DHHS due to the fear of DHHS taking away their children. Clarifying the 
role of DHHS in supporting the provision of substance use treatment may resolve 
misconceptions currently held by providers.
Work to Reduce Stigma: Many providers were most concerned with stigma from 
organizations, including DHHS, targeted at their clients. They viewed this stigma as a barrier 
to their clients’ ability to seek and maintain sobriety. Additional investigation into the sources 
and communication of this stigma may be warranted. 
Evaluate Current DHHS Efforts: In the 2018-2019 DOP DUB report7, approximately half of 
inpatient administrators indicated naloxone as a helpful prevention effort, but few LADC and 
PLADC providers found naloxone helpful. Additionally, few LADC and PLADC viewed strategies 
such as the Prescription Drug Monitoring Program and Public Service Announcements helpful 
prevention tools. Instead, providers overwhelmingly indicated prevention strategies aimed at 
middle and high school students, rather than other populations, are the most helpful. 
Additional investigation into the delivery and effectiveness of current DHHS efforts may be 
useful to inform outreach and prevention strategies.
Meet Training Needs: Training needs across the state include topics such as co-occurring 
disorders, trauma-informed care, EBPs, and drug use trends. Any offerings DHHS may be able 
to offer in these areas would be helpful for providers.
Target Efforts: Most results indicate that trends and needs for both clients and providers are 
consistent across the state. While delivery methods may need to be adapted to overcome 
geographic barriers, it does not appear as if DHHS needs to target most efforts to a particular 
area or region. 
Alleviate Treatment Barriers: Providers noted many systemic barriers to treatment, both 
from the perspective of providers and clients. Any policy or funding changes that can be made 
to alleviate these barriers would greatly increase the ability of clients to access treatment.
Share Findings: Share the findings of this needs assessment with DHHS staff, community 
members, providers, and other stakeholders. Sharing the results of the survey with those who 
provided input can make participants feel heard and valued, increasing their likelihood of 
participation in future evaluation efforts. By sharing information from this report with the 
Nebraska community, DHHS can be recognized for their efforts to better understand drug use 
behaviors and the needs of treatment providers. Publishing this needs assessment may also 
contribute to the knowledge base of substance use treatment for providers, public 
administrators, and researchers, leading to an increase in evidence-informed decision making 






STEPs emailed the anonymous survey link to each registered LADC and PLADC 
licensed by DHHS. Some individuals did not provide an email or the email provided 
was no longer active. In addition, emails may have inadvertently been sent to a spam 
folder or recipients may not have recognized the sender and ignored the email. STEPs used 
multiple rounds of follow-up emails to increase the response rate. Due to these technological 
barriers, some providers were not reached which negatively impacted the response rate.
2. Incomplete Survey Responses
A total of 213 providers started the survey, but only 193 respondents completed 
both the demographic items, the medication referral item, and at least one other 
item. These 20 individuals may have unintentionally only completed the first page of 
items on the survey, without realizing there were items beyond the first page. Other providers 
only completed some of the survey items (as noted by total n for each survey item). 
3. Disproportionate Representation from Urban Counties
Nearly twice as many urban providers responded as rural providers. Only 24 
providers serving the West responded, compared to 40 providers serving the Rural 
East. As such, we know less about drug use behaviors and provider needs in the 
West region. Additionally, nearly twice as many Omaha Metro providers responded 
as Lancaster providers. 
4. Limited Scope of Services Sampled
This report only included those individuals who hold a LADC or PLADC in Nebraska. 
The perspectives of those individuals who provide services to this population, but do 
not hold a LADC or PLADC may differ substantially from this sample.
5. Provider Self-Report
The measurement instrument asked providers to reflect on their perceptions of 
their clients’ experiences and behaviors. This may be less valid than asking 
individual clients directly about their own experiences. 
6. Aggregate Data
This survey asked providers to estimate the percentage of clients they see engaging 
in various drug use behaviors in aggregate form. This does not reflect an actual 
count of providers referring clients for MAT or clients engaging in a specific drug use 
behavior. From this survey, it is unknown at which rate clients actually engage in particular 
behaviors.
7. COVID-19
STEPs obtained survey data prior to the outbreak of COVID-19 in Nebraska. 
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Drug Use Behaviors Background
Support and Training for the Evaluation of Programs (STEPs) at the University of Nebraska at 
Omaha is a leader in conducting evaluations of and needs assessments for social service 
programs and policies. The Nebraska Department of Health and Human Services (DHHS) Drug 
Overdose Program (DOP) contracted with STEPs in the fall of 2019 to complete a needs 
assessment that included an identification and analysis of quality datasets, a survey of 
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The goal of this needs assessment is to deepen DOP’s understanding of individuals’ drug 
use behaviors in Nebraska through the lens of treatment providers.
The results of this study will aid DOP in providing training and other resources to treatment 
centers, focusing prevention efforts, and informing their strategic plan and future studies. 
Ultimately, this study will support DOP’s efforts to reduce opioid-involved fatal and non-fatal 
overdoses in Nebraska.




The purpose of the dataset analysis is to provide data on who is receiving treatment, who 
is referring people to treatment, and people’s age at first use. The current report includes 
analysis of quality datasets that can be useful now and in future evaluations. 
Five Recommended Substance Use Indicators





attributable to drugs 





Drug or alcohol 
dependence or 
abuse in the last 
year
Prevalence of 





Below is an outline of the activities STEPs completed to identify, select, and analyze quality 
secondary datasets.
STEPs conducted a review of the literature on health indicators, which found consistent 
references to documents published by the Centers for Disease Control and Prevention 
(CDC), the Substance Abuse and Mental Health Services Administration (SAMHSA), and 
the Council of State and Territorial Epidemiologists (CSTE). STEPs weighed the 
prevalence of established substance use indicators when determining the usefulness 
and quality of datasets. The CSTE’s Recommended CSTE Surveillance Indicators for 
Substance Abuse and Mental Health identified 10 substance use indicators 
recommended for use in surveillance systems (2019). Of these 10 indicators, 5 are 
included in the table below, and target non-alcohol drug use.
2
STEPs identified 12 secondary datasets relevant to substance use. Utilizing the 
substance use indicator literature and the CDC’s “Guidelines for Evaluating Public 
Health Surveillance Systems,” STEPs selected the following datasets to be used over 
time: the Nebraska Risk and Protective Factor Student Survey (NRPFSS), Nebraska 
Hospital Association Hospital Discharge Data (HDD), and Treatment Episode Data Set 
(TEDS). For more information on indicators and dataset selection, please see the Drug 
Overdose Prevention Dataset Methodology report in Appendix I.
3
Following the identification of datasets, STEPs downloaded publicly available data and 
requested non-public data from appropriate sources including the Nebraska Hospital 
Association and the Nebraska DHHS Division of Behavioral Health (DBH). STEPs 
analyzed available data in Microsoft Excel and SPSS.*




Nebraska Hospital Association (NHA) Inpatient Discharges
The Nebraska Hospital Association (NHA) provided STEPs inpatient hospital discharge data for 
cases with diagnoses related to substance use. The dataset included information on patients’ 
diagnosis, sex, age, home address, hospital location, and length of stay. The dataset included 
3,330 discharges between January 1, 2016 and September 30, 2019.
What are the characteristics of individuals discharged from inpatient treatment with 
diagnoses related to substance use?
Patient Sex (n=3,329)
For the entire population of Nebraska in 2018 (n=1,904,760), 50% of 
the population was female (n=954,850) and 50% was male 
(n=949,910) (United States Census Bureau, 2018). The percentage of 
female and male patients discharged from inpatient treatment related 
to substance abuse was similar with 52% (n=1,733) patients 






Patient Age in Years (n=3,330)
Patient ages ranged from 0 to 97 years with an 
average age 41 years (SD=17) and a median 
age of 39 years.
Patient Length of Stay in Days (n=3,330)
Patients’ lengths of stay ranged from 1 to 45 
days with an average length of 4 days (SD=4) 
and a median length of 2 days.
Substance Related to Patient Diagnosis  (n=3,330)
The most common substances related to the inpatient diagnoses were depressants (33%, 
n=1,105) followed by stimulants (26%, n=861) and narcotics (25%, n=841). 130 patients 
(4%) did not have a substance specified in their diagnosis code. Instead, their diagnoses were 
related to substance use complicating pregnancy, childbirth, or puerperium.



















What are the characteristics of individuals discharged from inpatient treatment with 
diagnoses related to substance use? (cont.)
Behavioral 
Health Region
% of all discharges 
(n=3,075)
% of Nebraska 
population (n=1,904,760)
Region 1 3% (n=102) 4% (n=85,550)
Region 2 7% (n=218) 5% (n=99,028)
Region 3 10% (n=311) 12% (n=230,690)
Region 4 6% (n=191) 11% (n=205,654)
Region 5 22% (n=671) 25% (n=467,891)
Region 6 51% (n=1,582) 43% (n=815,947)
Behavioral Health Region by Patient Address (n=3,325)
The greatest proportion (48%) of all hospital inpatient discharges were for patients whose 
home address was in Region 6 (n=1,582). Region 5 had the second greatest proportion (20%, 
n=671) of residents discharged.
102 




Region 1 Region 2 Region 3 Region 4 Region 5 Region 6 Out of State
The table below compares the percentage of discharged patients with home addresses in each 
behavioral health region in Nebraska (excluding patients with missing or out-of-state home 
addresses, n=3,075) to the percentage of all Nebraskans residing in each region (n=1,904,760, 
United States Census Bureau, 2018). As shown, Region 6 had a higher percentage of 
discharged patients than expected based on population (51% compared to 43%).
Region 4 had only 6% of inpatient discharges while comprising 11% of the population.
Updated Dataset Results
NHA INPATIENT DISCHARGES
What are the trends for the characteristics of individuals discharged from inpatient 
treatment with diagnoses related to substance use since 2016?
Substance Related to Patient 
Diagnosis  (n=3,330)
While depressants have been the 
most common substances related 
to inpatient treatment diagnoses 
overall, the 4-year trend analysis 
shows the percentage of 
diagnoses related to 
depressants have consistently 
decreased since 2016. A similar 
trend exists for narcotics. In 
contrast, diagnoses related to 
stimulants have been steadily 
increasing since 2016. The 
percentage of other substances 
related to diagnoses has remained 
consistent over time. See 





2016 2017 2018 2019
Number of Inpatient Treatment 
Discharges by Year (n=2,672)
The total number of inpatient 
discharges between January 1 and 
September 30 of each year is 
shown to the right. The 
comparison includes only 
discharges during this time as 
quarter 4 data for 2019 was not 
yet available at the time of this 
report. As shown, the number of 
inpatient discharges was at its 
highest point in 2017 and has 
seen modest declines in the 
following 2 years.
36% 34% 32% 29%
The percentage of depressant-related diagnoses has 
decreased since 2016.
28% 26% 25% 21%




The percentage of stimulant-related diagnoses has 
increased since 2016.
Many of the characteristics of individuals discharged from inpatient treatment with diagnoses 
related to substance use have remained stable since 2016. Patient sex, age, and length of stay 
have remained consistent. See Appendix K for tables.
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Updated Dataset Results
STEPs investigated changes in the characteristics of individuals discharged from 
inpatient treatment with diagnoses related to substance use behavior by behavioral 
health region and year. The behavioral health region was determined based on the 
patient’s home address. Five individuals discharged were excluded from the analysis as home 
address information was not provided. Notable findings are summarized below with additional 
tables located in Appendix K.
NHA INPATIENT DISCHARGES
What are the trends for the characteristics of individuals discharged from inpatient    












Region 1 3% 4% 3% 3%
Region 2 7% 6% 6% 8%
Region 3 8% 8% 10% 12%
Region 4 6% 7% 5% 5%
Region 5 18% 21% 21% 20%
Region 6 51% 48% 46% 44%
Out of State 8% 7% 8% 8%
Percentage of Patient Discharges by Behavioral Health Region and Year (n=3,325)
The percentage of individuals discharged from inpatient treatment residing in each behavioral 
health region stayed relatively consistent over the past 4 years. Two notable exceptions include 
Regions 3 and 6. Since 2017, the percentage of individuals discharged who resided in 
Region 3 increased by 2 percentage points. Conversely, since 2016, the percentage of 
individuals discharged who resided in Region 6 decreased each year resulting in a 7-
percentage-point decrease from 2016 to 2019.
Patient Sex (n=3,325)
The percentages of female and male patients by 
behavioral health region are similar to overall 
findings; a higher percentage of patients 
discharged from inpatient treatment with 
diagnoses related to substance use were 
female compared to male. There are some 
exceptions with Regions 1, 3, and 5 having a 
lower percentage of female patients than other 
health regions. Region 2 has a much higher 

























What are the trends for the characteristics of individuals discharged from inpatient 
treatment with diagnoses related to substance use by behavioral health region since 
2016? (cont.)
Patient Age in Years (n=3,325)
Overall, the average age for patients does not vary greatly across behavioral health regions. 
The average ages ranged from 39 to 42 years old.
Patient Length of Stay in Days (n=3,325)
Overall, the average length of stay for patients does not vary greatly across behavioral 
















Depressants 34% 31% 23% 26% 32% 36% 36%
Stimulants 20% 19% 42% 25% 28% 23% 27%
Narcotics 21% 25% 19% 27% 28% 26% 22%
Cannabis 4% 3% 3% 4% 3% 5% 5%
Hallucinogens 0% 0% 1% 1% 1% 1% 1%
Other 
psychoactive 
substances 9% 19% 5% 14% 4% 5% 4%
No substance 
specified
13% 2% 5% 4% 4% 3% 4%
Substance Related to Patient Diagnosis (n=3,325)
For most regions, the most common substances related to inpatient treatment diagnoses were 
depressants. Exceptions include Region 3 and Region 4, which had stimulants and narcotics, 
respectively, as their most common substances. The highlighted cells indicate the most common 






















NHA Emergency Department Discharges
NHA provided STEPs with  emergency department discharge data for cases with diagnoses 
related to substance use. The dataset included information on patients’ diagnosis, sex, age, home 
address, hospital location, and length of stay. The dataset included 7,712 discharges between 
January 1, 2016 and September 30, 2019.
What are the characteristics of individuals discharged from emergency departments 
with diagnoses related to substance use?
Patient Sex (n=7,709)
There was a slightly higher percentage of male than female patients 
discharged from emergency departments with diagnoses related to 
substance use with 53% (n=4,070) of patients identifying as male and 
47% (n=3,639) identifying as female.
Patient Age in Years (n=7,712)
Patient ages ranged from 0 to 97 years with an 
average age of 34 years (SD=16) and a median 
age of 31 years.
Patient Length of Stay in Days (n=7,712)
Patients’ lengths of stay ranged from 1 to 45 
days with an average and median length of 1 
day (SD=1).
Substance Related to Patient Diagnosis (n=7,712)
The most common substances related to the emergency department diagnoses were 
stimulants (31%, n=2,389), followed by narcotics (21%, n=1,634) and depressants (20%, 
n=1,559). 36 patients did not have a substance specified in their diagnosis code. Instead, their 
diagnoses were related to substance use complicating pregnancy or neonatal withdrawal.
For a sample of diagnosis codes and their related substance category, see Appendix J.
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Region 1 Region 2 Region 3 Region 4 Region 5 Region 6 Out of State
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What are the characteristics of individuals discharged from emergency departments 
with diagnoses related to substance use? (cont.)
Behavioral 
Health Region
% of all discharges 
(n=7,306)
% of Nebraska population 
(n=1,904,760)
Region 1 5% (n=362) 4% (n=85,550)
Region 2 3% (n=246) 5% (n=99,028)
Region 3 10% (n=741) 12% (n=230,690)
Region 4 5% (n=385) 11% (n=205,654)
Region 5 25% (n=1,853) 25% (n=467,891)
Region 6 51% (n=3,719) 43% (n=815,947)
Behavioral Health Region by Patient Address (n=7,712)
The greatest proportion of all emergency department discharges were for patients whose 
address was in Region 6 (48%, n=3,719). Region 5 had the second greatest proportion (24%, 
n=1,853) of residents discharged.
The table below compares the percentage of discharged patients with home addresses in each 
behavioral health region in Nebraska (excluding patients with out-of-state home addresses, 
n=7,306) to the percentage of all Nebraskans residing in each region (n=1,904,760, U.S. Census 
Bureau, 2018). As shown, Region 6 had a higher percentage of discharged patients than 
expected based on population (51% compared to 43%). 
Region 4 had only 5% of inpatient discharges while comprising 11% of the population.
NHA EMERGENCY DEPARTMENT DISCHARGESUpdated Dataset Results
25% 29%
33% 37%
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What are the trends for the characteristics of individuals discharged from emergency 
departments with diagnoses related to substance use since 2016?
Substance Related to Patient 
Diagnosis  (n=7,712)
Like the trends seen in inpatient 
treatment, the substances related 
to emergency department 
diagnoses show the percentage 
of diagnoses related to 
depressants and narcotics have 
decreased over time. In 
contrast, diagnoses related to 
stimulants have been steadily 
increasing since 2016. The 
percentage of diagnoses related to 
cannabis use also increased 
during this timeframe. The 
percentage of other substances 
related to diagnoses have 
remained consistent over time. 
See Appendix L for information 
on other substances.
Number of Emergency Department 
Discharges by Year (n=6,250)
The total number of inpatient 
discharges between January 1 and 
September 30 of each year is shown to 
the right. The comparison includes 
only discharges during these months 
as quarter 4 data for 2019 was not yet 
available at the time of this report. As 
shown, the number of emergency 
department discharges was at the  
lowest point in 2017 and saw 
increases in the following two 
years.
Many of the characteristics of individuals discharged from emergency departments with 
diagnoses related to substance use have remained stable since 2016. Patient sex, age, and length 
of stay have remained consistent. See Appendix L for tables.
NHA EMERGENCY DEPARTMENT DISCHARGES
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Updated Dataset Results
What are the trends for the characteristics of individuals discharged from emergency 
departments with diagnoses related to substance use by behavioral health region 
since 2016?
STEPs investigated changes in the characteristics of individuals discharged from 
emergency departments with diagnoses related to substance use by behavioral 
health region and year. The behavioral health region was determined based on the 












Region 1 6% 5% 4% 4%
Region 2 3% 3% 3% 3%
Region 3 11% 9% 9% 9%
Region 4 5% 6% 5% 5%
Region 5 24% 24% 25% 22%
Region 6 45% 49% 47% 52%
Out of State 6% 4% 6% 5%
Percentage of Patient Discharges by Behavioral Health Region and Year (n=7,712)
The percentage of individuals discharged from emergency departments residing in each 
behavioral health region has stayed relatively consistent over the past 4 years except for Region 
6. Since 2017, the percentage of individuals discharged who resided in Region 6 has 
increased by 7 percentage points and 209 patients.
Behavioral Health 
Region 2016 2017 2018 2019
Region 1 (n=293) 85 67 78 63
Region 2 (n=192) 49 47 50 46
Region 3 (n=584) 152 131 150 151
Region 4 (n=314) 69 82 86 77
Region 5 (n=1,521) 369 368 411 373
Region 6 (n=3,023) 668 706 772 877
Out of State (n=323) 87 60 88 88
Number of Patient Discharges by 
Behavioral Health Region and 
Year (n=6,250)
The total number of emergency 
department discharges between 
January 1 and September 30 of 
each year is shown to the right for 
each behavioral health region. The 
comparison includes only 
discharges during these months as 
quarter 4 data for 2019 was not yet 
available at the time of this report.























Out of State (n=405)
Female Male
What are the trends for the characteristics of individuals discharged from emergency 
departments with diagnoses related to substance use by behavioral health region 
since 2016? (cont.)
Patient Sex (n=7,709)
The percentages of female and male 
patients varied across health regions with 
Regions 2, 3, and 4 having higher 
percentages of female patients and 
Regions 1, 4, and 6 having higher 
percentages of male patients.
Patient Age in Years (n=7,712)
Overall, the average age for patients did not vary greatly across behavioral health regions. The 
average ages ranged from 33 to 36 years old.
Patient Length of Stay in Days (n=7,712)
Overall, the average length of stay for patients did not vary across behavioral health regions. 
















Depressants 19% 33% 28% 22% 19% 19% 13%
Stimulants 27% 27% 28% 31% 31% 32% 34%
Narcotics 31% 26% 23% 24% 18% 20% 26%
Cannabis 12% 4% 11% 9% 9% 13% 12%
Hallucinogens 2% 0% 1% 2% 2% 3% 2%
Other 
psychoactive 
substances 11% 9% 10% 12% 21% 12% 14%
No substance 
specified 0% 1% 0% 0% 0% 1% 0%
Substance Related to Patient Diagnosis (n=7,712)
For most regions, the most common substances related to emergency department diagnoses 
was stimulants. The highlighted cell indicates the most common substance for each region.
NHA EMERGENCY DEPARTMENT DISCHARGES
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Updated Dataset Results
Treatment Episodes Data Set–Discharges (TEDS-D)
The Treatment Episode Data Set (TEDS) is a compilation of admission and discharge 
data from substance use treatment facilities nationwide. TEDS–Discharges (TEDS-D) 
provides data from approximately 1.6 million discharges across the U.S. This data 
provides an opportunity to understand substance use treatment trends including demographic, 
substance use, and treatment episode characteristics. 
Missing Data
Missing data was handled using pairwise deletion in which client data were included in analysis 
regardless of whether that client had data for all items. The number of client data present for 
each item is shown by the “(n= )” in the item headings.
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TEDS
What substance use treatment trends exist in Nebraska over the past 5 years?












TEDS-D includes 53,605 discharges from substance use 
treatment facilities in Nebraska from 2013 to 2017. Sample 
sizes by year ranged from 8,275 discharges in 2014, to 13,198 
discharges in 2016 and 2017. TEDS-D reports information on 
admissions and discharges to treatment facilities, not 
individuals. Therefore, someone who is admitted to a treatment 
facility twice in one year may be included in two data points. 
The following analysis includes year-by-year comparisons for 
relevant items. 
Client Age at Admission by Year
Between 2013 and 2017, the percentage of clients between 30 and 39 years old at admission 
increased slightly from 26% (n=10,103) to 32% (n=10,162). Concurrently, the percentage of 
clients between 40 and 49 years old and those over 50 years old decreased slightly. The 
percentage of clients between 21 and 29 years of age and those 20 years of age and younger 
stayed consistent at approximately 28% and 6% respectively. For the full Age at Admission by 
Year table, see Appendix M.
30-39 Years Old
The percentage of clients between 30 and 39 years old increased slightly.
Note: The y-axis ranges from 0% to 50% to emphasize the percentage 
increase.












Client Race by Year
Clients who identified as White consistently made up the majority of treatment 
discharges, approximately 80%. Clients who identified as Black or African American 
made up approximately 9% of discharges and those who identified as American 
Indian comprised 8% of discharges between 2013 and 2017. For the full Race by Year table, see 
Appendix M.
Client Marital Status by Year
The percentage of clients by marital status stayed relatively consistent from 2013 to 2017. On 
average, 59% of clients had never married; 28% identified as either divorced, widowed, or 












Client Sex by Year
Across years, approximately 69% of clients 
identified as male and 31% identified as 
female.
69% Male
Client Ethnicity by Year
Between 2013 and 2017, approximately 8% 
of clients identified as being of Hispanic or 
Latino origin.











What substance use treatment trends exist in Nebraska over the past 5 years? 
(cont.)
Client Pregnant at Admission by Year
Approximately 3% of clients reported being pregnant at 
admission between 2013 and 2017. *Due to NE DHHS’ interest in 
drug use behaviors by women of childbearing age, STEPs 
requested additional data regarding client pregnancy status at 
admission from the DBH Data Team. Between 2013 and 2017, 
fewer than 0.5% of female clients were up to 6 weeks postpartum 
at time of admission. Overwhelmingly, female clients were neither 
pregnant nor within 6 weeks postpartum at time of admission.
<0.5%
*Up to 6 Weeks 
Postpartum
*Section updated on 8/6/2020
TEDSUpdated Dataset Results
Client Education by Year
The educational attainment of discharged clients varied little between 2013 and 
2017. The percentage of clients who indicated having 12 years of education or a GED 
increased slightly from 50% in 2013 (n=9,483) to 53% in 2017 (n=7,752). 
Concurrently, the percentage of clients who reported less than 12 years of education decreased 
slightly from 20% in 2013 to 18% in 2014 (n=7,569) through 2017 (n=7,752). For the full 
Education by Year table, see Appendix M.


















Not in labor force











Note: The y-axis for the above graph ranges from 0% to 50% to emphasize 
the percentage change.
Client Employment Status at Admission by Year
A higher percentage (22%, n=8,529) of discharged clients 
reported full-time employment at admission in 2017 
compared to clients in 2013 (16%, n=10,096). Similarly, 
slightly less clients reported not being in the labor force at 
admission in 2017 (36%) compared to 2013 (41%). The 
percentage of clients who reported working part-time or 
being unemployed at admission stayed relatively consistent 
across the 4 years. For the full Employment Status at 
Admission by Year table, see Appendix M.


































Client Living Arrangements at Admission by Year
The rate of clients reporting independent living at admission increased from 59% in 
2013 (n=9,761) to 77% in 2017 (n=8,072). The percentage of homeless clients and 
those reporting a dependent living arrangement at admission decreased at a similar 
rate from 2013 to 2017.
Source of Client Income/Support by Year
Both the percentage of clients indicating no income and those reporting wages or salary 
increased between 2013 (n=10,015) and 2017 (n=8,254). The percentage of clients receiving 
support from retirement, pension, or disability funding, similar to the percentage of clients 
indicating “Not in Labor Force,” decreased from 10% in 2013 to 5% in 2017. The percentage of 
individuals receiving public assistance remained relatively consistent. For the full Source of 
Income/Support by Year table, see Appendix M.
The percentage of  independent living reported by clients increased 
between 2013 and 2017.
Note: The y-axis for the above graph ranges from 25% to 75% to 
emphasize the percentage change.
What substance use treatment trends exist in Nebraska over the past 5 years? 
(cont.)
TEDSUpdated Dataset Results
Planned Medication-Assisted Opioid Therapy by Year
The percentage of clients receiving opioid medications, such as methadone, 
buprenorphine, or naltrexone, as a part of their treatment plan stayed relatively 
constant from 2013 to 2017, increasing slightly between 2016 and 2017.
Reason for Client Discharge by Year
The percentage of clients who were discharged from treatment due to treatment completion 
decreased slightly between 2013 (65%, n=10,103) and 2015 (60%, n=8,831). Between 2015 
and 2017, however, the rate of treatment completion rose to 71% (n=10,162).
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The length of stay in 
treatment increased 
slightly between 2013 and 
2017.
Client Length of Stay in Treatment (Days) by Year
In 2013, 35% of discharged clients stayed in 
treatment for 1 day (n=10,103). This 
percentage decreased slightly to 27% in 2017 
(n=10,162). Between 2013 and 2017, the percentage of 
discharged clients in treatment for 2-30 days, 31-90 
days, and over 90 days all increased slightly. For the full 
Length of Stay by Year table, see Appendix M.




Treatment Referral Source by Year
Between 2013 and 2017, the percentage of client referrals from courts increased 
from 49% in 2013 (n=10,099) to 54% in 2017 (n=9,626). The other approximately 
half of referrals each year was split between individuals (self-referral) and other 
people or entities. “Other people or entities” included alcohol/drug use care providers, other 
health care providers, school (educational), employer/EAP, and other community referrals.











Referrals from courts, criminal justice entities, and DUI/DWIs 
increased slightly between 2013 and 2017.
What substance use treatment trends exist in Nebraska over the past 5 years?     
(cont.)
*In the prior 2018⎼2019 drug use behavior 
study, STEPs found that Nebraska had a very 
high rate of treatment referrals from the 
criminal justice system compared to national 
referrals (59% of referrals in Nebraska; 28% 
nationally) in 2017. According to TEDS-A, 
55% of criminal justice referrals came from 
an “other” source. In addition, many separate 
referral sources are grouped together in the 
TEDS-A data. For example, as shown above, 























entities and DUI/DWIs were grouped together in one category. To understand the specific 
role of the criminal justice system in referring clients to treatment in Nebraska, STEPs 
requested additional referral information from the DBH Data Team. According to the DBH 
data, the highest percentage of criminal justice referrals come from law enforcement 
agencies (e.g. police/sheriff/highway patrol), which accounted for an average of 27% of 
all referrals each year from 2013 to 2017. The second highest source of referrals from the 
criminal justice system was probation, which accounted for an average of 9% of all 
referrals each year. For the full Detailed Referral Source by Year table, see Appendix N.
*Section updated on 8/6/2020
TEDSUpdated Dataset Results
Alcohol















Substance Use at Admission (Primary) by Year
A lower percentage of clients identified alcohol as their primary substance used at 
admission in 2017 (52%, n=10,159) compared to 2013 (65%, n=10,062). At the same 
time, the percentage of clients using stimulants at admission increased from 19% in 
2013 to 28% in 2017. The percentage of clients using marijuana, opioids, depressants, 
hallucinogens, over-the-counter medications, and other substances stayed relatively constant 
across years. For the full Substance Use at Admission by Year table, see Appendix M.
Each year, a small percentage of clients identified no substance use at admission. 
Frequency of Use at Admission by Year
The percentage breakdown of frequency of use remained relatively consistent across all 4 years. 
Nearly half of clients (44%) reported daily use, 28% reported no use in the past month and 28% 
reported some use. For the full Frequency of Use at Admission by Year table, see Appendix M.
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What substance use treatment trends exist in Nebraska over the past 5 years? 
(cont.)
Client Age at First Use by Year
The percentage of clients by age at first use remained consistent from 2013 to 2017. One third 
(34%) of clients used the substance identified as their primary substance at age 14 years or 
younger. Another one third (32%) first used their primary substance between the ages of 15 
and 17 years. The final one third of clients first used their primary substance at age 18 years or 
older. For the full Frequency of Use at Admission by Year table, see Appendix M.












The percentage of clients with no prior treatment episodes increased 
nearly every year.
*Number of Previous Substance Use Treatment Episodes by Year
The percentage of clients with no prior treatment episodes increased from 44% in 2013 
(n=10,090) to 62% in 2017 (n=10,141).
*Section moved from original page on 8/6/2020
TEDSUpdated Dataset Results
*Nebraska Risk and Protective Factor Student Survey
The NRPFSS captures data on students’ risk and protective factors related to substance use and 
other behaviors. The data is collected every other fall and made available the following spring or 
summer. The current report utilizes data provided to STEPs by the DBH Data Team. Respondents 
includes youth enrolled in 8th, 10th, and 12th grades across Nebraska in 2010, 2012, 2014, 2016, 
and 2018.
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What trends exist for youth substance use in Nebraska?
NRPFSS
*Percentage of Youth Indicating Lifetime Substance Use by Substance and Year
Youth were asked to indicate the frequency with which they had used each substance during 
their lives. The table below summarizes the percentage of youth who indicated they had used 
the substance at least once in their lifetime. As shown, the highest percentage of youth 
indicated using prescription drugs at least once in their life followed by inhalants. Over the 
past five administrations of NRPFSS, the percentage of youth reporting lifetime use of each 
substance has remained relatively stable.
Year
LSD/Other 
Psychedelics Cocaine/Crack Meth Inhalants
Prescription 
Drugs
2010 2% 2% 1% 6% 7%
2012 2% 1% 1% 4% 5%
2014 2% 1% 1% 4% 5%
2016 3% 1% 1% 3% 5%
2018 2% 1% 0% 4% 4%
*Percentage of Youth Indicating Lifetime Substance Use by Substance and Sex
Youth who identified as male had consistently higher rates of reported lifetime use of 
LSD/other psychedelics and cocaine/crack compared to youth identifying as female. In 
contrast, youth who identified as female reported higher rates of lifetime use of inhalants and 
prescription drugs. The reported lifetime use of meth did not vary much across sexes. For the 












Cocaine/Crack Meth Inhalants Prescription
Drugs
Female Male
*Sections added on 8/6/2020
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What trends exist for youth substance use in Nebraska? (cont.)
*Percentage of Youth Indicating Lifetime Substance Use by Substance and Grade
On average across survey years, youth in 12th grade reported the highest percentages of lifetime 
use of each substance with the exception of inhalants. Youth in 8th grade reported the highest 
average lifetime use of inhalants across survey years. The highlighted cell indicates the most 
common substance for each grade level.
Substance 8th Grade 10th Grade 12th Grade
LSD/Other 
Psychedelics 1% 2% 4%
Cocaine/Crack 0% 1% 3%
Meth 0% 1% 1%
Inhalants 5% 4% 4%
Prescription 
Drugs 2% 5% 9%
*Percentage of Youth Indicating Lifetime Substance Use by Substance and Race
On average across survey years, youth identifying as Alaska Native reported the highest 
percentage of lifetime use for all substances except for inhalants. Youth identifying as American 
Indian reported the higher percentage of lifetime use for inhalants. The highlighted cell indicates 








Black 3% 2% 1% 5% 7%
Asian 12%** 1% 1% 4% 5%
American 
Indian 4% 3% 2% 8% 8%
Pacific 
Islander 3% 2% 2% 6% 9%
Alaska 
Native 6% 4% 3% 6% 11%
White 2% 1% 1% 4% 5%
Other 2% 2% 1% 7% 5%
*Sections added on 8/6/2020
**The 2012 DBH data indicated 51% of youth identifying as Asian reported using LSD/Other Psychedelics. 
This data should be double-checked for accuracy.
NRPFSSUpdated Dataset Results
Summary
Nebraska Hospital Association Discharge Data
1. The number of inpatient discharges with diagnoses related to substance use between January 
1 and September 30 of the past 4 years was at its highest point in 2017 and has modestly 
declined in the past 2 years. An opposite trend occurred in the emergency department 
discharge data with the number of diagnoses related to substance use at its lowest point in 
2017 and increased the following 2 years.
2. Individuals discharged from inpatient treatment with diagnoses related to substance use 
tended to be older than those discharged from the emergency department. The percentage of 
female patients was also slightly higher for inpatient discharges than emergency department 
discharges.
3. For both inpatient and emergency department discharges, depressants, stimulants, and 
narcotics were the most common substances indicated in diagnoses. However, while the 
percentage of depressant- and narcotic-related diagnoses decreased since 2016, the 
percentage of stimulant-related diagnoses increased.
4. Behavior Health Region 6 had the highest number of both inpatient and emergency 
department discharges. For inpatient discharges, the percentage of patients who resided in 
Region 6 had decreased each year since 2016. In contrast, the number of individuals residing 
in Region 6 discharged from emergency departments increased each year since 2016.
5. Demographic trends for individuals who were discharged from inpatient and emergency 
department treatment stayed relatively consistent in Nebraska since 2016.
TEDS-D
1. Between 2013 and 2017, the percentage of clients who indicated being employed full-time at 
admission and those who indicated receiving wages or salary increased slightly.
2. The percentage of clients who reported alcohol as their primary substance decreased between 
2013 and 2017, and the percentage of clients who reported stimulant use increased.
3. Across all years, the demographics of discharged clients, such as age, race, ethnicity, and 
marital status varied little.
4. The increase in clients reporting independent living from 2013 to 2017 was the most 
significant trend indicated by the data.
5. Compared to 2013, clients in 2017 were more likely to indicate no prior treatment episodes 
and have a longer stay in treatment.
*Nebraska Risk and Protective Factor Student Survey
1. Youth in Nebraska were more likely to report using prescription drugs at least once in their 
lifetime than any other substance. Inhalants were the second most reported substance used.
2. Youth who identified as male had consistently higher rates of reported lifetime use of 
LSD/other psychedelics and cocaine/crack compared to youth identifying as female. In 
contrast, youth who identified as female reported higher rates of lifetime use of inhalants and 
prescription drugs.
3. Youth in 12th grade were more likely to report having used a substance at least once in their 
lifetime compared to youth in 8th or 10th grades.
4. On average, youth identifying as Alaska Native reported the highest percentage of lifetime use 
for all substances except for inhalants. 




Directions for Future Research
Nebraska Hospital Association Discharge Data
1. Support Additional Data Collection by Hospitals: According to NHA, hospitals are currently 
not collecting data related to race and ethnicity consistently. The collection of this data should 
be encouraged as it would allow for an examination of health disparities and barriers to 
access to care based on race.
2. Examine Differences between Inpatient and Emergency Department Patients: This 
analysis provided some insight to differences between inpatient and emergency department 
patients with diagnoses related to substance use. However, the reasons for these differences 
have not yet been explored. Some areas for exploration may include comparisons of services 
received, health insurance information, and access and availability of treatment options. This 
direction for research may provide useful insight for how individuals in Nebraska are 
accessing and receiving treatment, as well as any health disparities that may exist. Results 
may potentially be used to inform outreach efforts, develop practitioner and research 
knowledge, support substance use disorder screening at primary care facilities, encourage 
collaborations across healthcare facilities and treatment providers, and design tertiary 
prevention efforts.
TEDS-D
1. Continue Longitudinal Analyses: TEDS-D presents several emerging trends in substance use 
treatment across Nebraska. The analysis of 2018, 2019, and future years of TEDS data will 
help determine the consistency of these trends and monitor any changes that arise. By 
continuing to analyze TEDS data as it is published, DHHS will gain additional longitudinal 
data, increasing the reliability of results.
2. Conduct Additional Bivariate Analyses: Additional bivariate analyses of the 2013 to 2017 
TEDS-D data will support DHHS’ understanding of substance use treatment trends. For 
example, an analysis of client race by primary substance used or referral source may further 
inform treatment and prevention efforts. This may be particularly relevant for those 
populations currently targeted by DHHS efforts.
*Nebraska Risk and Protective Factor Student Survey
1. Utilize Results to Inform Analysis of Other Datasets: Based on the findings that youth of 
different gender and racial identities may utilize substances at different rates, consider 
examining the primary substance used by client sex and race from the TEDS-D dataset to 
understand if these differences persist in adulthood. This may provide insight on how to 
provide specific prevention messaging based on target populations.





Nebraska Hospital Association Data
1. Due to the timing of this report, quarter 4 discharge data for 2019 had not been finalized. 
This means any year-to-year comparisons for total counts excluded quarter 4 data for 2016-
2018.
2. These datasets included information on hospital discharges from inpatient and emergency 
departments, not individuals. Someone who is discharged from inpatient or emergency 
department treatment may be represented more than once within the data.
3. As per the CSTE (2019), hospital discharge data “captures [information] for which drug use is 
the primary reason, per the admitting physician. Thus, it does not capture admissions for 
which drug use may be an ancillary or indirect reason, e.g., a motor vehicle crash injury 
caused by drug-impaired driving” (p. 33). This means additional instances of substance use 
resulting in inpatient or emergency department admissions are likely excluded from this 
dataset.
4. The diagnoses related to substance use are contingent on “the recognition, documentation 
and coding of drug use and drug-related diagnoses by hospital staff, all of which are known to 
vary” (CSTE, 2019, p. 33). This suggests diagnosis coding may vary across hospitals, which 
limits the ability to draw concrete conclusions across jurisdictions.
5. Because diagnosis description data included 297 unique diagnosis descriptions, diagnosis 
information needed to be condensed into usable categories for analysis and interpretation. 
This condensing may have resulted in a loss of detail on diagnoses, including specific 
substances and level of severity.
TEDS-D Data 
1. TEDS-D reports information on admissions and discharges to treatment facilities, not 
individuals. Someone who is admitted to treatment twice in one year, therefore, may 
represent two data points. A client transferring from one service type to another (such as 
inpatient to outpatient) may be recorded as an additional admission or discharge depending 
on the facility, even if the services were provided within the span of one treatment episode.  
2. Most substance use treatment facilities in Nebraska are located within Douglas and Lancaster 
counties. TEDS data may disproportionately represent an urban demographic due to their 
proximity to treatment facilities and subsequent ease of access to treatment.
3. The sample sizes of variables throughout this report vary due to missing data and differences 
in sample sizes across years. These variations in sample size are important to consider when 
looking at percentages throughout the report.
4. Not all treatment admissions or discharges are captured by TEDS. While TEDS collects data 
from facilities receiving state funds, private treatment facilities and those operated by 





*Nebraska Risk and Protective Factor Student Survey
1. Due to differences in survey text across years, the frequency of lifetime use by substances was 
analyzed using only two categories: 1) youth who reported never using a substance in their 
lifetime and 2) youth who reported using a substance in their lifetime at least once. The 
necessary condensing of categories to allow for comparisons across time may have resulted in 
the loss of detailed data (for example, any differences among those who have used a given 
substance 1-2 times compared to those who have used 10 or more times).
2. While the survey is administered to students in 6th, 8th, 10th, and 12th grade students, a 
different version is administered to 6th graders, and it does not include substance use 
variables. Therefore, conclusions cannot be drawn about substance use by youth below 8th
grade.




References: Updated Dataset Results
Centers for Disease Control and Prevention. (2001). Updated guidelines for evaluating 
public health surveillance systems: Recommendations for the guidelines working 
group. https://www.cdc.gov/mmwr/preview/mmwrhtml/
rr5013a1.htm
Council of State and Territorial Epidemiologists (CSTE). (2019). Recommended CSTE
surveillance indicators for substance abuse and mental health, Version 3. 
https://www.cste.org/members/group.aspx?id=87616




U.S. Census Bureau (2018). Demographic and housing estimates, 2014-2018 American 





DRUG USE BEHAVIORS 
Treatment Provider Qualitative Interviews
August 2020
Liam Heerten-Rodriguez, Ph.D., MSW, CSE
Daniel Kreuzberg, MSW/MPA Student
Jennifer L. Smith, MPPA








Drug Use Trends 88
Treatment Trends 90
Access to Treatment 94
Funding and Stigma 100
Drug Overdose Prevention 104




Appendix P: Full Methodology 159
Appendix Q: Interview Request Template 166
Appendix R: Consent Handout 166
Appendix S: Interview Protocol 169
TABLE OF CONTENTSTreatment Provider Qualitative Interviews
78
Key Findings
STEPs conducted semi-structured interviews with 18 substance abuse treatment providers in 
Nebraska. Interviewers asked participants about the clients they serve, the field of substance 
abuse treatment, their professional needs, opinions on drug overdose prevention, and what 
they would want from a relationship with NE DHHS. STEPs engaged in several rounds of 
qualitative data analysis that identified important categories and relationships within the data. 
The following are key findings from the analysis of the data:
1. Clients are often caught in a cycle of substance abuse fueled by trauma and mental health 
problems but have many strengths and are determined to make positive changes in their 
lives.
2. While opioid use is increasing, participants described methamphetamine as the most 
commonly used drug in Nebraska. Some participants do not feel NE DHHS is paying enough 
attention to methamphetamine use.
3. Substance abuse treatment is drug overdose prevention.
4. There are significant barriers to accessing substance abuse treatment, especially in 
residential treatment and especially for women with children and other vulnerable and 
marginalized populations. 
5. For substance abuse treatment to be effective, clients also need access to housing, 
healthcare, and employment. Wraparound services would increase access to and 
effectiveness of treatment.
6. When political leaders believe addiction is a choice, they are less interested in funding and 
addressing substance abuse issues. 
7. Policies that increase access to naloxone and decrease fears of criminalization are crucial in 
preventing overdoses, but awareness and knowledge are inconsistent.
8. Education efforts are necessary to reduce overprescribing, promote safe use, raise 
awareness and reduce stigma within communities. 
9. Treatment providers do not have a clear understanding of who NE DHHS is or their role in 
drug overdose prevention. Many defined NE DHHS by their interactions with specific 
divisions and sections, like CFS.
10. Participants want an ongoing relationship with NE DHHS and suggested that NE DHHS 
develop and maintain a statewide substance abuse treatment resource guide and facilitate 
quarterly roundtable discussions.
KEY FINDINGSTreatment Provider Qualitative Interviews
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Recommendations
Based on interviews with 18 substance abuse treatment providers in Nebraska and the analysis 
of the data, STEPs offers the following recommendations:
1. Prioritize Nebraska-specific data when making decisions regarding drug overdose 
prevention efforts. While opioid use is a growing concern, treatment providers on the front 
lines are still seeing more methamphetamine use and mixed substance use, including 
alcohol use.
2. Understand the needs of various stakeholders regarding drug overdose prevention. 
Treatment providers have insights into the needs of people who abuse substances, other 
professionals, and community members, but these needs may be best identified by these 
groups themselves. Consider directly hearing from these voices in future evaluation and 
assessment efforts.
3. Provide and advocate for education that reduces overprescribing, promotes safe use, 
raises awareness, and reduces stigma within communities. Education should be targeted to 
the needs of specific stakeholders. Substance abuse treatment providers identified that they 
have educational gaps regarding naloxone access that, if filled, could help them reduce drug 
overdoses. 
4. Reduce stigma associated with substance use disorders and substance abuse treatment. 
While stigma is widespread, intervention activities that target policy makers and political 
leadership for stigma reduction may be especially effective in facilitating an environment 
that supports treatment and reduces drug overdoses. Interventions should humanize 
people with substance use disorders by providing an accurate understanding of who is at 
risk and the strengths they possess.   
5. Establish an identity for the Drug Overdose Prevention program that is independent of 
other state entities that are viewed negatively or with mistrust by treatment providers and 
substance use disorder clients, such as CFS and probation. Engaging treatment providers in 
a way that honors their expertise and facilitates ongoing communication will help 
treatment providers view the Drug Overdose Prevention program as a partner.
6. Create and maintain a statewide resource guide that helps treatment providers make 
efficient referrals and connect clients to the right level of treatment. The resource guide 
could also serve as an environmental scan that helps inform stakeholder assessment and 
strategic planning. 




This section summarizes the methodology of the qualitative component of the Drug Use 
Behaviors project. The full methodology is described in Appendix P of this report. 
Through semi-structured interviews with substance abuse treatment providers and qualitative 
data analysis, STEPs answered two primary questions:
1. What insights regarding drug use behaviors do drug treatment providers in Nebraska 
have that may inform drug use prevention planning?
2. What are the professional needs of drug treatment providers in Nebraska?
Sampling
Through the survey component of the Drug Use Behaviors project, STEPs developed a sample 
pool of 77 substance abuse treatment providers in Nebraska who were interested in 
participating in a qualitative interview. From this sample pool, STEPs staff interviewed 18 
participants between April 29, 2020 and June 2, 2020. See Appendix Q for interview request 
template and Appendix R for the consent handout. 
Data Collection
STEPs conducted semi-structured interviews over Zoom, an online videoconferencing service. 
STEPs staff followed an interview protocol consisting of six primary questions and multiple, 
flexible follow-up questions. See Appendix S for the full interview protocol. 
Sample Demographics
STEPs staff collected demographic information from all participants. Participants’ years of 
experience in the field ranged from 1 year to 33 years, with 10 years of experience on average. 
Participants were all licensed in Nebraska, with the most common license types being Licensed 
Alcohol and Drug Counselor (LADC) and Licensed Independent Mental Health Provider 
(LIMHP). The diversity of the sample’s geographic and practice settings are summarized in the 
following graphics. 
Purpose
The purpose of the qualitative component of the Drug Use Behaviors project was to provide NE 
DHHS with rich and in-depth information regarding the professional experiences and needs of 
drug treatment providers in Nebraska. Through the perspectives and insights of drug treatment 
providers, NE DHHS can better understand the experiences and needs of people with substance 
use disorders in Nebraska. 
Treatment Provider Qualitative Interviews
Methodology Summary (cont.)
Geographic Regions Served
Practice Settings and Roles
Data Analysis
STEPs analyzed the data using the methods of constructivist grounded theory (Charmaz, 2014). 
Data analysis included multiple, iterative stages initial coding, focused coding and 
categorization, and theory development. The purpose was not to develop a theory in the 
traditional sense, but to identify meaningful relationships between the categories and codes 
that could tell a narrative about the data. STEPs staff also engaged in memoing throughout the 
data analysis process. 
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Results
STEPs’ analysis of the data yielded seven key narratives which address the following topics:
RESULTS
1. Client Profile
2. Drug Use Trends
3. Treatment Trends
4. Access to Treatment
5. Funding and Stigma
6. Drug Overdose Prevention
7. Relationship with NE DHHS
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Client Profile
As part of the qualitative interview protocol, STEPs asked all participants, “Please 
tell me a little bit about the clients that you serve. Would you say that there is a 
typical story among your clients? Or something that all or most of them have in 
common?” Based on the analysis of the participants’ responses, STEPs developed a composite 
description of clients treated for substance use disorder. 
While a few participants used demographic terms, most participants defined the “typical” 
substance use disorder client by experiences rather than identities. Participants were 
quick to point out that they see clients with a wide variety of identities and backgrounds. 
Several participants used similar phrasing to exemplify the variation, “everybody from 
multimillionaires to homeless people.” Participants were clear that substance use disorders 
affect people of all ages, races, genders, and income level. As one participant stated, “It doesn't 
discriminate, it picks on anyone.”
Instead of commonalities in identity, participants highlighted the shared experiences of their 
clients. At the core of these shared experiences is trauma. All but two participants explicitly 
identified a trauma history as something that all or most of their clients have in common. 
“Experiencing trauma” was among the most frequently occurring initial codes within the 
analysis. Most participants identified trauma that their clients experienced in childhood and 
several participants specified complex trauma, which is trauma that is chronic and long-term. 
Participants named poverty; neglect; and physical, verbal, and sexual abuse, as well as 
witnessing abuse such as domestic violence, as common types of trauma that their clients have 
experienced. 
One participant summarized the presence of trauma by saying, “I guess the thing that I feel like 
everyone has in common is some form of underlying trauma. The shapes that that takes varies 
some, but I very rarely work with someone with a substance use disorder who does not have either 
complex developmental trauma or some sort of, usually, relational-based trauma.”
Section highlights:
1. The typical substance use disorder client is defined by shared experiences, rather than 
shared identities.
2. Clients are caught in a cycle of substance abuse fueled by trauma and mental health 
problems.
3. Clients have many strengths and are very determined to make positive changes in their lives.
4. Women face additional challenges and stressors but are often highly motivated by their 
children.
RESULTSTreatment Provider Qualitative Interviews
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Client Profile (cont.)
Participants also described clients as typically having a family history of substance abuse, 
which was often implicated in their trauma experiences. As one participant put it, “9 times 
out of 10 there was a substance use disorder in a close family member or a parent.”
However, there were differences in how participants made meaning of this commonality. Some 
participants pointed to a genetic or hereditary component to addiction, while others discussed 
environments where drug use was normalized, including children who began using with their 
parents. Other participants identified the family history of drug use as leading to children 
experiencing abuse, neglect, or other traumatic experiences.
Perhaps unsurprisingly, given their clients’ experiences of trauma and family histories of 
substance abuse, participants identified that many of their clients have co-occurring mental 
health problems and dual diagnoses. There was variation in how participants described the 
proportions of their clients who have or qualify for a dual diagnosis, with estimates from “50% 
at least” to “most of them” to “practically everyone.”
Participants brought up clients with dual diagnoses at all stages of the interview, not just when 
describing their typical client. In particular, participants noted the lack of substance use 
treatment providers and programs prepared to address the needs of dual diagnosis clients. 
Additional details on dual diagnoses are discussed in the “Access to Treatment” section of this 
report.
In the face of all of these difficulties, participants observed a severe lack of adaptive coping 
mechanisms and strategies among their clients, even among clients who had previous 
treatment experience. One participant said, “I think again it comes down to a lot of people do not 
have coping skills and, even when they've been to treatment and whatnot, they just have not 
developed coping skills.”
In the absence of adaptive coping skills, substance use becomes their primary 
mechanism. Another participant described this saying, “The majority of drug 
and alcohol clients that I [see] have a really difficult time with self-regulation, with 
dealing with emotion … it's kind of coping, they just have a difficult time coping and 
drugs or alcohol tend to be an escape for them or a way to get away.”
Some participants described these typical client experiences and characteristics without 
directly applying a linear, causal relationship to them. Other participants, however, identified 
relationships in which these experiences were connected. As one participant put it, “There's 
always a reason for addiction, right? Nobody wakes up and says, ‘I wanna be an addict today.’”
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Client Profile (cont.)
The participants were clear that their clients 
want to break these cycles. A participant described 
this struggle saying, “I think that [clients] want people to know 
that they're just regular people who happen to get caught up in 
that addictive process … If you don't treat the trauma, then you can't really treat the addiction. A 
lot of what they deal with is multigenerational trauma. And I think that most everybody I work 
with would really want you to know that they they're just regular people. They want to be parents, 
they want to live their lives like other people do, and they really find themselves struggling to not 
be in the middle of their addictive process.”
While attempting to break these cycles can be a significant undertaking, substance use disorder 
clients also possess strengths that they can leverage in this struggle. Participants identified a 
number of strengths that their clients possess. 
Participants described their clients as adaptable, brave, caring, charismatic, compassionate, 
connected, creative, determined, driven, empathetic, entrepreneurial, hardworking, humble, 
intelligent, motivated, open, patient, persevering, problem-solving, resilient, resourceful, 
strong, supportive, survivors, vulnerable, willing, and worthy. The most commonly referenced 
client strength was determination. 
Participants identified these relationships as 
patterns, processes, or cycles. While no single 
participant linearly identified all of these 
relationships, the data taken as a whole suggests 
that many substance use disorder clients are 
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Client Profile (cont.)
One participant said of her clients, “I would say that the majority of them have great potential 
and drive to be successful. I think that it's very interesting that the majority of them have solid 
goals that they want for their life. And they want to achieve things just like everybody else, but of 
course, they're dealing with many barriers.” This participant also emphasized that any 
investment that NE DHHS makes in providing resources or help to people with substance use 
disorders will be used, because clients “want help, they need help, and with that help, they 
can be successful citizens.”
Gender-Based Differences
STEPs also asked participants in what ways, if any, the experiences of women, 
especially women of a childbearing age, were different. In general, participants 
expressed that women with substance use disorders often face additional 
challenges and stressors. 
Participants identified finances to be a stressor for most clients, but that the burden was 
especially high for women. Women start at a financial disadvantage due to gender-based wage 
gaps, which participants suggest may be especially large for women with substance use 
disorders due to generally lower educational attainment and spotty work histories. 
Additionally, several participants highlighted that many women with substance use disorders 
have been financially dependent on a man, such as a boyfriend or spouse, including for their 
substance use. This financial dependency can make them more vulnerable to abusive 
relationships and create additional barriers to leaving abusive relationships and seeking 
substance abuse treatment. 
Women are also disproportionately responsible for childcare, which can create barriers to 
steady employment and additional challenges to finding and affording healthcare, housing, and 
supplemental childcare. These stressors can keep women from accessing and continuing 
substance abuse treatment and can be triggers for women’s continued substance use.
One participant told us, “We know that women won't go to treatment because they don't want to 
leave their children. So, in order to engage women and to help them get into recovery, we have to 
not do it the way we think it needs to be done, but we need to listen to what they're telling us, and 
they're telling us they need to have their kids with them.” 
For women with substance use disorders who have had children removed from their care, 
these stressors can be magnified. Participants were clear that, while removal is sometimes 
necessary for the safety of the child, disrupting families fuels substance use. 
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Client Profile (cont.)
One participant illustrated the dynamic as follows: “The police or whoever has contact with the 
family, and there's some substance use going on there, and they automatically pull the kids out of 
the home. But then sometimes there's no contact for weeks, just trying to get back into the court 
system. I think sometimes that fuels the substance use more than it helps it.” And the burdens of 
Children and Family Services (CFS) or law enforcement involvement disproportionately 
impacts women because, as one participant told us, “women are expected to do more to get their 
kids back.”
While these are significant barriers and challenges that disproportionately affect women, 
participants also spoke to women’s strengths. In particular, participants told us that women 
are highly motivated by their children to stop or manage their substance use. 
Whereas some participants felt that men were more motivated by their employment to seek 
treatment, women were often motivated by their children’s well-being and their strong desire 
to be good mothers. One participant framed it like this, “We know from the research and from 
my practical experience that women are more likely to recover and stay in recovery if they have 
their children placed back with them because the biggest motivation, the biggest driving factor, in 
women getting clean and staying clean is that they desperately want to be with their kids and to 
be really, really good moms.” 
Age-Based Differences 
STEPs did not directly ask about age-based differences, but several participants 
identified ways in which younger clients differed from older clients. Participants 
stated their younger clients are more commonly using marijuana and alcohol, 
while older clients are more commonly using methamphetamines and alcohol. 
Participants also indicated that while involvement with law enforcement was a common 
pathway for all clients, younger clients were more likely to be in treatment due to pressure 
from family members. However, this dynamic is complicated by some participants reporting 
that it is common for younger clients to use substances around or even with their parents. 
While these differences are notable, they should also be treated tentatively, as they were not 
discussed extensively or consistently by participants. 
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Drug Use Trends
As part of the qualitative interview protocol, STEPs asked all participants to 
identify changes or trends they had observed within the field of substance use 
treatment. Almost all participants commented on the use of specific drug types, 
although the consensus among participants was that they are not seeing many 
changes in this area. According to our participants, the drugs of choice in Nebraska have 
consistently been methamphetamines and alcohol. 
While many participants identified that dominant methamphetamine and alcohol use has been 
the case for some time, they felt that this has not been reflected in NE DHHS priorities. One 
participant said, “I would say 90–95% of the folks I work with, meth is their drug of choice. And 
meth is still a huge problem in Nebraska, and I feel like we keep forgetting about that. So, I would 
just like to remind DHHS of that sometimes. And alcohol will always be one of the top two.”
Instead, some participants felt that NE DHHS is chasing national trends that do not reflect 
Nebraska, specifically opioid use. One participant encouraged NE DHHS to stay focused on the 
realities of drug use in Nebraska, saying “I think it can be really easy to focus on one aspect of a 
problem and get a little bit of tunnel vision on it, which happens a lot in substance use treatment 
overall, and not just in Nebraska. There just tends to be an area of treatment where things get 
trendy, or things become buzzwords, and then the focus of funding and the focus of training and 
the focus of new initiatives becomes very pigeonholed. And that's not always in the client's best 
interest, you know.”
This is not to say, however, that participants were not concerned with opioid use in Nebraska. 
Opioids were the most frequently discussed drug type in the interviews. While participants did 
not view opioid use as being as widespread as methamphetamines, many identified opioid 
abuse as a growing problem in Nebraska. 
Participants frequently discussed opioids in the specific context of overdose prevention, 
highlighting the need for greater access to naloxone and interventions to address 
overprescribing. These suggestions are presented in greater detail in the “Drug Overdose 
Prevention” section of this report. 
Section highlights:
1. Participants identified methamphetamines as the most commonly used drug in Nebraska, 
but some do not feel that NE DHHS is prioritizing it appropriately.
2. Opioid use is increasing, and participants want to see interventions that address abuse and 
overdoses.
3. More clients are mixing drugs or using any drug type that is available to them.
4. Marijuana use has remained constant, but the marijuana has become more potent and 
available.
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In addition to increases in opioid abuse, participants identified increases in clients mixing 
drug types and an increase in clients with no drug of choice as trends that they have 
observed. Participants stated that abusing alcohol in addition to illicit or prescription drugs has 
been common for some time, with one participant saying, “I mean alcohol seems to be a part of 
everything.”
Increasingly, though, participants are seeing clients abuse both methamphetamines and opioids 
or, in some cases, using mixtures of the two. Some participants felt that they were seeing an 
increasing number of clients with no drug type preferences whatsoever, indiscriminate in their 
abuse of drugs. 
One participant stated, “There's a lot of meth addiction, but they're combining it with other 
things such as alcohol and the opiates and the benzos. There's just a lot of multiple drug use. I 
don't know if maybe in the past if people just used one, they had a drug of choice. But now it's like 
just, ‘Whatever's in front of me.’”
Participants also identified marijuana use as common and consistent, but they 
believed that the potency, availability, and potential negative consequences 
of using marijuana had increased over time. Speaking to the potency issue, 
one participant stated, “I'd also add that just the difference in marijuana from now 
and even 2011, when I started in the field. It's just a lot stronger now. It's just not 
the same marijuana that it was.”
Other participants spoke to the changes that have come with the legalization of marijuana in 
other states, which has changed people’s perceptions of the drug. Participants also noted that 
legalization has made marijuana more available and available in more forms than it previously 
has been. 
One participant pointed to the potential consequences of these changes, even without an 
increase in overall marijuana use, saying, “Marijuana used to be kind of a different situation 
where it was just viewed as a gateway drug or that type of thing, or it's not as serious. But some of 
this high THC-level type things we're seeing from different dispensaries with higher THC levels, 
you are seeing a little bit more influx or increase in psychotic symptoms with that use and more 
people being hospitalized around that… You can get a lot less or not as much use with more 
serious consequences sometimes.”
Finally, while not speaking to any specific drug type, some participants believed that depth of 
individual’s substance abuse has become more severe. One participant told us, “It seems to have 
gotten a lot worse. People are having a lot more problems in my opinion. So, for a long time I was 
with the drug court and I thought I was seeing what could possibly be the worst, but it's gotten 
worse since then.”
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Section highlights: 
1. Regardless of their length of time in the field, participants have seen improvements in 
substance abuse treatment. 
2. Diagnostic changes have led to more individualized treatment and potentially less stigma 
for clients. 
3. The field has moved away from abstinence- and shame-based models and has largely 
embraced harm reduction and medication assisted treatment approaches.
4. Participants want to see even more individualization in substance abuse treatment. 
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Treatment Trends
As part of the qualitative interview protocol, STEPs asked all participants to 
identify changes or trends they had observed within the field of substance use 
treatment. In addition to trends in clients’ drug use, participants also 
substantively discussed trends in substance abuse treatment.
In general, the consensus among participants was that substance abuse treatment has 
improved during their time in the field. This was true for both participants with significant 
tenure in the field and those who are newer practitioners, suggesting that there are ongoing 
positive treatment developments occurring within the field.
One positive treatment development noted by participants is the evolution in diagnostic 
conceptualization, criteria, and terminology regarding substance use disorders. 
Participants noted the changes that have occurred specifically between the 4th and 5th editions 
of the Diagnostic and Statistical Manual of Mental Disorders (DSM).
While many of the details of these changes are technical and primarily of interest to clinical 
audiences, participants noted that some of these changes have real impacts on clients. For 
example, several participants identified that previous editions of the DSM had differentiated 
between clients’ experiences of substance abuse and substance dependence. In the DSM-5, 
however, there is one diagnosis of substance use disorder and a continuum of qualifiers, from 
mild to moderate to severe.
One participant described how this change has helped her treat her clients saying, “So when we 
diagnose someone with a substance use disorder it's on a continuum rather than just, ‘Oh you're 
abusing meth,’ or ‘You're addicted to meth,’ which is just black and white. So that's changed a lot 
and helps us to kind of meet clients where they're at and match them up to the right level of care.”
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Treatment Trends (cont.)
Another participant noted the change also removes the language of “dependent” or “addict” 
when describing the client, which can help reduce stigmatization. Another participant noted 
that the change in the remission criteria from 30 days sober to 90 days sober can also help 
clients access needed treatment options. In summary, a participant stated that these changes 
are not solely semantic but have “changed the way we think” about substance use disorders and 
their treatment. 
Participants also noted trends of moving away from specific treatment models, especially 
ones that required clients to maintain complete abstinence from all substance use and 
models that either explicitly or implicitly relied on shaming the client. Participants were 
clear that these approaches to treatment still exist and, in some cases, individual treatment 
providers or clients may even prefer them, but they are less dominant than they once were. 
As the dominance of these approaches wanes, there is increasing room within the field for 
other approaches. A participant framed this shift saying, “I would say even 6 years ago, the 12-
step model was pretty much really what was encouraged, and I feel like [now] facilities are more 
open to other types of models for clients in terms of their path of recovery.” Similarly, another 
participant stated, “I'd also say that substance use treatment, even before I was in the field, used 
to be really, I don't know if ‘punitive’ is the right word, but very, you know, you'd put someone in 
the hot seat, and you'd tell them everything that was wrong with them. And put them on the spot 
in group therapy and just kind of scare them into sobriety, for lack of a better word. And now 
we're a lot more client centered.”
A specific way that participants observed this change was in how the field has 
come to treat client relapses back into substance use. Many participants 
identified that, within these abstinence- and shame-based models, relapse was 
treated as a failure on the part of the client and their treatment. Participants 
noted that this approach was both shaming and inconducive to keeping people 
in treatment. 
One participant described the previous way of viewing relapse as follows: “In an abstinence-
based model, with your outcomes, any type of a relapse is considered a failure sometimes. And so 
it's kind of looked at that way in programs or in treatment, then sometimes our clients or 
participants view it that way, too.” Another participant contrasted this view of relapse with what 
they believed was a more contemporary understanding, “I mean, people relapsing is not a 
failure. It's a learning process.”
RESULTSTreatment Provider Qualitative Interviews
92
Treatment Trends (cont.)
In the place of these models, participants noted trends of moving towards harm reduction 
and medication assisted treatment (MAT) approaches. Participants highlighted many 
different treatment approaches and models that have gained greater acceptance in the decline 
of abstinence- and shame-based models, including motivational interviewing, eye movement 
desensitization and reprocessing (EMDR), and mindfulness-based therapies. However, the 
most commonly and frequently referenced treatment approaches were harm reduction and 
MAT approaches. 
Participants also frequently framed this shift as one of the biggest changes that they have 
observed in the field. For example, one participant stated, “Treatment has changed quite a bit 
as far as just focusing on relapse prevention or abstinence-type treatment, moving more into 
kind of harm reduction or other medication assisted treatment. That's been probably the biggest 
change I've seen over the past 18 years.” 
Across the board, participants acknowledged the ascent of these approaches and generally 
considered this a positive shift. One participant explained, “I think sometimes it's unrealistic to 
think the first time that you try to stop using substances, you're going to be completely abstinent 
the rest of your life and that's the expectation. Sometimes, harm reduction is the goal.” Similarly, 
another participant stated, “Harm reduction is a big thing now. If I'm seeing someone and 
you're smoking weed, drinking on the weekends, and using IV meth daily, if I can get you to stop 
using IV meth daily, that's a win, you know.”
While participants were generally supportive of these shifts, they did note 
several barriers and problems associated with the move towards harm 
reduction and MAT. For example, several participants noted that their ability 
to fully embrace harm reduction and MAT in client treatment was stifled by 
systems to which their clients were accountable, most notably CFS and probation. 
One participant summarized the situation, stating, “Sometimes [harm reduction] is not 
accepted by HHS or by probation or parole type entities. 'Cause you know you have that strict 
guideline of no use whatsoever. So even some appropriate use or healthy use is viewed as a 
violation at that point in time. And so sometimes, a treatment model of harm reduction would be 
more appropriate for the person you're working with, but because of their legal circumstances, 
you can't use it.”
Additionally, some participants noted that they did not use harm reduction approaches in 
their work because their treatment setting, residential and corrections, did not allow for it. 
One participant stated that, in a residential setting, any drug use on the part of a client could 
be triggering to other clients. They also pointed out that not all clients are interested in a 
harm reduction approach, stating that harm reduction “doesn't seem to be effective and a lot of 
our clients say if they drink one, they're all in again.”
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While not a specific shift in treatment model, several participants identified greater use of 
trauma-informed practices as a positive trend. One participant was discussing changes in the 
field and stated “What really comes to mind is the focus on trauma. In the past, trauma was kind 
of reserved for the strictly mental health domain. And now there's much more focus on [trauma]. 
While you can go to substance use treatment and learn your recovery and relapse prevention 
skills, you really have to heal from those deeper wounds and that deeper pain in order to truly 
prevent returning to use in the future.” 
While this participant saw greater trauma-informed care in the field, they also qualified the 
trend as “leveling-off” and identified a need for greater growth in this area.
Overall, participants were happy with the shifts in treatment approaches, but 
they were not completely satisfied with the current state of treatment. 
Participants identified several treatment changes that they wanted to see in the 
field. The most commonly and frequently identified change was a need for 
greater levels of individualization within substance abuse treatment. 
Participants repeatedly referenced the need for treatment and treatment providers to “meet 
clients where they are.” While participants used this sentiment to advance several changes to the 
current state of treatment, they most frequently expressed a need for clients to be able to 
access the right level of service at the right time and the need for higher levels of client 
self-determination.
One participant made the case for this approach by saying, “We know that when an addict's 
ready to get help, they're willing in that moment. And we have to capture that willingness when 
it's available because we know the nature of addiction means they're going to go on a bender 
again, and it could have the potential for an overdose.” 
While participants identified several barriers to greater levels of individualization within 
substance abuse treatment, participants frequently named NE DHHS and other state 
agencies as significant barriers. In some cases, this was in reference to necessary treatments 
not being covered by Medicaid or the regional behavioral health system. In other cases, 
participants were referencing actions by CFS or probation that were not client-centered or 
interfered with treatment in some way. 
One participant spoke to this dynamic, saying, “We have a lot of providers within the agency that 
don't want to take HHS cases because they're dictating the care and the level of treatment. And it 
just fuels that earlier concept of that, you know, the clients feel like it's a ‘me versus them’ 
mentality.”
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Access to Treatment
As part of the qualitative interview protocol, STEPs asked all participants about 
the resources they needed, changes they believed would reduce drug overdoses, 
and what they would want from a partnership with NE DHHS. In response to 
these questions, participants mentioned the pressing need for increased access 
to substance abuse treatment. Participants were clear that they believe substance abuse 
treatment is drug overdose prevention.
When asked specifically about drug overdose prevention, one participant recognized the theme 
across many of her responses: “I'm gonna sound like a broken record, but I would say 
accessibility to care. If people can get the help when they need it, then the chance of overdose 
decreases significantly.”
However, participants identified significant barriers to accessing substance abuse 
treatment. Many of these barriers were financial. For many people, especially those without 
health insurance or who are seeking services voluntarily, substance abuse treatment can 
simply be out of reach financially. 
One participant said, “I think it goes back to providing care for individuals who don't have any 
resources. The individuals who need the funding to be able to enter into treatment. That's pretty 
much all I can come up with as being the barrier. Just being able to provide that service to people 
in need, who don't have the resources to do it.”
However, even when financial resources are available, there can still be significant delays in 
accessing the needed treatment. Waitlists for services were a particularly frustrating barrier 
identified by the participants. One of them said, “The waitlists are long–sometimes weeks. So if I 
think that somebody is really needing inpatient treatment and I call somewhere to try to get them 
on the waitlist and they'll give me a date like 6 weeks or 8 weeks or something like that. And I just 
sit there and I'm like, wow.”
Section highlights: 
1. Substance abuse treatment is drug overdose prevention.
2. There are significant barriers to accessing treatment, especially residential treatment and 
especially for women with children and other vulnerable and marginalized populations.
3. For substance abuse treatment to be effective, clients need access to housing, healthcare, 
and employment.
4. Participants viewed NE DHHS as a barrier to meeting these basic needs.
5. Some level of wraparound services would increase access to and effectiveness of treatment.
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While participants identified financial barriers as an issue at all levels of treatment, delays in 
accessing treatment were most often specific to higher levels of care. Participants identified a 
significant lack of inpatient, residential treatment options. 
One participant spoke of the volatility of the situation as follows: “Where I run into problems is 
maybe getting somebody into an inpatient setting. A lot of times there's waiting lists and we've 
got, you know, kind of unstable patients that really shouldn't be sent home that end up being told 
there's no inpatient bed.” Another participant spoke of referring Nebraska clients to residential 
treatment centers in Kansas saying, “It's easier to get someone in there than it is to get them in 
for treatment anywhere in Nebraska.”
For some clients, the waitlist is only one part of the delay. For example, one 
participant qualified her waitlist complaint saying, “One of the hardest things is 
when someone needs to get into treatment, there's nothing. It's at least a 2-week 
wait, and that's if they're accepted on day one.” 
And clients often face additional barriers to being accepted for service. One participant spoke 
about trying to get letters of agreement so NE DHHS would pay for services, “but that process is 
very long and cumbersome so you see services get delayed by a month or two to start. You see 
them have delays of weeks in between while they're trying to get the payment funding going. And 
again, I just think it's bureaucratic, you know, it's like the caseworker does one thing, hands it off 
to another team, and so forth.” 
While the general shortage of residential options and subsequent delays are likely to impact all 
clients, barriers to access rarely affect all clients equally. As a general rule, barriers to 
accessing treatment are not evenly distributed. Clients who are already vulnerable or 
marginalized often experience more barriers and experience them more intensely. 
For example, some participants identified that women need residential treatment options 
that allow them to be with their children. While participants were able to identify programs 
that serve mothers and their children, the need is high and the resources severely lacking. 
One participant laid out the realities of the situation saying, “One of the biggest barriers that we 
run into is finding sober and safe and affordable housing. Because women who don't have children 
or men have wide access to halfway houses, three-quarter way houses, right? Like in Lincoln, 
where I'm located, I think there are twice or three times as many Oxford houses for men as there 
are for women. And, of the three Oxford houses that are available for women, not a single one of 
them will allow a woman to bring a child with her at this point in time. So, I only know of one 
three-quarter way house in Lincoln that takes women who need to have housing with their 
children, and it only has five beds available. So, there is an utter lack of safe, sober support for 
women who have children and want to have their children with them.”
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Similarly, clients in rural areas of the state also face unique challenges and barriers to 
accessing treatment. For substance abuse treatment providers serving rural regions, the 
frustrations abounded. One participant said, “We kind of forget about all these rural areas. 
People don't have transportation. There are no treatment centers within a 60-mile radius. It's just 
not the same access of care.”
It’s not only difficult accessing care, but the same participant went on to discuss 
how some rural clients are punished for their difficulties in accessing treatment. 
“Something specific when we look at like HHS clientele, their transportation 
provider exists, but a lot of times they won't come to this area... If transportation 
cancels on them 2 hours in advance, or a day in advance, they're being 
consequenced [sic] for not following through with an appointment.” 
And it’s not only treatment centers that are hard to access in rural areas. Participants 
specifically noted the lack of rural access to detox services, AA meetings, naloxone, and even 
outpatient treatment. 
Participants also discussed specific barriers to accessing treatment for clients who are 
undocumented, experiencing homelessness, or are currently or were previously 
incarcerated. These barriers are often unique and especially burdensome. 
For example, one participant who worked within correctional services discussed how many 
entities, including insurance companies, use the date of incarceration as the start date of 
sobriety. Then, depending on their length on incarceration, some clients are ineligible for 
services upon release. The combination of forced sobriety and lack of adequate treatment can 
be deadly for clients after they are released. According to the same participant, “A lot of times 
they've been sober for 60 days or 90 days, and they use the exact same amount they were using 
before coming to jail. They may be on a wait list for treatment, but it doesn't matter because if 
they can't get into treatment when they need it, then they're at risk of going and using, and when 
they use they're more likely to overdose because they don't know the amount that they can have.” 
Other participants discussed the difficulties in accessing MAT while experiencing homelessness 
or programs that denied funding to undocumented immigrants. These examples highlighted 
the unequal distribution of treatment services with groups who are already vulnerable or 
marginalized having greater difficulties accessing substance abuse treatment.  
Participants were also clear that, especially for vulnerable or marginalized clients, barriers to 
accessing treatment are only part of the equation. Clients with substance use disorders often 
need more than just treatment. Participants identified how a general lack of resources in a 
client’s life can hinder their ability to consistently attend and be successful in treatment. 
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For example, one participant started listing the needs and challenges that many mothers face: 
“Daycare, not having enough food to eat, finding a job, adequate transportation, adequate 
housing. Usually, if they're in the middle of their own addictive process, they have therapy, they're 
expected to go to 12-step meetings. They're expected to do parenting classes. Their kids are 
usually in therapy, so there's just significant demands.”
A common client need that participants identified was safe and affordable 
housing. While participants mentioned housing needs in a variety of contexts, 
they often emphasized it in the context of women with children. 
One participant told this story regarding housing: “A lot of the moms that I work with need that 
long-term support where they have a place where they have safe housing and safe community 
with other moms, but it's not available, right? So we're sending them out into the world, often into 
whatever apartment they can find that accepts housing vouchers or Section 8 vouchers from the 
Housing Authority. Very often, those are apartments in areas of town that have very concentrated 
drug use. So we're sending them back out very quickly, with very little recovery time under their 
belts, into the very situation that we just took them out of, and expecting them to function 
differently in it, which doesn't just happen magically with just a little bit of treatment.” 
Another need that participants consistently identified was for general 
healthcare access. Participants described accessing healthcare as a major 
source of stress for their clients. 
One participant said, “When you're worried about all of these things that you can't access because 
you don't have health insurance, it makes it really hard to focus on recovery. So I'd like to think 
that if folks had the resources to take care of those, what we might consider like little things - like 
going to your doctor's appointments, having access to your medication, having access to a dentist 
when you need it - then they could use all of that energy that they'd be saving on actually focusing 
on recovery and engaging in treatment and not having to worry about all this stuff in addition to 
that.” 
Participants also identified employment needs as being important to treatment 
success for many clients. Not only does employment generally mean greater 
access to financial resources, but it can also mean greater independence for some 
clients. 
One participant referred to this as the “domino effect,” in which successful employment triggers 
“a very positive effect because when you've got someone who starts over and they feel success in 
that and they see a future in recovery, there's going to be a huge decrease in drug overdoses 
because there's going to be a decrease in use.”
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In some cases, participants viewed NE DHHS as a barrier to clients getting 
these basic needs met. Participants described bureaucratic catch-22s in which 
clients lose important benefits when they get a job, sometimes leaving them with 
fewer financial resources than they had before. Participants also described 
caseworkers with unrealistic, and often misguided, expectations for clients that left them with 
no good options for bettering their situations. One participant discussed the “unspoken rules” 
of caseworkers, which can leave clients frustrated and can unnecessarily prolong separation 
from their children. 
One participant told a specific and vivid story of a system-involved woman’s struggle. “I 
remember a case that this lady had significant drug issues, and she struggled finding a job. She 
didn't have very good history with jobs. Had difficulty getting a good reference, and the only job 
she could find was a nights and weekends waitressing job. And she did well, it paid well enough to 
where she was able to get her car fixed and had transportation for everything, but it didn't work 
out. I mean her job interfered with visits that had to be in the afternoon because of other people's 
schedule that were in the case. So she ended up basically giving up the job. 
The participant felt like the situation did not need to have this outcome, stating, “She wasn't 
forced to quit it, but at the same time, she wasn't given any other option for it. So it's situations 
like that, that I feel we need to have an open, honest discussion about what we are asking these 
parents to do. And how much can we expect them to do given any other constraints. You're asking 
them to deal with a substance use disorder while they're dealing with high stress of not having 
their kids, in addition to trying to find a job, and their car isn't running, but if they miss a visit, 
because they can't get there because their car's broken down, then it's the end of the world.”
While participants identified many significant problems and barriers to treatment, they also 
discussed solutions. Participants spoke of expanding access to telehealth services to meet rural 
needs. One participant discussed starting a program that increased the availability of treatment 
for women with children. Some discussed Medicaid expansion. 
Many participants discussed some version or level of wraparound 
services as a solution that would significantly increase access to treatment 
and success within treatment. Participants felt that a treatment team approach 
with coordination of care and access to a wide variety of services would 
significantly improve outcomes for many of their clients. 
One participant discussed a stalled attempt to implement a program in Omaha to provide these 
services: “We had this vision of [a program] where all the services that are needed are under one 
roof. So it's kind of a one-stop shop, and it actually got something like this going… and it had to do 
with the community taking care of its own and making services available. So easily available that 
there was absolutely no excuse for not using them.” 98
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The same participant listed the agencies and services that would be needed to 
meet people’s needs, saying, “And the bottom line was they put all the services, 
including a court room and a judge, probation, treatment, education, whatever a 
person needs, it was all not only located in the neighborhood where people needed it, but it was all 
under one roof. And this was actually discussed in Omaha a long time ago, but it never went 
anywhere.” While this participant’s vision was particularly comprehensive, several participants 
expressed a need for a similar program or services. 
The most commonly and frequently referenced solution to treatment access issues was 
increased funding. Participants believed that many treatment access issues would be solved if 
there was adequate funding available, whether that be provided directly to substance abuse 
treatment agencies, expanded treatment subsidization, or higher reimbursement rates for 
treatment providers. 
While directly connected to access to treatment, funding issues were both prevalent and 
nuanced enough to warrant their own analysis. See the “Funding and Stigma” section of this 
report for a full discussion of funding. 
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Funding and Stigma
STEPs did not ask participants about funding in the interview protocol, but 
participants brought up funding issues and nearly all directly discussed them. 
Participants mentioned funding in the context of both the financial needs of 
people with substance use disorders and the funding provided to agencies who 
support people with substance use disorders. 
In both contexts, the consensus was clear: participants felt that the funding available for 
substance abuse treatment was insufficient to meet the need and that the lack of funding 
is directly tied to the stigmatization of substance use and those with substance use 
disorders. Without changes to the funding context, people with substance use disorders will go 
without substance abuse treatment and be at risk for overdose.  
Participants framed funding as a tool that helps clients access treatment and helps 
providers better support clients. The participants largely see this tool as insufficient for the 
amount of work that needs to be done in substance abuse treatment. 
Participants identified seven funding sources that support substance abuse treatment: 
1. Funding through NE DHHS,
2. Funding through state and foundation grants,
3. Funding through the regional behavioral health system,
4. Insurance reimbursement,
5. Payment for service by clients,
6. Private donations, and
7. Funding through probation vouchers. 
While almost all participants discussed the need for increased funding, some generally and 
some identifying specific funding sources that need increased, many participants also believed 
that funding sources are often doing the best they can with what they have. 
Section highlights:
1. Funding available for substance abuse treatment is insufficient to meet the need.
2. Lack of funding is directly tied to the stigmatization of substance use and those with 
substance use disorders.
3. When political leaders believe addiction is a choice, they are less interested in funding and 
addressing substance abuse issues.
4. Community education about substance use and substance use disorders is needed to 
increase compassion and reduce stigma.
5. Efforts to reduce stigma and increase access to treatment would benefit entire 
communities.
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While many participants discussed a general need for increased substance abuse treatment 
funding, some participants identified specific changes to the current funding landscape. 
For example, one participant discussed the need for coordination of care, but that most funding 
sources do not currently reimburse for that service. 
The participant wanted “reimbursable rates for coordination of care so you can have more 
wraparound services for the client. You've got your behavioral health, your medical, your 
medication management provider, the whole treatment team being able to collaborate, but right 
now that's all unbillable time.”
Another participant identified the ongoing reimbursement rate disparity between medical and 
mental health providers as a problem. Several participants also discussed Medicaid expansion 
as an improvement that would increase access to substance abuse treatment. 
Participants also identified specific gaps in funding that have left some clients without the 
means to access substance abuse treatment. While participants recognized that substance 
abuse disorders do not discriminate based on socioeconomic status, access to treatment is not 
equal. Clients with limited financial resources and who are not system-involved may have 
a particularly hard time accessing substance abuse treatment on a voluntary basis.
One participant stated, “If you're not involved with CPS and you're an adult, there really isn't a 
system out there unless you go and commit a crime and then the probation system or the judicial 
system kicks in. And even that's a minimal amount of support. So somebody who wants to go out 
there and do it alone has no financial, has no emotional, has no other support to be able to do it.”
Participants shared that agencies’ use of sliding fee scales sometimes allows 
this population to access services but isn’t a sustainable solution. Participants 
discussed that when agencies use sliding fee scales and are not reimbursed for 
the service, it impacts the available funding for other necessary services. 
As one participant explained, “So we charge them on a sliding fee scale ... but we're not getting 
any reimbursement for it. And so, program-wise, it is a hit to our budget. And we're deeply rooted 
in social work values, so I don't ever see a time when we would turn people away, but it affects our 
budget.”
Participants connected the insufficient funding for substance abuse treatment to the 
stigma attached to substance at large. Like funding, STEPs did not ask participants directly 
about stigma, but most brought it into their interview regardless. 
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Funding and Stigma (cont.)
Participants expressed that the belief of “addiction is a choice” is still prominent and is a major 
source of stigmatization for clients and accessing substance abuse treatment. One participant 
said, “I think most of society is still in a place of wanting to punish addicts for their choices rather 
than trying to understand that no one chooses to be an addict. Yes, they may have chosen to use 
substances in the first place, but no one is choosing the utter hell that active, full-blown addiction 
is.” 
While some participants discussed seeing an overall increase in compassion for substance use 
disorder clients over the years, participants were clear that stigmatization remains a major 
problem. 
While participants discussed stigmatization as widespread, several participants 
specifically identified the stigmatizing beliefs of those in positions of political 
leadership as having a negative impact on funding availability. According to these 
participants, when political leaders believe addiction is a choice, they are 
less interested in funding and addressing substance abuse issues.
Instead, substance use is framed as an issue of criminality. For example, several participants 
discussed what they believed to be high criminal penalties for drug offenses compared to other 
crimes. One participant stated, “I think we could do a better job of educating and rehabilitating 
rather than throwing people in jail or prison.” 
Some participants discussed decriminalizing substance use to support substance use disorder 
clients and reduce stigma. Other participants discussed needle exchange programs as another 
way to support clients, but they believe these programs are not available due to the stigma 
attached to them. One participant explained, “I don't think it does us any good to act like there's a 
moral superiority and addicts who are dying from their addiction deserve it because they made a 
choice. And unfortunately, I do still see that attitude explicitly or implicitly in a lot of policy and a 
lot of policy makers.”
Participants discussed the need for education in schools and communities 
addressing drug use and addiction. Participants believed that education would 
decrease stigma and make it easier for people with substance use disorders to 
access treatment and support. 
While participants believed that education would decrease stigma, they also believed it was not 
currently implemented, and in some cases unlikely to be implemented due to stigma. Several 
participants identified the misconception that talking about substance use will encourage 
substance use as a barrier to meaningful educational interventions.
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Funding and Stigma (cont.)
However, some participants felt that a general mental health education intervention could be 
effective and accessible in ways that substance use education might not be. One participant 
described what mental health education should entail saying, “You need to talk about what 
mental health is, what it looks like, what are symptoms, it's okay to talk to someone about those 
things. Reduce the stigma and then educate on where to find help.”
Some participants also discussed research as a means of reducing stigma. One 
participant discussed seeing a recent study showing a correlation between 
menstrual cycles and craving cocaine. The participant went on to say, “It could be 
the same with the men, too. Like as they age and their testosterone goes down, we 
just know that older men tend to like phase out of using. Well, the belief has been for a long time, 
they just get, quote, ‘tired of the life.’ But is it connected to their testosterone levels dropping?”
This participant believed that having access to up-to-date biological studies would enhance 
treatment methods and the understanding of addiction. However, the participant said studies 
like this are not prevalent due to stigma, the prevailing belief being, “why would you invest in 
figuring out bad people?”
Participants not only believed that efforts to reduce stigma would increase funding for 
substance abuse treatment and benefit people with substance use disorders, but that the 
benefits would be felt by entire communities. One participant stated, “Bottom line, it's got to 
be important to everyone. The communities have to see value in treating a whole person. That 
there's a big investment up front for addictions recovery, but everyone has to see the long-term 
effects. You know, we might pay $40,000 to treat this individual, but then they're going to go get a 
job, they're going to pay taxes. You know, this is going to pay off down the road, it's just going to 
take a while.”
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Drug Overdose Prevention
As part of the qualitative interview protocol, STEPs asked all participants a series of 
questions directly addressing drug overdose prevention. As discussed in the “Access to 
Treatment” section of this report, participants felt strongly that substance abuse 
treatment is overdose prevention. 
However, participants also discussed several other strategies they believed would significantly 
reduce the number of drug overdoses in Nebraska. Across the board, participants believed that 
increased access to naloxone was preventing overdoses, and they want access to 
continue to increase. 
Participants had many ideas regarding where naloxone should be distributed in order to 
increase access and reduce overdoses. While many participants were aware that naloxone is 
available at some pharmacies, they also felt it should be available at or distributed to drug 
treatment centers and providers, homeless shelters, law enforcement officers, emergency 
rooms and ambulances, hotels, stores and other public places. 
Many participants emphasized the need for access not just for those who use drugs, but also 
family and community members. Many participants stated that they as treatment providers 
should have access or know where to access naloxone for their clients but did not feel properly 
educated. One participant stated, “I bet if I walked around and asked three or four counselors 
right now, do you know where you could get some NARCAN® for no money? I don't think they 
would know what to say or where to go.”
Other opioid overdose prevention strategies suggested by participants focused on increasing 
education, training, and resources for pain medication prescribers. Many participants 
believed that increases in opioid abuse or overdoses were the result of overprescribing opioids 
for pain management. 
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Section highlights:
1. Naloxone is crucial in preventing overdoses, but knowledge about how to access them is 
inconsistent.
2. Pain medication prescribers need more education, training, and resources to reduce opioid 
overprescribing. 
3. Substance use disorder clients need harm reduction and safe use education in case of 
relapse. 
4. Decriminalizing drug use behaviors in circumstances where overdoses are occurring may 
reduce barriers to accessing emergency services.
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Drug Overdose Prevention (cont.)
Some participants believed that prescribers were not adequately considering patients’ 
substance abuse histories or exploring alternative forms of pain management before 
prescribing opioids. Some participants suggested increased education and training for 
prescribers on both the potential dangers of opioid abuse and the availability of alternative 
pain management approaches. 
While participants believed that clients, medical providers, and insurance companies all have 
responsibility for decreasing the use of opioid pain medication, one participant specified that 
any educational interventions directed at physicians need to come from within the physician 
community in order to be effective. “Well, I think you'd have to have people within the physicians’ 
community do that… I think it needs to come from within their community to say, ‘Okay, we need 
to change this.’”
Some participants discussed utilizing alternative pain management methods as a 
way of reducing overdoses. While participants felt that this approach could be 
effective, they anticipated barriers to widespread implementation, even beyond 
provider education. One participant said, “The biggest barrier I see is insurances. 
It's cheaper to treat somebody with one medication than it is to send them to lots of different 
services as a total care of that person.”
Another participant suggested that prescribers need increased resources to ensure that opioids 
are not overprescribed, such as access to a prescription tracking database.
In addition to providing education to prescribers, participants also suggested education on 
harm reduction and safe use strategies targeting people at risk for a drug overdose. 
While participants acknowledged that such an approach would be controversial and may not 
be politically feasible in all communities, it could be a crucial strategy in preventing overdoses. 
One participant said, “I think the education to the clients is one thing. I mean it seems odd to say, 
‘If you go back out, don't start at your old amount.’” Several participants identified that 
overdoses occur when a client resumes use at the same amount after being sober for an 
extended time. Many participants felt that this strategy was not being used due to 
misinformation regarding harm reduction. 
One participant drew a comparison between drug overdose prevention and suicide prevention 
strategies, stating that fear and misinformation keep people from doing what we know works. 
“It's no different than like suicide. If you ask a client, are you thinking about suicide, there's this 
belief that that's going to plant the seed. And I can see that same kind of mindset with the drug 
and alcohol conversation.” The participant stated while it might feel odd to talk about, it is 
crucial in preventing overdoses.
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Drug Overdose Prevention (cont.)
Participants also suggested several community-based education programs. 
Some participants brought up in-school and afterschool programming for young 
people, but participants had different visions for these programs. Some 
suggested drug use prevention education and safe drug use education, and others 
envisioned general mental health awareness education. Other participants believed that the 
whole community not just young people needed education. One participant felt that many 
people were not aware of the level of drug use occurring within their communities and, if they 
became aware, they would be more involved in substance use prevention.
Participants also noted the need for emergency services to be contacted in the 
case of an overdose but believed that clients were reluctant to call out of fear of 
arrest. Participants felt that decriminalizing drug use behavior in situations 
where an overdose has occurred may increase the likelihood of emergency 
services being contacted.
One participant stated, “The biggest piece of that, I think, is making sure that we're 
decriminalizing any activity that's happening if someone were to call for help for an overdose, if 
that makes sense. You know, like if there's four people in a place that has a lot of paraphernalia, 
and one person is overdosing, and nobody wants to call 911 because they're afraid that they'll all 
get charged with possession charges.”
Some participants also suggested other forms of drug decriminalization, such as reducing 
sentencing associated with drug possession, but it was less clear that participants believed 
those suggestions would reduce drug overdoses. 
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Relationship with NE DHHS
As part of the qualitative interview protocol, STEPs asked all participants, “What 
would it look like if NE DHHS were to be a full partner to you in your work?” and 
a series of follow-up questions regarding their experiences with and expectations 
of NE DHHS. 
While participants gave a notably diverse set of responses to these questions, several 
participants responded by trying to understand from the interviewer what NE DHHS’ role in 
overdose prevention is. One participant said, “I don't know much about how DHHS contributes to 
preventing overdose and getting people substance abuse treatment. Could you give me some 
information on how DHHS is doing that now?” This questioning of the interviewer exemplifies 
the general confusion that participants had regarding NE DHHS and its role in preventing 
drug overdoses.  
Another common response from participants was to define the entirety of NE DHHS by the 
division, section, or subsection with which they had the most interaction. Participants 
frequently associated NE DHHS with CFS or Medicaid or even with systems outside of NE 
DHHS, such as probation. 
These associations made sense to the participants because of the important and emotionally 
charged role that these state entities play in the lives of their clients and in their own 
professional experiences. These associations were elevated in the analysis not only due to the 
number of participants who made them or the frequency with which they brought it up, but 
because of the intensity of the statements that they made. 
Section highlights: 
1. Treatment providers do not have a clear understanding of who NE DHHS is or their role in 
drug overdose prevention. 
2. Many participants defined all of NE DHHS by their interactions with specific divisions and 
sections, like CFS.
3. Participants are interested in developing partnerships with NE DHHS if they feel that their 
subject matter expertise will be valued.
4. Participants had specific suggestions for actions steps they would like NE DHHS to take, 
including developing and maintaining a statewide substance abuse treatment resource 
guide and facilitating quarterly roundtable discussions.
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One participant for example, shared these feelings when asked about NE DHHS: “Okay, yeah, I 
have strong reactions to the CPS system. I think it is a huge failure to our families that we work 
with … I know that their primary goal is child well-being and child safety and that absolutely 
should be. I don't think it has to be mutually exclusive with parental involvement. I think parents 
are vilified; I think they're not given chances. I think there's an automatic belief about the parents 
that use substances and there's an automatic alignment with the foster parents.” 
The participant explained how this belief impacts clients and their treatment success. The 
participant shared, “The clients want the system to know that they are not bad people. We try so 
hard to help them work on shame. And it's really hard to do that when there are systems that 
continually perpetuate their belief that they should be ashamed.”
The participant went on to discuss how this relationship with NE DHHS not only impacts 
clients, but also the treatment providers who work with them. “So the therapists in my 
programs spend more time than what they need to be spending–because we don't get paid for this 
work, right?–advocating for our clients. We're happy to do it, that's what helps with the 
relationship, but [the therapists] shouldn't have to spend this much time advocating to a system.” 
Not all participants had such intense and negative reactions to NE DHHS. Several 
participants described generally good and functional relationships with NE 
DHHS. One participant said, “I've got a pretty good working relationship with our, 
well, what I consider DHHS, I'm talking about Child Protective Services and Adult 
Protective Services and then Developmental Disabilities Services that I work with.” 
Many other participants simply described a neutral relationship with NE DHHS. For example, 
one participant discussed a primarily transactional relationship, saying, “I see the Department 
of Health and Human Services as a referral source and a resource for a number of different things 
that I may need or that my clients may need.” The participant went on to say, though, “As far as 
seeing them as a partner in things? I feel like, especially with drug overdose stuff–and maybe I just 
need to look a little bit harder–but I haven't seen a whole lot of trainings or different 
opportunities to learn about what exactly they are doing when it comes to stuff like this.”
Participants were generally interested in what NE DHHS was doing to prevent drug overdoses 
and how they might be a partner. Specifically, participants expressed interest in a relationship 
in which NE DHHS valued treatment providers for their subject matter expertise and 
were actively helping treatment providers provide better services. 
Some participants expressed these interests in very general ways or described it as a feeling 
that they would get when it was true, but other participants had very specific ideas for how NE 
DHHS could help foster this sort of relationship. Participants brought up–and fleshed out with 
some level of detail–three specific suggestions.
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Relationship with NE DHHS (cont.)
The first suggestion was for NE DHHS to create and maintain a statewide substance abuse 
treatment resource guide, which would include programs and providers, the services they 
offer, and accepted payment methods. One participant added, “And even knowing what levels of 
care are available at what agencies and their payment sources so that we can move this along 
much quicker and not have gaps in service.” 
Many participants discussed not knowing what levels of care are available at each agency 
because services change depending on available funding. One participant stated, “It's somewhat 
hard to find. And when we do find–we've created a list, we're actually updating our list and 
looking through all the different internet sources and calling all the different places, but then 
levels of care change all the time or people stop providing a certain level of care or they change 
their referral process. And we just don't have the resources to keep updating that list every 
month.” Participants hoped that a resource guide like this would help them connect substance 
use disorder clients to appropriate resources quicker and would enhance treatment for 
individuals.
The next suggestion was for NE DHHS to better support their CFS caseworkers and 
implement changes to improve relationships between treatment providers and 
caseworkers. Some participants believed that if caseworkers were better supported through 
access to advanced trainings, they’d be better equipped for the difficult situations they 
encounter. 
One participant suggested the following: “Maybe some education and training to the HHS 
workers, like the people who are working with their clients around drug and alcohol needs and 
levels of addiction and/or levels of treatment and stuff, so that way the people who maybe are 
getting a call first can recognize more clearly and quickly the severity of what they're dealing 
with. I don't know what they receive now. And not that their training now is poor, but I would just 
say that the more people know, the better.”
Participants also discussed feeling their relationship with caseworkers was 
“purely transactional,” with some noting that communication between them only 
occurs “right before court.” Some participants felt this lack of communication and 
teamwork hindered progress for their substance use disorder clients. 
Participants believed that having conversations between all team members on 
these cases would improve outcomes. One participant stated, “I think it would just help get 
everybody on the same page about what perspective they're bringing that from.”
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Relationship with NE DHHS (cont.)
Other participants discussed feeling that NE DHHS caseworkers did not respect their 
recommendations for clients. One participant said, “So often we might make a recommendation, 
but we will get called by the caseworker wanting that recommendation changed based on they 
think it‘s too much treatment, or they need less treatment, right? And I just feel like a lot of times 
those caseworkers are making clinical decisions that they should not be.” Participants stated 
decisions made by both practitioners and caseworkers regarding treatment “are incredibly 
impactful to these families, like lifelong impacts. And sometimes these decisions appear to be 
taken fairly lightly, from [the caseworker’s] end. So, them trusting more the treatment providers.” 
Finally, participants discussed the segmented way the system currently works, 
which leaves them feeling left out of the loop on issues that impact their practice. 
Participants felt like they did not understand what decisions were being made or 
how they were being made regarding issues like funding availability or the 
selection of priorities or the incorporation of various standards or best practices. 
Participants suggested quarterly roundtable discussions between substance abuse 
treatment providers and NE DHHS administrators to help bridge this gap. Multiple 
participants stated participating in the interview was a good first step in improving 
communication. 
As one participant put it, “I think this is the first time anyone from a policy standpoint, and I know 
that's coming down through the lens of program evaluation in this specific situation, has ever 
asked me what we even need, kind of like on the ground level.” Participants would like to continue 
to be asked about their needs and experiences as well as informed about NE DHHS’ roles and 
services. 
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Limitations
All research has limitations. The findings and recommendations within this report should be 
understood in the context of the following limitations: 
1. STEPs made changes to the sampling procedure during the recruitment phase. In these 
changes, STEPs prioritized a larger sample size, which often provides more data, over the 
use of theoretical sampling, which often provides richer data.
2. While the sample size was well within the acceptable range for qualitative research, it may 
not have been fully saturated, and additional findings may have developed from additional 
data.
3. Participants in the qualitative study are a subsect of participants from the quantitative 
survey. While the results of the two studies can inform one another, overlapping results 
should not be interpreted as verification. It is not known if this sampling strategy restricted 
the range of the data. 
4. STEPs used purposeful, criterion sampling. While STEPs attempted to recruit a 
geographically diverse sample of substance use treatment providers, the sample should not 
be viewed as representative of all substance use treatment providers in Nebraska.
5. STEPs conducted all interviews via Zoom, an online videoconferencing platform. While 
researcher and participant satisfaction with qualitative data collection via Zoom has been 
documented, it is unknown if the use of this platform affected the type or quality of data 
compared to in-person interviews. 
6. STEPs conducted all interviews during the COVID-19 pandemic. It is not known if this 
affected the type or quality of data collected.
7. Bias exists within all research. STEPs used two coders who engaged in initial coding 
independently and subsequent data analysis collaboratively in an effort to reduce the 
impact of bias. 
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APPENDICES: LADC/PLADC Quantitative Survey 
Appendix A
Initial Email to Treatment Providers
Hello,
We are seeking input from outpatient substance use treatment providers throughout 
Nebraska. If you are not currently an outpatient treatment provider, we ask that you please 
forward this survey to any outpatient treatment providers at your practice or agency. 
The Nebraska Department of Health and Human Services (DHHS) has contracted with the 
University of Nebraska at Omaha's STEPs (Support and Training for the Evaluation of 
Programs) to conduct a survey with treatment providers across Nebraska. Results of the 
survey will be used to inform DHHS on future treatment and prevention programs. 
• Survey responses will be anonymous and will be sent directly to STEPs.
• We expect this survey to take 10 to 12 minutes to complete.
• The survey will remain open until a desired number of responses are gathered, so please 
make sure your voice is heard!
Please complete the survey by clicking below: 
Thank you for your help with this project. Your feedback is invaluable and will be used to 
improve Nebraska’s prevention and response efforts. If you have any questions, please contact 
STEPs at steps@unomaha.edu.
Follow-Up Email to Treatment Providers
Hello, 
You were recently invited to participate in a 10- to 12-minute treatment provider survey 
regarding clients’ misuse of substances. Please make sure your voice is heard.
• Results will be used to inform DHHS on future treatment and prevention programs. 
• Responses are confidential.
• If you have already completed the survey, please disregard this email. 
Please complete the survey by clicking below: 









Thank you for taking part in this important survey to gauge drug use behaviors, treatment 
needs, and prevention efforts through the lens of treatment providers across Nebraska.
This survey is part of a statewide needs assessment by the Nebraska Department of Health and 
Human Services' (DHHS) Division of Public Health to focus prevention efforts, provide training 
and other resources to treatment centers, prepare for a more in-depth study in the near future, 
and inform their strategic plan.
This survey is administered by STEPs (Support and Training for the Evaluation of Programs) 
through the University of Nebraska at Omaha. Aggregate responses to this survey will be used 
by DHHS to allocate grant funds, resources, and develop a strategic plan. 
We expect this survey to take 10-15 minutes to complete. Responses will be received and 
analyzed by STEPs; you will remain anonymous. The STEPs team will provide a final report with 
recommendations to DHHS using your invaluable feedback. The final report will be made 
available to you through DHHS.
Provider Information
We would like to know about you and the services you offer. 
1. Which professional licenses or certifications do you have? (select all that apply)
• Licensed or Provisionally Licensed Alcohol and Drug Counselor (LADC or PLADC)
• Licensed Independent Mental Health Provider (LIMHP)
• Licensed or Provisionally Licensed Mental Health Provider (LMHP or PLMHP)
• Licensed Independent Professional Counselor (LIPC)
• Licensed or Provisionally Licensed Professional Counselor (LPC or PLPC)
• Licensed Independent Clinical Social Worker (LICSW)
• Certified or Provisionally Certified Master Social Worker (CMSW or PCMSW)
• Other (please specify): __________
2. In which county or counties do you provide substance use treatment? (select multiple 
counties by holding down Ctrl (on a PC) or Cmd (on a Mac) when clicking)





3. In which counties do your clients typically reside? (select multiple counties by holding 
down Ctrl (on a PC) or Cmd (on a Mac) when clicking)
4. Do you provide substance use treatment in an outpatient setting? 
• Yes
• No







• Medications for psychiatric disorders
• Other (please specify): __________
Substance of Choice
For this section, we are interested in hearing your perceptions of the most common and most 
recent trends in substance use among the clients you serve. For the following questions, please 
give your best estimate based on the clients you have seen. 
6. Thinking about clients presenting for substance use over the past year, 
approximately what percentage of these clients have presented needing treatment 
for the use of: (choose % on a slider)
The substance indicated below need not be their primary drug of choice. (Total must sum to 
100%)
• Alcohol 
• Prescription pain relievers (i.e. hydrocodone, oxycodone, etc.)
• Heroin





• Hallucinogens (i.e. LSD, PCP)
• Inhalants
• Cocaine/crack
• Other (please specify): __________




7. Thinking about clients you treated for substance use over the past year, what have 
been their most common primary drugs of choice? (select all that apply)








• Hallucinogens (i.e. LSD, PCP)
• Inhalants
• Cocaine/crack
• Other (please specify): __________
8. In the past year, what percentage of your clients have had an opioid use disorder 
(prescription pain relievers, fentanyl, heroin)? (choose % on a slider)
9. In the past year, what percentage of your clients were polysubstance dependent? 
(choose % on a slider)
Polysubstance dependence refers to a type of substance dependence disorder in which an 
individual uses at least three different classes of substances indiscriminately and does not have 
a favorite drug that qualifies for dependence on its own (Encyclopedia of Mental Disorders, 
2019).
10. We would like to know about trends you are seeing in the use of multiple substances. 
For each of the primary substances listed below, please indicate the drug or drugs 
that you commonly see paired with each substance. (open ended box after each option)
For example, if a common substance combination is methamphetamines with alcohol and 
prescription pain relievers, please type "alcohol and prescription pain relievers" in the box 
next to "methamphetamines." 
• Alcohol 












• Hallucinogens (i.e. LSD, PCP)
• Inhalants
• Cocaine/crack
• Other (please specify): __________
Drug Use Initiation
For this section, we would like to hear your perceptions about your clients’ experiences of 
initiation to drug use. For the purposes of this survey, “drug use initiation” is defined as the first 
misuse of a substance. For example, the first time binge drinking rather than the first time 
tasting alcohol. 
11. What is your perception of the most common substance that is first misused by your 
clients? For example, choosing alcohol would convey that most clients first began 
their misuse of substances by using alcohol, regardless of the current substances they 
misuse.









• Other (please specify): __________
12. What age do most clients you serve indicate as their first misuse?
• 14 years or younger
• 15-18 years old
• 19 years or older
13. In your opinion, what are the most common reasons for clients’ first substance 
misuse? (select all that apply)
• Pain relief
• Relax or relieve tension
• Experiment/see what it’s like
• Feel good/get high
• Help with sleep





• Help be alert or stay awake
• Help study or concentrate
• Help with feelings or emotions
• Help lose weight
• Parents or other family members encouraged them to
• Peers encouraged them to
• Other reason (please provide the reason): __________
14. Where did clients most commonly get the substance they first misused?
• From a doctor
• Stole from doctor’s office, clinic, hospital, or pharmacy 
• From friend or relative for free 
• Bought from friend or relative 
• Took from friend or relative without asking 
• Bought from drug dealer or other stranger 
• Some other way (please provide source): __________
Treatment Barriers and Facilitators
For this section, we would like to hear your perceptions about your clients’ treatment 
experiences. We are interested to hear about what motivates clients to enter treatment 
(facilitators) and what prevents them from seeking treatment (barriers). 
15. What are the most common reasons people do NOT receive treatment? (select all 
that apply)
• No healthcare coverage and cannot afford cost
• No transportation/too far away
• Hours inconvenient 
• Do not want treatment; lack motivation to stop using
• Takes too long to access treatment; window of motivation closes before treatment is 
available
• They do not think they need treatment 
• They do not think treatment will help
• They do not want others to find out they need treatment
• Too embarrassed, ashamed, afraid, or prideful 
• Other problems to deal with (emotional, family, etc.)
• Family members/others are unsupportive 
• Do not know how to access treatment; do not know where to start
• Fear of having children removed from the home
• Other (please specify): __________




16. Which of these statements best describes how your clients were prompted to get 
treatment? (select all that apply)
• They decided on their own to get treatment
• They got treatment because someone else thought they should
• They were ordered to get treatment
• Injury or near-death experience
• Overdose or witnessing an overdose
• Other health issue
• Other (please specify): __________
17. For what percentage of your clients in the past year was this their first treatment 
experience EVER?
A “treatment experience” refers to any professional help they have received for substance 
use, inclusive of outpatient, intensive outpatient, and residential programs. (choose % on a 
slider)
Prevention Efforts
For this section, we would like to hear your experiences and ideas related to current and future 
prevention efforts. We would also like to know what needs you have, and what needs your 
clients have, that DHHS may be able to fill in the future. 
18. In your opinion, what prevention efforts are most helpful? (select up to three in each 
category)
Primary Prevention (targeted at non-users and general public)
• Prescriber education 
• Public service announcements (PSAs) and media campaigns for general public
• Public education about medication assisted treatment (MAT)
• School-based substance use prevention programs for elementary students
• School-based substance use prevention programs for middle school students
• School-based substance use prevention programs for high school students
Secondary Prevention (targeted at early use, before serious complications)
• Addiction screening at primary care facilities (similar to ways in which they might screen 
for mental health)
• Addiction screening for those presenting for early refills (to refer for treatment and 
services)
• Use of Prescription Drug Monitoring Program before prescribing controlled substances
Tertiary Prevention (rehabilitation strategies after addiction is established, targeted at 
heavy users)
• Medication assisted treatment (methadone, buprenorphine, naltrexone, suboxone)
• Mandatory counseling and services with buprenorphine or naltrexone administration 
(similar to methadone requirements)





Tertiary Prevention (rehabilitation strategies after addiction is established, targeted at 
heavy users)
• Increased access to 12-step programs
• Increased access to mental health treatment
• Increased access to and training on naloxone
• Education about harm reduction practices (i.e. how to clean needles, reducing the 
amount of the substance used)
19. In your opinion, what populations are most in need of additional substance use 
prevention efforts? (select up to five)
• Current substance users
• Adults (26-64 years)
• Young adults (18-25 years)
• Middle school and high school students
• Elementary school students
• Persons in rural areas
• Families living in poverty
• Persons who lack a stable residence
• Incarcerated individuals
• Individuals with mental illness
• Women of child-bearing age
• American Indians/Alaska Natives
• Latinos/Latinas
• Other (please specify): __________
Training and Resources for Treatment Providers 
For this section, we would like to know about any needs you have for training or resources, both 
for yourself as a provider and for your clients. 
20. What training have you received that has been helpful to your work? 
21. Which of the below topics would be useful for future training for yourself or other 
staff at your facility? (select up to five)
• Medication assisted treatment (methadone, buprenorphine, naltrexone, suboxone)
• Harm reduction (i.e. safe injection practices, reducing the amount of the substance used) 
• Client assessments (i.e. trauma screening tools, addiction screening tools, etc.)
• Evidenced-based treatments (i.e. EMDR, DBT, TF-CBT, etc.)
• Trauma-informed care
• Alternative pain management strategies






• Compassion fatigue, stress, and burnout
• Ethics and boundaries
• Prescription Drug Monitoring Program (PDMP)
• Physical and mental effects of substance use
• Naloxone use and/or administration 
• Treatment for opioid addiction
• Treatment for methamphetamine addiction 
• Non-substance use addictions (i.e. gambling, internet, etc.) 
• Domestic violence 
• Other (please specify): __________
22. What additional resources do your clients need? (select up to five)
• Naloxone kits
• Condom distribution
• Financial assistance for medication assisted treatment (MAT)
• Childcare
• MAT prescriber
• Funding for rural area
• Education about MAT
• Reduction in waiting lists and wait time
• Facilities that accommodate women with dependent children
• Community outreach
• Other (please specify): __________
23. What would you most like DHHS to know about your clients and your work? 
24. DHHS is committed to hearing directly from providers about needs and trends as they 
develop future programming. Would you be willing to participate in a follow-up 
interview or focus group on drug use behaviors?
• Yes (if yes, please provide email address or send a brief email to steps@unomaha.edu
indicating your interest): __________
• No
Thank you for taking the time to complete this survey.
Your responses will be used to inform the work of the Nebraska DHHS’ Division of Public Health. 
STEPs will analyze responses collectively, and respondents will remain anonymous. 





CMSW or PCMSW Certified or Provisionally Certified Master Social Worker 
DHHS Nebraska Department of Health and Human Services
DOP Drug Overdose Prevention
DUB Drug Use Behaviors
EBP Evidence-based practice
LADC or PLADC Licensed or Provisionally Licensed Alcohol and Drug Counselor 
LICSW Licensed Independent Clinical Social Worker 
LIMHP Licensed Independent Mental Health Provider 
LIPC Licensed Independent Professional Counselor 
LMHP or PLMHP Licensed or Provisionally Licensed Mental Health Provider 
LPC or PLPC Licensed or Provisionally Licensed Professional Counselor 
MAT Medication Assisted Treatment
STEPs Support and Training for the Evaluation of Programs
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Appendix D
Nebraska Region Index by County
Lancaster
Omaha 
Metro Rural East West
Lancaster Douglas Adams Wayne Arthur Morrill
Sarpy Antelope Webster Banner Perkins
Boone York Blaine Phelps
Burt Cass Box Butte Red Willow
Butler Boyd Rock
































APPENDICES: LADC/PLADC Quantitative Survey 
124
Appendix E







Public service announcements  and media
campaigns for general public
Public education about medication assisted
treatment
Prescriber education
School-based substance use prevention
programs for high school students
School-based substance use prevention
programs for elementary students
School-based substance use prevention
programs for middle school students
Primary Prevention:




Use of Prescription Drug Monitoring Program
before prescribing controlled substances
Addiction screening for those presenting for
early refills
Addiction screening at primary care facilities
Secondary Prevention:
Percentage of Providers Who Indicated the Prevention Effort as Helpful
In your opinion, what prevention efforts are most helpful?
The full list of response options are provided in Appendix B.
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Increased access to and training on naloxone
Mandatory counseling and services with
buprenorphine or naltrexone administration
Increased access to 12-step programs
Education about harm reduction practices
Medication assisted treatment
Increased access to mental health treatment
Tertiary Prevention:
Percentage of Providers Who Indicated the Prevention Effort as Helpful
In your opinion, what prevention efforts are most helpful?
The full list of response options are provided in Appendix B.
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Appendix F
Populations in Need of Prevention (n=189)
In your opinion, what populations are most in need of additional substance use prevention 
efforts? 

















Women of child-bearing age
American Indians/Alaska Natives
Elementary school students
Persons in rural areas
Incarcerated individuals
Persons who lack a stable residence
Adults (26-64 years)
Current substance users
Families living in poverty
Individuals with mental illness
Young adults (18-25 years)
Middle school and high school students
Percentage of Providers Who Indicated the Population as Most in Need 
of Prevention 
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Appendix G



















Treatment for methamphetamine addiction
Prescription Drug Monitoring Program
Naloxone use and/or administration






Physical and mental effects of substance use
Client assessments
Compassion fatigue, stress, and burnout
Trauma-informed care
Alternative pain management strategies
Evidenced-based treatments
Co-occurring disorders
Percentage of Providers Who Indicated Interest in the Topic for Future 
Training
Which of the below topics would be useful for future training for yourself or other staff at your 
facility? 
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Appendix H
Additional Resources for Clients (n=178)


















Funding for rural area
Facilities that accommodate women with
dependent children
Community outreach
Reduction in waiting lists and wait time
Financial assistance for medication assisted
treatment (MAT)
Percentage of Providers Who Indicated Interest in the Future Training 
Topic
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Drug Use Behaviors Background
Support and Training for the Evaluation of Programs (STEPs) at the University of Nebraska at 
Omaha is a leader in conducting evaluations of and needs assessments for social service 
programs and policies. The Nebraska Department of Health and Human Services (DHHS) Drug 
Overdose Program (DOP) contracted with STEPs in the fall of 2019 to complete a needs 
assessment that included an identification and analysis of quality datasets, a survey of 
outpatient treatment providers, and focus groups with treatment providers. 
Purpose
The goal of this needs assessment is to deepen DOP’s understanding of individuals’ drug 
use behaviors in Nebraska through the lens of treatment providers.
The results of this study will aid DOP in providing training and other resources to treatment 
centers, focusing prevention efforts, and informing their strategic plan and future studies. 
Ultimately, this study will support DOP’s efforts to reduce opioid-involved fatal and non-fatal 
overdoses in Nebraska.





The purpose of the dataset analysis is to provide data on who is receiving treatment, who 
is referring people to treatment, and people’s age at first use. The current report 
emphasizes identifying quality datasets that can be useful now and in future evaluations. 
Literature Review of Substance Use Indicators
Prior to considering the quality of secondary datasets, STEPs identified substance use indicators 
commonly used by reputable public health agencies. Literature on health indicators consistently 
referred to documents published by the Centers for Disease Control and Prevention (CDC), the 
Substance Abuse and Mental Health Services Administration (SAMHSA), and the Council of State 
and Territorial Epidemiologists (CSTE). STEPs weighed the prevalence of established substance 
use indicators when determining the usefulness and quality of datasets.
The CSTE’s Recommended CSTE Surveillance Indicators for Substance Abuse and Mental Health
identified 10 substance use indicators recommended for use in surveillance systems (2019). 
Five of these 10 indicators, included in the table below, target non-alcohol drug use. 
The CSTE document references publications by the National Institutes of Health, U.S. DHHS, and 
the CDC and has been endorsed by the National Public Health Surveillance System, U.S. DHHS, 
and SAMHSA. The sources used in the development of the document and the endorsements 
from other reputable organizations support the reliability of these surveillance indicators. 
The United Nations Office on Drugs and Crime (2018), the Office of Disease Prevention and 
Health Promotion (2020), and SAMHSA (2018) utilize similar indicators, except for the 
hospitalization data and prescription opioid sales data. STEPs also assessed publications by the 
CDC for relevant surveillance indicators. However, the CDC often targeted data related to alcohol 
consumption and chronic diseases.
Recommended Substance Use Indicators





attributable to drugs 





Drug or alcohol 
dependence or 
abuse in the last 
year
Prevalence of 
use of selected 
prescription and 
illicit drugs
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Applying CDC’s Guidelines for Evaluating Public Health 
Surveillance Systems
To determine quality datasets that can be used over time to understand drug use behavior in 
Nebraska, STEPs utilized the CDC’s “Guidelines for Evaluating Public Health Surveillance 
Systems.” The CDC guidelines outline nine assessment characteristics for public health 
surveillance systems: simplicity, flexibility, data quality, acceptability, sensitivity, predictive 
value positive, representativeness, timeliness, and stability. Of these characteristics, STEPs 
prioritized those able to be assessed using publicly available information and those most 
relevant to the DOP project. The selected characteristics, CDC definition, and STEPs’ application 
of the characteristic can be found in the table below:
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Applying CDC’s Guidelines for Evaluating Public Health Surveillance Systems
Characteristic CDC Definition STEPs’ Application
Simplicity “Refers to both its structure and ease 
of operation. Surveillance systems 
should be as simple as possible while 
still meeting their objectives” (CDC, 
2001, Section D.2.a.)
STEPs prioritized datasets with 
low barriers to access such as 
publicness of the data, cost of data 
access, and accessible data 
formats. 
Data quality “The completeness and validity of the 
data recorded in the public health 
surveillance system” (CDC, 2001,  
Section D.2.c.)
STEPs prioritized datasets 
affiliated with leaders in 
substance use expertise, such as 
the CDC and SAMHSA, as found in 
the literature review.
Representativeness “Accurately describes the occurrence of 
a health-related event over time and its 
distribution in the population by place 
and person” (CDC, 2001, Section D.2.g.)
STEPs prioritized datasets providing 
place-specific data (such as those 
able to be desegregated by county 
and local health department) and 
demographic data.
Timeliness “The speed between steps in a public 
health surveillance system” (CDC, 2001, 
Section D.2.h.)
STEPs prioritized datasets that 
publish data at least every two 
years.
Stability “Refers to the reliability (i.e., the ability 
to collect, manage, and provide data 
properly without failure) and 
availability (the ability to be operational 
when it is needed) of the public health 
surveillance system” (CDC, 2001, 
Section D.2.i.)
STEPs prioritized datasets 
published by reputable 
organizations such as the Nebraska 
Department of Health and Human 
Services, as well as the CDC and 
SAMHSA.
In addition to these characteristics, STEPs also prioritized datasets containing data not captured 
in existing Nebraska DHHS reports, as well as datasets containing data closely aligned with the 
CSTE Recommended Surveillance Indicators for Substance Abuse and Mental Health. 




STEPs identified 12 secondary datasets relevant to current and future evaluations. Utilizing the 
previously outlined criteria, STEPs selected three quality datasets that can be used over time. 
These selected datasets include the Nebraska Risk and Protective Factor Student Survey 
(NRPFSS), Nebraska Hospital Association Hospital Discharge Data (HDD), and Treatment 
Episode Data Set (TEDS). The tables on the following pages outline the datasets examined, their 
purpose, and reason for inclusion or exclusion.
Dataset Screening: Excluded from Analysis







SEDD, sponsored by the Agency 
for Healthcare Research and 
Quality, includes information on 
those emergency department 
visits that do not result in 
admission to determine 
longitudinal trends related to 
emergency department visits.
An alternative provider (Nebraska 
Hospital Association) of 
emergency department discharge 
data was recommended by DOP; 






SID, sponsored by the Agency for 
Healthcare Research and Quality, 
includes inpatient data for 
hospitals to determine 
longitudinal trends related to 
inpatient care.
An alternative provider (Nebraska 
Hospital Association) of inpatient 
discharge data was recommended 










BRFSS, published by the CDC, is a 
collection of adult health surveys 
informing prevention and health 
promotion efforts.
The information provided by BRFSS 
included little direct alignment with 
CSTE Recommended Surveillance 
Indicators for Substance Abuse and 
Mental Health.
CDC WONDER
(Centers for Disease 
Control and 
Prevention, 2018)
CDC WONDER, published by the 
CDC, is a collection of public health 
data available to the general public. 
CDC WONDER is intended to 
promote data-driven decisions and 
increase public access to public 
health data. 
Mortality-related data is already 
sufficiently included in the NE 
DHHS’ Division of Behavioral 
Health’s Substance Use, Mental 
Illness and Associated Consequences 
in Nebraska: An Epidemiological 
Profile report.
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Dataset Purpose Exclusion Reason









N-SSATS, published by SAMHSA, is 
a census of substance use 
treatment providers. N-SSATS 
aims to inform SAMHSA and state 
administrators on the trends and 
resource needs of treatment 
services. 
The information provided by N-
SSATS included little direct 
alignment with CSTE Recommended
Surveillance Indicators for Substance 
Abuse and Mental Health.
National Survey on 
Drug Use and 
Health (NSDUH)
(National Survey on 
Drug Use and 
Health, 2020)
NSDUH, published by SAMHSA, 
determines the prevalence of 
substance use and mental health 
disorders and the receipt of care.
Much of the publicly available data is 
state-level only; this state-level data 
is already sufficiently included in the 
NE DHHS’ Division of Behavioral 
Health’s Substance Use, Mental 
Illness and Associated Consequences 











PRAMS, published by CDC, collects 
data related to pre- and postnatal 
risk factors. PRAMS aims to 
identify at-risk populations and 
capture state changes in the health 
of mothers and infants.
The information provided by N-
SSATS included little direct 
alignment with CSTE Recommended
Surveillance Indicators for Substance 
Abuse and Mental Health.
Youth Risk Behavior 
Surveillance System 
(YRBS)
(National Center for 
HIV/AIDS, Viral 
Hepatitis, STD, and 
TB Prevention, 
2018)
YRBS, published by the CDC, 
collects information on the health 
behaviors of youth related to 
causes of death and disability. The 
purpose of YRBS is to understand 
the prevalence and trends of youth 
health behaviors.
YRBS data is already sufficiently 
included in the NE DHHS’ Division of 
Behavioral Health’s Substance Use, 
Mental Illness and Associated 
Consequences in Nebraska: An 
Epidemiological Profile report.
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Dataset Screening: Included in Analysis






NRPFSS, published by BOSR-
UNL, aims to assess 
students’ risk and protective 
factors related to substance 
use and other problem 
behaviors. 
NRPFSS data is available through request at no 
cost to researchers. Data is collected every other 
fall with reports made available the following 
spring/summer. Data can be disaggregated by 
health department district, grade, race, age, and 
gender. Data is related to evaluation questions 
regarding age of first substance use and trends 






TEDS-A, published by 
SAMHSA, captures 
admissions data to 
substance use and mental 
health treatment to better 
understand those receiving 
behavioral health care.
TEDS data is publicly available at no cost to 
researchers. Data is from trusted sources such 
as state-level administrative data and reported 
by SAMHSA, a leader in the field of substance 
use. Data can be disaggregated by location and 
demographic variable. Data is related to 
evaluation questions and recommended 
substance use indicators including access to and 
referrals to substance use treatment. TEDS data 
collection has remained relatively stable over 
time allowing for year-by-year analyses.
Additional state-level data was requested to 
provide more specific information about 






TEDS-D, published by 
SAMHSA, captures discharge 
data from substance use and 
mental health treatment to 
better understand those 












HDD, published by the 
Nebraska Hospital 
Association is used to track 
public health conditions and 
inform the development of 
interventions.
HDD is available on request to researchers for a 
small fee. This data source was referred to 
STEPs by DOP. Data can be disaggregated by 
health department district, age, length of stay, 
and gender. Data is related to evaluation 
questions and substance use indicators 
including hospitalizations related to substance 
use. 
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Dataset Availability and Release
After identifying the quality datasets, STEPs assessed the recency of data available and the next 
expected release of data. The following table outlines the data availability in the past 10 years, 
the most recent data available, and the next release of new data.
Dataset Availability and Release
Dataset
Years of Data 
Availability
Most Recent Data 
Available 
Next Expected Data 
Release
Nebraska Hospital 















Fall 2019 data received 
in March 2020
On request
Nebraska Risk and 





Fall 2018 data published 
in 2019
Fall 2020 data will be 
sent from BOSR-UNL 
to DHHS in mid-
spring 2021





2017 admissions data 
published in June 2019
Unknown; not 
enough information





2017 discharge data 
published in June 2019
Unknown; not 
enough information
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Appendix J
The diagnosis description data provided by NHA included 297 unique diagnosis 
descriptions. To analyze and interpret the diagnosis data, these unique descriptions needed 
to be condensed into a smaller number of categories. Based on the information provided in 
the diagnosis description, STEPs determined the most appropriate form of categorization 
for the current project would be by substance classification. STEPs utilized the Drug 
Enforcement Administration’s (2020) Drugs of Abuse: A DEA Resource Guide to determine 
drug classes for each diagnosis substance. The substances named in the diagnoses 
description and their associated categories are outlined in the table below.
Category Diagnosis Description Substances
Cannabis Cannabis, cannabis (derivatives)
Depressants Antiepileptic and sedative-hypnotic drugs;  barbiturates; 
benzodiazepines; sedative, hypnotic or anxiolytic
Hallucinogens Ecstasy, hallucinogen, lysergide, other psychodysleptics, 
unspecified psychodysleptics
Narcotics Heroin, methadone, opioid, opium, other narcotics, other 
opioids, other synthetic narcotics, unspecified narcotics
No substance 
specified*
Drug use complicating childbirth, drug use complicating 
pregnancy, drug use complicating the puerperium, 





Stimulants Amphetamines, caffeine, cocaine, methylphenidate, other 
psychostimulant, other stimulant, unspecified 
psychostimulants
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Appendix K
Below are additional data tables for the Nebraska Hospital Association (NHA) Inpatient 
Discharges data.
Patient Age in Years by Year (n=3,330)
The trend for patient age has remained stable over the past 4 years.
Patient Length of Stay in Days by Year (n=3,330)




2016 (n=824) 42 18
2017 (n=931) 41 17
2018 (n=911) 41 17
2019 (n=664) 41 17
Year
Average 
Length of Stay 
in Days SD
2016 (n=824) 4 4
2017 (n=931) 3 4
2018 (n=911) 4 4
2019 (n=664) 3 3
Patient Sex by Year (n=3,329)
The trend for the percentage of female and male patients has remained relatively stable over 
the past 4 years. 2019 was the only year where the percentage of males (51%) was greater than 
that of females (49%). 
Year
% of Female 
Patients
% of Male 
Patients
2016 (n=824) 53% 47%
2017 (n=931) 53% 47%
2018 (n=911) 52% 48%
2019 (n=664) 49% 51%
APPENDICES: Updated Dataset Results 
2016 (n=824) 2017 (n=931) 2018 (n=911) 2019 (n=664)
Depressants 36% 34% 32% 29%
Stimulants 21% 25% 27% 32%
Narcotics 28% 26% 25% 21%
Cannabis 3% 4% 4% 6%
Hallucinogens 1% 1% 2% 1%
Other psychoactive 
substances 7% 6% 6% 8%
No substance specified* 3% 4% 5% 4%
Appendix K (cont.)
Substance Related to Patient Diagnosis by Year  (n=3,330)
Except for diagnoses related to depressants, narcotics, and stimulants (discussed within the 
body of the report), the percentage of diagnoses related to other substances has remained 
consistent over the past 4 years.
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Behavioral Health 
Region 2016 2017 2018 2019
Region 1 (n=83) 17 23 24 19
Region 2 (n=176) 37 47 38 54
Region 3 (n=250) 50 64 59 77
Region 4 (n=146) 35 49 28 34
Region 5 (n=536) 104 140 156 136
Region 6 (n=1,277) 319 330 336 292
Out of State (n=199) 46 48 55 50
Number of Inpatient Treatment Discharges by Behavioral Health Region and Year 
(n=2,667)
The number of inpatient discharges between January 1 and September 30 of each year is 
shown below for each behavioral health region. The comparison includes only discharges 
during this time as quarter 4 data for 2019 was not yet available at the time of this report.
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Percent of Female Patients by Behavioral Health Region and Year (n=3,324)
Overall, no trend related to the percentage of female patients by behavioral health region and 
year can be discerned in this data. 
Patient Age by Behavioral Health Region and Year (n=3,325)
Overall, no trend related to the average age of patients by region and year can be discerned in 
this data. One trend that may be emerging in Region 3 would be the decrease in average age, 
which began in 2017.
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Behavioral Health 
Region 2016 2017 2018 2019
Region 1 (n=102) 37 40 34 46
Region 2 (n=218) 45 45 40 40
Region 3 (n=311) 39 42 40 37
Region 4 (n=191) 47 39 42 40
Region 5 (n=671) 40 39 41 39
Region 6 (n=1,582) 43 41 43 43
Out of State (n=250) 39 37 39 42
Behavioral Health 
Region 2016 2017 2018 2019
Region 1 (n=102) 30% 67% 30% 58%
Region 2 (n=218) 69% 60% 63% 44%
Region 3 (n=311) 52% 43% 43% 48%
Region 4 (n=191) 47% 64% 52% 44%
Region 5 (n=670) 43% 49% 47% 46%
Region 6 (n=1,582) 56% 55% 55% 51%
Out of State (n=250) 60% 46% 57% 54%
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Behavioral Health 
Region 2016 2017 2018 2019
Region 1 (n=102) 3 3 3 5
Region 2 (n=218) 3 3 3 4
Region 3 (n=311) 5 4 4 3
Region 4 (n=191) 4 4 4 4
Region 5 (n=671) 3 3 4 3
Region 6 (n=1,582) 3 3 4 3
Out of State (n=250) 5 5 3 4
Appendix K (cont.)
Patient Length of Stay in Days by Behavioral Health Region and Year (n=3,325)
Overall, no trend related to the average length of stay by region and year can be discerned in 
this data.
Substance Related to Diagnosis by Behavioral Health Region and Year 
The tables below and on the following two pages show the percentage of inpatient discharges 











Depressants 26% 36% 22% 58% 34%
Stimulants 30% 9% 19% 26% 20%
Narcotics 22% 21% 30% 5% 21%
Cannabis 4% 3% 7% 0% 4%
Other 
psychoactive 
substances 17% 3% 15% 0% 9%
No substance 
specified 0% 27% 7% 11% 13%
Region 1












Depressants 31% 34% 30% 28% 31%
Stimulants 11% 8% 25% 33% 19%
Narcotics 24% 32% 28% 17% 25%
Cannabis 4% 6% 2% 2% 3%
Other 
psychoactive 
substances 28% 21% 12% 17% 19%
No substance 













Depressants 37% 26% 21% 13% 23%
Stimulants 28% 44% 37% 58% 42%
Narcotics 25% 16% 22% 16% 19%
Cannabis 2% 4% 2% 4% 3%
Hallucinogens 2% 0% 2% 1% 1%
Other 
psychoactive 
substances 5% 6% 8% 3% 5%
No substance 
specified 3% 4% 9% 5% 5%
Region 3












Depressants 18% 27% 34% 24% 26%
Stimulants 20% 33% 23% 18% 25%
Narcotics 41% 19% 27% 21% 27%
Cannabis 2% 2% 2% 12% 4%
Hallucinogens 0% 2% 2% 0% 1%
Other 
psychoactive 
substances 16% 13% 9% 21% 14%
No substance 













Depressants 36% 30% 34% 28% 32%
Stimulants 27% 27% 24% 38% 28%
Narcotics 26% 34% 28% 23% 28%
Cannabis 3% 2% 5% 3% 3%
Hallucinogens 1% 2% 1% 0% 1%
Other 
psychoactive 
substances 3% 3% 4% 7% 4%
No substance 
specified 4% 4% 4% 2% 4%
Region 5












Depressants 38% 38% 34% 34% 36%
Stimulants 18% 22% 28% 24% 23%
Narcotics 32% 26% 24% 21% 26%
Cannabis 2% 6% 3% 9% 5%
Hallucinogens 1% 1% 2% 1% 1%
Other 
psychoactive 
substances 5% 5% 5% 7% 5%
No substance 
specified 4% 2% 3% 4% 3%
Appendix K (cont.)
Region 6
APPENDICES: Updated Dataset Results 
146
Appendix L
Below are additional data tables for the Nebraska Hospital Association (NHA) Emergency 
Department Discharges data.
Patient Age in Years by Year (n=7,712)
The trend for patient age has remained stable over the past 4 years.
Patient Length of Stay in Days by Year (n=7,712)
The trend for patients’ lengths of stay has remained stable over the past 4 years.
Year
Average Age in 
Years SD
2016 (n=1,938) 34 17
2017 (n=1,914) 33 16
2018 (n=2,185) 34 16
2019 (n=1,675) 34 16
Year
Average 
Length of Stay 
in Days SD
2016 (n=1,938) 1 1
2017 (n=1,914) 1 0
2018 (n=2,185) 1 1
2019 (n=1,675) 1 0
Patient Sex by Year (n=7,709)
The percentage of male patients increased slightly in 2017 and 2018. The percentage of male 
and female patients in 2019 remained unchanged from 2018.
Year
% of Female 
Patients
% of Male 
Patients
2016 (n=1,938) 49% 51%
2017 (n=1,914) 48% 52%
2018 (n=2,185) 46% 54%
2019 (n=1,672) 46% 54%
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Behavioral Health 
Region 2016 2017 2018 2019
Region 1 (n=362) 46% 54% 47% 48%
Region 2 (n=246) 67% 69% 55% 52%
Region 3 (n=741) 53% 56% 59% 51%
Region 4 (n=385) 61% 54% 55% 49%
Region 5 (n=1,851) 48% 43% 39% 44%
Region 6 (n=3,719) 46% 47% 46% 45%









Depressants 22% 22% 20% 17%
Stimulants 25% 29% 33% 37%
Narcotics 25% 23% 20% 16%
Cannabis 9% 11% 12% 13%
Hallucinogens 2% 2% 2% 3%
Other psychoactive 
substances 17% 13% 13% 13%
No substance specified* 0% 0% 1% 1%
Appendix L (cont.)
Substance Related to Diagnosis by Year  (n=7,712)
Diagnoses related to depressants, narcotics, and stimulants, as discussed within the body of the 
report, have changed over time. The percentage of diagnoses related to cannabis have 
increased over time. The percentage of diagnoses related to other substances has remained 
consistent over the past 4 years.
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Percent of Female Patients by Behavioral Health Region and Year (n=7,709)
Overall, no trend related to the percentage of female patients by behavioral health region and 
year can be discerned in this data. However, it is worth noting Regions 2, 3, and 4 have 
consistently had higher percentages of female than male patients, which differs from the overall 
trend.
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Patient Age by Behavioral Health Region and Year (n=7,712)
Overall, no trend related to the average age of patients by region and year can be discerned in 
this data. 
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Behavioral Health Region 2016 2017 2018 2019
Region 1 (n=362) 1 1 1 1
Region 2 (n=246) 1 1 1 1
Region 3 (n=741) 1 1 1 1
Region 4 (n=385) 1 1 1 1
Region 5 (n=1,853) 1 1 1 1
Region 6 (n=3,719) 1 1 1 1
Out of State (n=406) 1 1 1 1
Behavioral Health Region 2016 2017 2018 2019
Region 1 (n=362) 37 35 37 35
Region 2 (n=246) 35 37 38 36
Region 3 (n=741) 35 35 35 33
Region 4 (n=385) 36 34 37 34
Region 5 (n=1,853) 33 32 34 34
Region 6 (n=3,719) 33 33 33 34
Out of State (n=406) 35 34 33 34
Patient Length of Stay in Days by Behavioral Health Region and Year (n=7,712)
The average length of stay has not varied across behavioral health regions or years for the past 
4 years.
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Substance Related to Patient Diagnosis by Behavioral Health Region and Year 
The tables on the following three pages show the percentage of emergency department 












Depressants 17% 20% 14% 27% 19%
Stimulants 29% 31% 18% 32% 27%
Narcotics 31% 32% 34% 22% 31%
Cannabis 15% 9% 15% 5% 12%
Hallucinogens 2% 0% 1% 5% 2%
Other 
psychoactive 












Depressants 41% 34% 25% 33% 33%
Stimulants 19% 32% 27% 30% 27%
Narcotics 30% 24% 28% 22% 26%
Cannabis 3% 3% 5% 7% 4%
Other 
psychoactive 
substances 6% 6% 12% 9% 9%
No substance 
specified 0% 0% 3% 0% 1%
Region 2











Depressants 25% 31% 30% 24% 28%
Stimulants 25% 28% 26% 32% 28%
Narcotics 31% 19% 21% 18% 23%
Cannabis 7% 11% 11% 15% 11%
Hallucinogens 2% 1% 0% 1% 1%
Other 
psychoactive 














Depressants 20% 18% 28% 22% 22%
Stimulants 24% 32% 30% 40% 31%
Narcotics 29% 27% 25% 12% 24%
Cannabis 8% 11% 5% 12% 9%
Hallucinogens 1% 0% 3% 4% 2%
Other 
psychoactive 
substances 17% 12% 9% 10% 12%
No substance 
specified 1% 0% 0% 0% 0%
Region 4











Depressants 22% 17% 22% 15% 19%
Stimulants 26% 28% 35% 35% 31%
Narcotics 19% 22% 17% 15% 18%
Cannabis 8% 10% 9% 8% 9%
Hallucinogens 2% 2% 1% 1% 2%
Other 
psychoactive 
substances 22% 22% 16% 25% 21%
No substance 














Depressants 21% 23% 18% 15% 19%
Stimulants 25% 28% 35% 39% 32%
Narcotics 24% 24% 18% 14% 20%
Cannabis 10% 12% 13% 17% 13%
Hallucinogens 3% 3% 3% 4% 3%
Other 
psychoactive 
substances 17% 9% 11% 9% 12%
No substance 
specified 0% 1% 1% 1% 1%
Region 6
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Appendix M
Below are additional data tables for the Treatment Episode Data Set–Discharges (TEDS-D).
Client Age at Admission by Year 
Overall, no trend related to the age of clients by year can be discerned in this data. One trend 
that may be emerging would be an increase in clients between the ages of 21 and 39 years.
Client Race by Year
Overall, no trend related to the race of clients by year can be discerned in this data. “Other” 
race includes clients who identified as Alaska Native, Asian or Pacific Islander, Asian, other 













2013 (n=10,103) 5% 26% 26% 24% 18%
2014 (n=8,275) 6% 27% 25% 21% 20%
2015 (n=8,831) 6% 28% 27% 21% 18%
2016 (n=13,198) 5% 28% 30% 20% 17%







2013 (n=10,060) 78% 10% 9% 3%
2014 (n=8,251) 82% 8% 8% 2%
2015 (n=8,831) 81% 9% 7% 2%
2016 (n=12,873) 80% 10% 7% 4%
2017 (n=9,553) 77% 10% 7% 6%
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Appendix M (cont.)
Client Education by Year 
Overall, no trend related to the number of school years completed by clients by year can be 
discerned in this data. One trend that may be emerging would be an increase in clients who 
have at least 12 years of education or a GED.
Client Employment Status at Admission by Year









2013 (n=9,483) 50% 20% 30%
2014 (n=7,569) 50% 18% 32%
2015 (n=7,998) 51% 18% 31%
2016 (n=11,449) 51% 18% 31%
2017 (n=7,752) 53% 18% 29%
Year Full-time Part-time Unemployed
Not in Labor 
Force
2013 (n=10,096) 16% 9% 34% 41%
2014 (n=8,272) 18% 9% 32% 40%
2015 (n=8,820) 20% 9% 31% 40%
2016 (n=12,449) 20% 9% 33% 38%
2017 (n=8,529) 22% 10% 32% 36%
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Appendix M (cont.)
Client Source of Income/Support by Year
Similar to the increase in employed clients, an increase in the percentage of clients who 
reported receiving an income of wages or salary may be an emerging trend.
Client Length of Stay in Treatment (Days) by Year 
The length of stay in treatment remained relatively constant between 2013 and 2017. A slight 









2013 (n=10,015) 29% 2% 10% 9% 49%
2014 (n=8,195) 31% 2% 8% 6% 53%
2015 (n=8,735) 32% 1% 7% 6% 54%
2016 (n=12,380) 32% 1% 5% 5% 57%
2017 (n=8,254) 34% 1% 5% 4% 56%
Year 1  Day 2-30 Days 31-90 Days 91 Days and Over
2013 (n=10,103) 35% 28% 18% 19%
2014 (n=8,275) 32% 28% 17% 23%
2015 (n=8,831) 29% 32% 18% 21%
2016 (n=13,198) 25% 29% 19% 26%
2017 (n=10,162) 27% 31% 23% 20%
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Appendix M (cont.)
Substance Use at Admission (Primary) by Year
Between 2013 and 2017, the rate of clients reporting alcohol as their primary substance 
gradually decreased while reports of stimulant use gradually increased. The use of marijuana, 
opioids, depressants, and other substances stayed relatively constant. “Other” includes 
hallucinogens and over-the-counter medications.
Year Alcohol Depressants Stimulants Opioid Marijuana Other None
2013 
(n=10,062) 65% 0% 19% 4% 10% 0% 2%
2014 
(n=8,262) 64% 0% 19% 4% 10% 1% 2%
2015 
(n=8,820) 59% 0% 22% 5% 11% 1% 2%
2016 
(n=13,176) 55% 0% 26% 4% 10% 1% 5%
2017 
(n=10,159) 52% 0% 28% 4% 11% 0% 5%
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*Appendix N
Below is the additional data table for the detailed referral sources, as provided by NE DHHS 
Division of Behavioral Health Data Centralized Data System.
Detailed Referral Source by Year
Overall, no trend related to the referral source by year can be discerned in this data. As 















Agency 2.9% 2.7% 2.5% 3.0% 3.7%
Community: Employer or 
Employee Assistance 
Program (EAP) 0.3% 0.3% 0.2% 0.2% 0.1%
Community: Family or Friend 3.6% 3.9% 4.0% 3.3% 2.6%
Community: Homeless 
Shelter 0.5% 0.9% 0.9% 0.8% 0.7%
Community: Nebraska Family 
Helpline 0.0% 0.0% 0.0% 0.0% 0.0%
Community: Nebraska 
Vocational Rehabilitation 0.0% 0.0% 0.0% 0.0% 0.0%
Community: School 0.6% 0.5% 0.4% 0.3% 0.2%
Community: Self-Help Group 0.2% 0.2% 0.1% 0.2% 0.2%
Community: Tribal Elder or 
Official 0.0% 0.0% 0.0% 0.0% 0.0%
Emergency/Crisis MH 
Services 0.2% 0.1% 0.1% 0.3% 0.7%
Emergency/Crisis SUD 
Services 2.6% 2.6% 2.4% 1.9% 1.4%
Justice System:  Pre-trial 
Diversion 0.4% 0.5% 0.5% 0.3% 0.3%
Justice System: Corrections 1.0% 1.2% 1.5% 1.0% 1.0%
*Appendix added on 8/6/2020













Justice System: Court Order 5.0% 4.5% 4.5% 5.1% 4.6%
Justice System: Court Referral 2.1% 1.8% 1.3% 1.8% 1.1%
Justice System: Defense 
Attorney 5.4% 5.6% 5.4% 4.7% 5.0%
Justice System: Drug Court 1.3% 1.8% 1.6% 1.6% 1.1%
Justice System: Law 
Enforcement Agency (e.g. 
Police/Sheriff/Highway 
Patrol) 26.8% 28.9% 27.3% 26.8% 26.2%
Justice System: Mental Health 
Court 0.1% 0.1% 0.1% 0.1% 0.0%
Justice System: Parole 1.0% 1.1% 1.5% 1.9% 1.5%
Justice System: Probation 7.6% 8.2% 8.2% 8.9% 9.8%
Justice System: Prosecutor 0.0% 0.0% 0.1% 0.1% 0.0%
MH Commitment Board 1.1% 0.9% 0.9% 0.7% 0.5%
Not Available 0.4% 0.5% 0.6% 3.7% 7.4%
Other 0.0% 0.0% 0.0% 1.9% 2.0%
Provider: Medical/Health 
Care Provider 4.0% 3.7% 3.4% 2.6% 2.5%
Provider: MH Services 
Provider 1.0% 0.6% 0.8% 1.1% 1.1%
Provider: SUD Services 
Provider 10.3% 10.6% 10.3% 9.2% 8.6%
Regional Behavioral Health 
Authority 0.0% 0.0% 0.0% 0.0% 0.0%
Regional Center/State 
Psychiatric Hospital 0.2% 0.1% 0.1% 0.3% 0.1%
Self (e.g. Self/Internet/Yellow 
Pages) 21.4% 18.9% 21.1% 18.2% 17.2%
*Appendix added on 8/6/2020
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*Appendix O
Below are the additional data tables for the Nebraska Risk and Protective Factor Student 
Survey.
Percentage of Youth Identifying as Female Lifetime Substance Use by Substance and Year
Overall, no trend related to the reported lifetime use by substance and year could be discerned 
in this data. The greatest percentage of youth identifying as female reported using prescription 
drugs and inhalants.
Percentage of Youth Identifying as Male Lifetime Substance Use by Substance and Year
Overall, no trend related to the reported lifetime use by substance and year could be discerned 




Psychedelics Cocaine/Crack Meth Inhalants
Prescription 
Drugs
2010 2% 1% 1% 6% 7%
2012 1% 1% 1% 5% 5%
2014 2% 1% 1% 4% 5%
2016 2% 1% 0% 3% 6%
2018 2% 1% 1% 4% 5%
Year
LSD/Other 
Psychedelics Cocaine/Crack Meth Inhalants
Prescription 
Drugs
2010 2% 2% 1% 6% 7%
2012 2% 1% 1% 4% 5%
2014 2% 2% 1% 3% 4%
2016 3% 2% 1% 3% 5%
2018 3% 1% 0% 4% 4%
*Appendix added on 8/6/2020
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Appendix P: Full Methodology
Through semi-structured interviews, STEPs collected qualitative data from drug treatment 
providers in Nebraska. STEPs analyzed the data to identify information and themes relevant to 
the NE DHHS Drug Overdose Prevention program. The analysis answered two primary 
questions:
1. What insights regarding drug use behaviors do drug treatment providers in Nebraska 
have that may inform drug use prevention planning?
2. What are the professional needs of drug treatment providers in Nebraska?
Sampling
Through the survey component of the Drug Use Behaviors project, 77 drug treatment providers 
in Nebraska identified that they were willing to participate in a follow-up study and provided 
an email address for follow-up. These providers formed the sample pool for the qualitative 
component. 
STEPs’ initial sampling procedure called for all potential participants to be grouped by the 
primary behavioral health region that they serve and for potential participants to be randomly 
selected from each regional group for an interview request. The purpose of these sampling 
procedures was to maximize geographic representation within the qualitative component 
while providing a systematic process for contacting and scheduling interviews with potential 
participants. These procedures were designed to allow for theoretical sampling (Charmaz, 
2014), an iterative process of simultaneous data collection and initial coding. In theoretical 
sampling, rounds of data collection and initial coding continue until the emergent codes and 
categories are saturated, at which point data collection is complete. While there can be 
significant variability, saturation generally occurs between 15 and 30 participants.
Using this procedure, STEPs sent out an initial interview request to 17 potential participants on 
April 2, 2020. After 10 days, we had received one decline and no response from the rest of the 
potential participants. This was a very low response rate, especially from a pool of potential 
participants who had recently completed another evaluation and had indicated interest in 
participating in future studies. Many factors may have affected potential participants' ability or 
willingness to respond and complete an interview. However, STEPs staff speculated that the 
growing threat and realities of the COVID-19 pandemic, which was emerging at the same time 
as participant recruitment was taking place, may have been a particularly salient factor. 
APPENDICES: Treatment Provider Qualitative Interviews
Purpose
The purpose of the qualitative component of the Drug Use Behaviors project was to provide NE 
DHHS with rich and in-depth information regarding the professional experiences and needs of 
drug treatment providers in Nebraska. From the perspectives and insights of drug treatment 
providers, NE DHHS can better understand the experiences and needs of people with substance 
use disorders in Nebraska. 
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Appendix P: Full Methodology (cont.)
At this point, STEPs staff judged that potential risks of the initial sampling procedure–
inadequate sample size and delayed data collection–outweighed the potential benefits–
maximizing geographic diversity and avoiding over-saturation. In place of the original sampling 
procedures, STEPs staff implemented a new procedure that called for all potential participants 
to be contacted with an interview request and to schedule all interviews at the participants’ 
earliest convenience. Between April 13, 2020 and April 18, 2020, all potential participants were 
sent an interview request, including a follow-up request to the initial potential participant 
group. On May 13, 2020 all potential participants were sent a follow-up request. 
After implementing the new sampling protocol, STEPs received more responses from potential 
participants. It may have been that the new sampling procedure was better suited to quickly 
identify interested participants, which the previous procedure would have slowly identified 
over multiple rounds of targeted recruitment. It is also possible that potential participants had 
better adjusted to the new realities of the pandemic at this point and had greater capacity to 
participate. In total, STEPs conducted 17 interviews with 18 participants between the dates of 
April 29, 2020 and June 2, 2020. See Appendix B for interview request template and Appendix 
C for the consent handout. 
Data Collection
STEPs conducted semi-structured interviews to collect data for the qualitative component. 
STEPs conducted interviews over Zoom, an online videoconferencing service, at a time that was 
convenient for participants. Both qualitative researchers and research participants have found 
Zoom to be a highly satisfactory method of conducting interviews, highlighting its convenience 
and user-friendliness (Archibald, Ambagtsheer, Casey, & Lawless, 2019). STEPs scheduled all 
interviews for 30 minutes. Actual interview times ranged from 24 minutes to 46 minutes, with 
an average interview time of 34 minutes. STEPs audio recorded the interviews and all 
interviews were professionally transcribed to ensure accuracy for analysis. 
The STEPs interviewer was guided by the interview protocol (see Appendix D). STEPs staff 
collaboratively developed the interview protocol, drawing on multiple conversations with the 
NE DHHS Drug Overdose Prevention Program staff to identify their information goals and 
needs. The interview protocol was designed to facilitate a conversation with participants 
around their professional experiences and needs, the experiences and needs of their clients 
with substance use disorders, the participants’ thoughts and ideas on how to reduce drug 
overdoses in Nebraska, as well as their needs regarding and perceptions of NE DHHS. The 
interview protocol consisted of six primary questions and multiple, tentative follow-up 
questions. The STEPs interviewer engaged participants consistently with the six primary 
questions, but was flexible in follow-up questions in order to elicit data that was both relevant 
and rich. 
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Appendix P: Full Methodology (cont.)
Sample Description
The sample pool for the qualitative component came from a subsect of participants from the 
quantitative survey component of the Drug Use Behaviors project. The two samples share 
common parameters, such as being comprised entirely of substance use treatment providers in 
Nebraska. Substance use treatment providers support individuals’ ability to understand and 
overcome their substance use disorder and maintain recovery.
Providers Offer
• Intake, assessment, and treatment planning,
• Counseling for individuals, groups, and significant others,
• Case management and crisis intervention, and
• Referrals to medical providers and other professionals when appropriate.
Providers Support
• Individuals with substance use, mental health, or co-occurring disorders, and
• Clients in self-help recovery groups, outpatient treatment, intensive outpatient 
treatment, residential or inpatient treatment, or continuing care.
Common Licenses Held by Providers
• Licensed or Provisionally Licensed Alcohol and Drug Counselor (LADC/PLADC),
• Licensed Mental Health Practitioner (LMHP), and
• Licensed Independent Clinical Social Worker (LICSW).
Substance Use 
Treatment Providers Medical Providers
• Prescribe medication; 
provide medical care
• Includes doctors, 
psychiatrists, physicians 
assistants, nurses and nurse 
practitioners
• Refer to substance use 
treatment providers for 
mental and emotional 
health needs
Both
• Provide therapy, crisis 
counseling, and case 
management
• Include social workers, 
counselors, and case 
managers
• Refer to medical 
providers for physical 
health needs





• Collaborate with 
other professionals 
to meet client 
needs
APPENDICES: Treatment Provider Qualitative Interviews
162
Appendix P: Full Methodology (cont.)
Years of Experience
Participants varied in length of experience from 1 year to 33 years. On average, participants 
indicated working in the field of substance abuse treatment for 10 years. In some cases, years 
working in the field included roles other than direct treatment provision, such as 
administration or case management. 
Licenses Held
Participants held a variety of licenses. The most frequently held were Licensed Alcohol and 
Drug Counselor (LADC) and Licensed Independent Mental Health Practitioner (LIMHP). The 
table below illustrates the variety of licenses held by participants. Similar to the quantitative 
survey respondent demographics, LIMHP, LMHP, and LPC were the most frequently held license 
besides LADC and PLADC.  
License Type Total
Licensed Alcohol and Drug Counselor 11
Licensed Independent Mental Health Practitioner 10
Licensed Mental Health Practitioner 7
Provisional Licensed Alcohol and Drug Counselor 6
Licensed Professional Counselor 4
Licensed Master Social Worker 3
Provisional Licensed Mental Health Practitioner 2
Osteopathic Physician and Surgeon 1
Provisional Dispensing Practitioner Pharmacy License 1
Least Years of 
Experience:
1
Average Years of 
Experience:
10
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Geographic Regions Served
STEPS identified four geographic regions for the purpose of the report: West, Rural East, 
Omaha Metro, and Lancaster. The number in each region represents the number of participants 
who provided services in each region. Some participants provided services in multiple regions. 
The most frequently served region within the sample was Lancaster County and the Omaha 
Metro.
Practice Settings and Roles
Participants represented a variety of practice settings and roles. These settings included 
nonprofits, private practice, corrections, residential treatment, and hospitals. Participants’ 
roles in their agencies included clinical director, clinical supervisor, community outreach, 
outpatient therapist providing evaluations and treatment, and intake coordinator, and medical 
provider. Many participants played multiple roles within their agency such as clinical 
supervisor and outpatient therapist.
Omaha Metro – 8
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Data Analysis
STEPs analyzed the data using the methods of constructivist grounded theory (Charmaz, 2014). 
While the purpose of the project is not to develop theory, the stages of initial coding, focused 
coding and categorization, and theory development provided structure and rigor to the data 
analysis process. 
In the initial coding stage, two STEPs staff independently coded the interview transcripts. The 
goal at the initial coding stage was to identify significant statements with tentative codes. STEPs 
prioritized the use of gerund coding, using verbs that end in “–ing” in order to capture action 
within the data. Descriptive coding, which labeled data based on the topic or theme, and in-vivo 
coding, which labeled data using the participants’ own words, were also used when 
appropriate. STEPs’ use of multiple coding strategies allowed a flexible  approach to the data 
and, in combination with multiple coders, allowed the construction of a wide variety of initial 
codes for subsequent rounds of analysis.  
From the initial coding stage, STEPs staff progressed to focused coding and categorization. In 
this stage, STEPs staff identified and clustered initial codes that were conceptually similar or 
overlapping. Within these emergent categories, redundant initial codes were merged and new, 
overarching codes were developed for overlapping, but conceptually distinct, initial codes. 
STEPs staff then reviewed all the categories and codes and, through a consensus process, 
identified the categories and codes that were most crucial to telling the authentic narrative of 
the data. Guiding questions included, “Is this code necessary to tell the story of the data?” and 
“Would our report be incomplete without this code?” and “Would our participants be surprised 
or disappointed if they read our report and didn’t see this?” These questions pushed STEPs 
staff to elevate categories and codes with the greatest relevance, insight, and analytic power. 
After the focused coding and categorization stage, STEPs staff engaged in a theory development 
stage. The purpose of this stage was not to develop a theory in the traditional sense, but to 
identify meaningful relationships between the categories and codes that could tell a narrative 
about the data. Guiding questions within this stage included “What codes have led to this 
code?” and “What codes are caused by this code?” and “What codes could address this code?” 
As STEPs staff identified and developed relationships between categories and codes, 
disconfirming evidence and dissenting voices were identified within the data. STEPs also 
sought to identify how diverse identities, experiences, and contexts might affect the 
relationships. STEPs specifically looked for codes and data that addressed the role of race, 
socioeconomic status, gender and parenting status, and geography. 
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STEPs then reviewed the focused codes, categories, and relationships and elevated some, 
guided by similar questions as in the previous round of elevating.
Additionally, in this round, STEPs looked specifically for focused codes, categories, and 
relationships that may be actionable in some way by the Drug Overdose Prevention program or 
other stakeholders. STEPs staff developed recommendations based on these focused codes, 
categories, and relationships. 
Throughout this process, STEPs staff used MAXQDA software to facilitate data analysis. STEPs 
used a two-coder system with all data initially coded independently. The two coders 
collaborated and sought consensus in all subsequent stages. While the data analysis involved 
progressive stages of analysis, the process was not strictly linear. At all stages of data analysis, 
STEPs staff engaged in memoing, in which they captured initial impressions and 
understandings of the data, including tentative ideas and hunches regarding later stages of data 
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Appendix Q: Interview Request Template
Initial Email to Treatment Providers
Hello  ______________. 
Thank you for your recent participation in the Drug Use Behaviors Treatment Provider Survey!
At the conclusion of that survey, you indicated your willingness to participate in a follow-up 
interview. We are excited to include you in this portion of our project, and we are thankful for 
your interest in sharing your time and experience with us. 
The Nebraska Department of Health and Human Services (DHHS) Division of Public Health has 
contracted with the University of Nebraska at Omaha’s STEPs (Support and Training for the 
Evaluation of Programs) to conduct follow-up interviews with select treatment providers 
across Nebraska. The purpose of these interviews is to hear directly the voices and 
experiences of outpatient treatment providers on issues relevant to drug overdose prevention 
in Nebraska. Participating in this interview is an opportunity for your agency to confidentially 
share your perspectives and needs with Nebraska DHHS and other relevant stakeholders. 
Interviews will be scheduled at a time that is convenient for you, and they will take place over 
Zoom, an online videoconferencing service. Zoom is user-friendly and participants can 
connect via internet or phone, so there is no travel, no software, and no camera required. We 
anticipate the interview will take approximately 30 minutes. More information can be found in 
the consent document attached to this email. 
If you are still willing and able to participate in the follow-up interview portion of our project, 
please confirm by responding to this email by XX.XX.2020. Please include in your response 2-3 
dates/times that would work best for you within the date range of XX.XX.2020 to XX.XX.2020. 
We look forward to hearing from you. 
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Appendix R: Consent Handout
Consenting Information
Drug Use Behaviors 
Treatment Provider Interviews
Thank you for your interest in participating in a treatment provider interview. Interviews are 
being conducted through the Support and Training of the Evaluation of Programs (STEPs) at 
the University of Nebraska at Omaha. Nebraska Department of Health and Human Services 
(NE DHHS) Division of Public Health has contracted with STEPs to complete a needs 
assessment for the Drug Overdose Prevention (DOP) Program. The purpose of the DOP Drug 
Use Behaviors project is to equip NE DHHS with the information necessary to develop effective 
drug use prevention plans, as well as provide relevant trainings and resources for treatment 
providers. Hearing directly from treatment providers is crucial to the development of those 
plans. 
What will happen during the interview?
The interview will last approximately 30 minutes. The interview will be scheduled at a time 
that is convenient for you and will take place over Zoom, an online videoconferencing service. 
Zoom is user friendly and participants can connect over the internet or by phone, no software 
or camera required.  A link and phone number to connect with Zoom will be emailed to you 
prior to your interview. The interview will consist of several open-ended questions regarding 
your professional experiences and perspectives on drug use behaviors in Nebraska. You can 
opt out of any question or opt out of the interview at any time. STEPs will record the interview 
in order to best capture your perspectives and have a transcript of our conversation. 
What will happen after the interview?
STEPs will analyze the transcript, along with the transcripts from other interviews, in order to 
develop a report. Your participation in the interview will be kept confidential and no 
personally identifying information will be included in the report. The report will be given to 
NE DHHS, who may distribute it to relevant stakeholders. At your request, a copy of the report 
can also be made available to you. 
Why should I participate?
There are no direct, material benefits or incentives for you participating in the interview. 
However, by sharing your professional experiences and perspectives, you can ensure that your 
voice is heard by NE DHHS and other stakeholders as they develop plans relevant to your 
work. By including the voices of treatment providers, we hope to improve drug overdose 
prevention and treatment efforts in Nebraska.
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Appendix R: Consent Handout (cont.)
Consenting Information (cont.)
If I have questions about the interview, who can I ask?
If you have any questions prior to or after the interview, you can contact STEPs:
Liam Heerten-Rodriguez, PhD
STEPs Faculty Affiliate
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Appendix S: Full Interview Protocol
Interview Protocol
1. Please tell me a little about your professional role involving drug treatment.
• How long have you been doing this work? 
• How have things changed since you started in the field?
2. Please tell me a little about the clients that you serve.
• Would you say that there’s any “typical” story among your clients? Or something that 
all or most of them have in common?
• When you think about your clients’ strengths, what comes to mind? 
• What do you think your clients would want NE DHHS to know about them or their 
experiences?
• NE DHHS is especially interested the experiences and needs of women of 
childbearing age. In what ways, if any, are their experiences or needs different than 
those of other clients?
3. Please tell me about a time when you could have done your job better if you had the 
resources that you needed,
• Resources might include things like information or research, training, services, or 
policies.
• What would have been different if you had had that resource?
• Why do you think you don’t have access to that resource?
4. What’s one change to the current system that you believe would reduce drug overdoses?
• Why do you think that change would be effective? 
• Who do you believe is responsible for making that change?
• How likely do you think the change is?
• What barriers do you think stand in the way of the change?
• Are there any current opportunities that might make the change more likely?
5. What would it look like if NE DHHS were to be a full partner to you in your work? 
• How would that be different from how you perceive their current role?
• What impact do you think that would have on your clients or on drug overdoses?
6. What else would you like NE DHHS to know?
• Why do you want them to know that?
• What do you want them to do differently because of that information?
• How will you know that DHHS has gotten your message?
* The bulleted prompts listed after each question are meant to be flexible guides to help keep 
the conversation going and to dig deeper into what the interviewee is sharing. Not all prompts 
need to be asked. We may also need to ask prompts that are not listed here. The goal is always 
to dig deeper, eliciting stories, examples, and meaning from the interviewee. At any point in 
the interview in which the experiences or needs of women of a childbearing age might be 
relevant, we will ask specific follow-up questions. 
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